QUARTERLY REPORT

Q2 2024 — Quarterly report on Form 10-Q

Q2 2024PDF · 161 pages1.5 MB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 28, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 001-02217
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware 58-0628465
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta Georgia 30313
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.25 Par Value KO New York Stock Exchange
1.875% Notes Due 2026 KO26 New York Stock Exchange
0.750% Notes Due 2026 KO26C New York Stock Exchange
1.125% Notes Due 2027 KO27 New York Stock Exchange
0.125% Notes Due 2029 KO29A New York Stock Exchange
0.125% Notes Due 2029 KO29B New York Stock Exchange
0.400% Notes Due 2030 KO30B New York Stock Exchange
1.250% Notes Due 2031 KO31 New York Stock Exchange
3.125% Notes Due 2032 KO32 New York Stock Exchange
0.375% Notes Due 2033 KO33 New York Stock Exchange
0.500% Notes Due 2033 KO33A New York Stock Exchange
1.625% Notes Due 2035 KO35 New York Stock Exchange
1.100% Notes Due 2036 KO36 New York Stock Exchange
0.950% Notes Due 2036 KO36A New York Stock Exchange
0.800% Notes Due 2040 KO40B New York Stock Exchange
1.000% Notes Due 2041 KO41 New York Stock Exchange
3.500% Notes Due 2044 KO44 New York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to
file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

-- 1 of 161 --

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. ☐
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
Class of Common Stock Shares Outstanding as of July 25, 2024
$0.25 Par Value 4,309,868,150

-- 2 of 161 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page
Forward-Looking Statements 1
Part I. Financial Information
Item 1. Financial Statements 2
Consolidated Statements of Income — Three and Six Months Ended June 28, 2024 and June 30, 2023 2
Consolidated Statements of Comprehensive Income — Three and Six Months Ended June 28, 2024 and
June 30, 2023 3
Consolidated Balance Sheets — June 28, 2024 and December 31, 2023 4
Consolidated Statements of Cash Flows — Six Months Ended June 28, 2024 and June 30, 2023 5
Notes to Consolidated Financial Statements 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 33
Item 3. Quantitative and Qualitative Disclosures About Market Risk 49
Item 4. Controls and Procedures 49
Part II. Other Information
Item 1. Legal Proceedings 50
Item 1A. Risk Factors 52
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 52
Item 5. Other Information 52
Item 6. Exhibits 52
Signatures 56

-- 3 of 161 --

FORWARD-LOOKING STATEMENTS
This report contains information that may constitute “forward-looking statements.” Generally, the words “believe,” “expect,”
“intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which
generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a
statement is not forward-looking. All statements that address operating performance, events or developments that we expect or
anticipate will occur in the future — including statements relating to volume growth, share of sales and net income per share
growth, and statements expressing general views about future operating results — are forward-looking statements.
Management believes that these forward-looking statements are reasonable as and when made. However, caution should be
taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date
when made. Our Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are
subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical
experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, the
possibility that the assumptions used to calculate our estimated aggregate incremental tax and interest liability related to the
potential unfavorable outcome of the ongoing tax dispute with the U.S. Internal Revenue Service could significantly change;
those described in Part II, “Item 1A. Risk Factors” and elsewhere in this report and in our Annual Report on Form 10-K for
the year ended December 31, 2023; and those described from time to time in our future reports filed with the Securities and
Exchange Commission.
1

-- 4 of 161 --

Part I. Financial Information
Item 1. Financial Statements
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions except per share data)
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Net Operating Revenues $ 12,363 $ 11,972 $ 23,663 $ 22,952
Cost of goods sold 4,812 4,912 9,047 9,229
Gross Profit 7,551 7,060 14,616 13,723
Selling, general and administrative expenses 3,549 3,321 6,900 6,506
Other operating charges 1,370 1,338 2,943 1,449
Operating Income 2,632 2,401 4,773 5,768
Interest income 275 224 521 392
Interest expense 418 374 800 746
Equity income (loss) — net 537 538 891 813
Other income (loss) — net 2 91 1,515 706
Income Before Income Taxes 3,028 2,880 6,900 6,933
Income taxes 627 359 1,314 1,299
Consolidated Net Income 2,401 2,521 5,586 5,634
Less: Net income (loss) attributable to noncontrolling interests (10) (26) (2) (20)
Net Income Attributable to Shareowners of The Coca-Cola
Company $ 2,411 $ 2,547 $ 5,588 $ 5,654
Basic Net Income Per Share1 $ 0.56 $ 0.59 $ 1.30 $ 1.31
Diluted Net Income Per Share1 $ 0.56 $ 0.59 $ 1.29 $ 1.30
Average Shares Outstanding — Basic 4,309 4,325 4,309 4,325
Effect of dilutive securities 10 16 12 18
Average Shares Outstanding — Diluted 4,319 4,341 4,321 4,343
1 Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.
2

-- 5 of 161 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Consolidated Net Income $ 2,401 $ 2,521 $ 5,586 $ 5,634
Other Comprehensive Income:
Net foreign currency translation adjustments (1,014) 252 (1,317) 801
Net gains (losses) on derivatives 118 (25) 167 (95)
Net change in unrealized gains (losses) on available-for-sale debt
securities (27) 1 (22) 9
Net change in pension and other postretirement benefit liabilities 27 2 23 13
Total Comprehensive Income 1,505 2,751 4,437 6,362
Less: Comprehensive income (loss) attributable to noncontrolling
interests 48 (101) 32 (170)
Total Comprehensive Income Attributable to Shareowners
of The Coca-Cola Company $ 1,457 $ 2,852 $ 4,405 $ 6,532
Refer to Notes to Consolidated Financial Statements.
3

-- 6 of 161 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except par value)
June 28,
2024 December 31,
2023
ASSETS
Current Assets
Cash and cash equivalents $ 13,708 $ 9,366
Short-term investments 3,691 2,997
Total Cash, Cash Equivalents and Short-Term Investments 17,399 12,363
Marketable securities 1,594 1,300
Trade accounts receivable, less allowances of $502 and $502, respectively 4,545 3,410
Inventories 4,763 4,424
Prepaid expenses and other current assets 3,298 5,235
Total Current Assets 31,599 26,732
Equity method investments 18,940 19,671
Other investments 167 118
Other noncurrent assets 7,274 7,162
Deferred income tax assets 1,409 1,561
Property, plant and equipment, less accumulated depreciation of $9,492 and $9,233, respectively 9,508 9,236
Trademarks with indefinite lives 13,510 14,349
Goodwill 18,324 18,358
Other intangible assets 471 516
Total Assets $ 101,202 $ 97,703
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses $ 21,909 $ 15,485
Loans and notes payable 3,793 4,557
Current maturities of long-term debt 1,939 1,960
Accrued income taxes 1,622 1,569
Total Current Liabilities 29,263 23,571
Long-term debt 38,085 35,547
Other noncurrent liabilities 4,077 8,466
Deferred income tax liabilities 2,366 2,639
The Coca-Cola Company Shareowners’ Equity
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares 1,760 1,760
Capital surplus 19,468 19,209
Reinvested earnings 75,189 73,782
Accumulated other comprehensive income (loss) (15,458) (14,275)
Treasury stock, at cost — 2,731 and 2,732 shares, respectively (55,106) (54,535)
Equity Attributable to Shareowners of The Coca-Cola Company 25,853 25,941
Equity attributable to noncontrolling interests 1,558 1,539
Total Equity 27,411 27,480
Total Liabilities and Equity $ 101,202 $ 97,703
Refer to Notes to Consolidated Financial Statements.
4

-- 7 of 161 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
Six Months Ended
June 28,
2024 June 30,
2023
Operating Activities
Consolidated net income $ 5,586 $ 5,634
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization 531 567
Stock-based compensation expense 140 120
Deferred income taxes (202) (211)
Equity (income) loss — net of dividends (274) (467)
Foreign currency adjustments (87) 34
Significant (gains) losses — net (1,398) (442)
Other operating charges 2,867 1,375
Other items (66) (225)
Net change in operating assets and liabilities (2,984) (1,756)
Net Cash Provided by Operating Activities 4,113 4,629
Investing Activities
Purchases of investments (3,827) (2,103)
Proceeds from disposals of investments 2,662 1,608
Acquisitions of businesses, equity method investments and nonmarketable securities (25) (43)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 2,907 320
Purchases of property, plant and equipment (792) (615)
Proceeds from disposals of property, plant and equipment 21 38
Collateral (paid) received associated with hedging activities — net (76) (15)
Other investing activities 127 44
Net Cash Provided by (Used in) Investing Activities 997 (766)
Financing Activities
Issuances of loans, notes payable and long-term debt 6,832 4,638
Payments of loans, notes payable and long-term debt (4,734) (2,366)
Issuances of stock 437 359
Purchases of stock for treasury (874) (1,084)
Dividends (2,184) (2,089)
Other financing activities (9) (456)
Net Cash Provided by (Used in) Financing Activities (532) (998)
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and
Restricted Cash Equivalents (357) 162
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
during the period 4,221 3,027
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 9,692 9,825
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 13,913 12,852
Less: Restricted cash and restricted cash equivalents at end of period 205 288
Cash and Cash Equivalents at End of Period $ 13,708 $ 12,564
Refer to Notes to Consolidated Financial Statements.
5

-- 8 of 161 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles
generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q
and Rule 10-01 of Regulation S-X. They do not include all information and notes required by U.S. GAAP for complete
financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the
Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the
year ended December 31, 2023.
When used in these notes, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola
Company and all entities included in our consolidated financial statements. In the opinion of management, all adjustments
(including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the
three and six months ended June 28, 2024 are not necessarily indicative of the results that may be expected for the year ending
December 31, 2024. Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters
typically accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather
conditions.
Each of our quarterly reporting periods, other than the fourth quarter, ends on the Friday closest to the last day of the
corresponding quarterly calendar period. The second quarter of 2024 and the second quarter of 2023 ended on June 28, 2024
and June 30, 2023, respectively. Our fourth quarter and our fiscal year end on December 31 regardless of the day of the week
on which December 31 falls.
Advertising Costs
The Company’s accounting policy related to advertising costs for annual reporting purposes is to expense production costs of
print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing
expenditures are expensed in the annual period in which the expenditure is incurred.
For quarterly reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple quarters to
each of those quarters. We use the proportion of each quarter’s actual unit case volume to the estimated full year unit case
volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard
rate per unit case. At the end of each quarter, we review our estimated full year unit case volume and our estimated full year
marketing expenditures that benefit multiple quarters in order to evaluate if a change in estimate is necessary. The impact of any
change in the full year estimate is recognized in the quarter in which the change in estimate occurs. Our full year marketing
expenditures are not impacted by this interim accounting policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of
purchase as cash equivalents or restricted cash equivalents, as applicable. Restricted cash and restricted cash equivalents
generally consist of amounts held by our captive insurance companies, which are included in the line item other noncurrent
assets in our consolidated balance sheet, and when applicable, cash and cash equivalents related to assets held for sale are
included in the line item prepaid expenses and other current assets in our consolidated balance sheet. We manage our exposure
to counterparty credit risk through specific minimum credit standards, diversification of counterparties and procedures to
monitor our concentrations of credit risk. Refer to Note 2 for additional information on our assets held for sale and Note 4 for
additional information on our captive insurance companies.
The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute
the total amounts shown in our consolidated statements of cash flows (in millions):
June 28,
2024 December 31,
2023
Cash and cash equivalents $ 13,708 $ 9,366
Restricted cash and restricted cash equivalents 205 326
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 13,913 $ 9,692
6

-- 9 of 161 --

June 30,
2023 December 31,
2022
Cash and cash equivalents $ 12,564 $ 9,519
Restricted cash and restricted cash equivalents 288 306
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 12,852 $ 9,825
Recently Issued Accounting Guidance
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands annual and interim
disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses.
The expanded annual disclosures are effective for the year ending December 31, 2024, and the expanded interim disclosures are
effective in 2025 and will be applied retrospectively to all prior periods presented. The Company is currently evaluating the
impact that ASU 2023-07 will have on our consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures,
which requires, among other things, additional disclosures primarily related to the income tax rate reconciliation and income
taxes paid. The expanded annual disclosures are effective for the year ending December 31, 2025. The Company is currently
evaluating the impact that ASU 2023-09 will have on our consolidated financial statements and whether we will apply the
standard prospectively or retrospectively.
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $25 million and
$43 million during the six months ended June 28, 2024 and June 30, 2023, respectively.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the six months ended
June 28, 2024 totaled $2,907 million, which primarily related to the refranchising of the Company’s bottling operations that
were classified as held for sale as of December 31, 2023. Also included was the sale of our ownership interest in an equity
method investee in Thailand for which we received cash proceeds of $728 million and recognized a net gain of $516 million,
which was recorded in the line item other income (loss) — net in our consolidated statement of income.
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the six months ended
June 30, 2023 totaled $320 million, which primarily related to the sale of our ownership interest in an equity method investee in
Indonesia to Coca-Cola Europacific Partners plc (“CCEP”), an equity method investee, for which we received cash proceeds of
$302 million and recognized a net gain of $12 million. The Company also refranchised its bottling operations in Vietnam in
January 2023 and recognized a net gain of $439 million as a result of the sale. The Company received the related cash proceeds
of $823 million in December 2022. These gains were recorded in the line item other income (loss) — net in our consolidated
statement of income.
Assets and Liabilities Held for Sale
As of December 31, 2023, the Company’s bottling operations in the Philippines, Bangladesh and certain territories in India met
the criteria to be classified as held for sale. As a result, we were required to record the related assets and liabilities at the lower
of carrying value or fair value less any costs to sell. As the fair values less any costs to sell exceeded the carrying values, the
related assets and liabilities were recorded at their carrying values. These assets and liabilities were included in the Bottling
Investments operating segment.
The Company refranchised its bottling operations in certain territories in India in January and February of 2024, for which we
received net cash proceeds of $476 million and recognized a net gain of $290 million, including the impact of post-closing
adjustments. The Company refranchised its bottling operations in Bangladesh to Coca-Cola İçecek A.Ş. (“CCI”), an equity
method investee, in February 2024, for which we received net cash proceeds of $27 million and a note receivable of $29 million
and recognized a net loss of $18 million, primarily due to the related reversal of cumulative translation adjustments.
Additionally, in February 2024, the Company refranchised its bottling operations in the Philippines to CCEP and a local
business partner, for which we received net cash proceeds of $1,656 million and recognized a net gain of $599 million. These
gains and losses were recorded in the line item other income (loss) — net in our consolidated statement of income.
7

-- 10 of 161 --

The following table presents information related to the major classes of assets and liabilities that were classified as held for sale
and were included in the line items prepaid expenses and other current assets and accounts payable and accrued expenses,
respectively, in our consolidated balance sheet (in millions):
December 31,
2023
Cash, cash equivalents and short-term investments $ 37
Marketable securities 8
Trade accounts receivable, less allowances 95
Inventories 299
Prepaid expenses and other current assets 60
Equity method investments 4
Other noncurrent assets 51
Deferred income tax assets 28
Property, plant and equipment — net 1,267
Goodwill 231
Other intangible assets 14
Assets held for sale $ 2,094
Accounts payable and accrued expenses $ 464
Loans and notes payable 63
Accrued income taxes 24
Long-term debt 2
Other noncurrent liabilities 108
Deferred income tax liabilities 58
Liabilities held for sale $ 719
NOTE 3: NET OPERATING REVENUES
The following tables present net operating revenues disaggregated between the United States and International and further by
line of business (in millions):
United States International Total
Three Months Ended June 28, 2024
Concentrate operations $ 2,278 $ 5,216 $ 7,494
Finished product operations 2,462 2,407 4,869
Total $ 4,740 $ 7,623 $ 12,363
Three Months Ended June 30, 2023
Concentrate operations $ 2,347 $ 4,703 $ 7,050
Finished product operations 1,955 2,967 4,922
Total $ 4,302 $ 7,670 $ 11,972
United States International Total
Six Months Ended June 28, 2024
Concentrate operations $ 4,403 $ 9,746 $ 14,149
Finished product operations 4,455 5,059 9,514
Total $ 8,858 $ 14,805 $ 23,663
Six Months Ended June 30, 2023
Concentrate operations $ 4,336 $ 9,047 $ 13,383
Finished product operations 3,815 5,754 9,569
Total $ 8,151 $ 14,801 $ 22,952
Refer to Note 17 for disclosures of net operating revenues by operating segment and Corporate.
8

-- 11 of 161 --

NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in
millions):
June 28, 2024
Marketable securities $ 381 $ —
Other investments 125 42
Other noncurrent assets 1,628 —
Total equity securities $ 2,134 $ 42
December 31, 2023
Marketable securities $ 345 $ —
Other investments 76 42
Other noncurrent assets 1,585 —
Total equity securities $ 2,006 $ 42
Fair Value with
Changes
Recognized in
Income
Measurement
Alternative —
No Readily
Determinable
Fair Value
The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of
the period is as follows (in millions):
Three Months Ended
June 28,
2024 June 30,
2023
Net gains (losses) recognized during the period related to equity securities $ 52 $ 130
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 4 22
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period $ 48 $ 108
Six Months Ended
June 28,
2024 June 30,
2023
Net gains (losses) recognized during the period related to equity securities $ 235 $ 255
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 21 33
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period $ 214 $ 222
Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized Estimated
Fair Value	Cost Gains Losses
June 28, 2024
Trading securities $ 44 $ 1 $ (1) $ 44
Available-for-sale securities 1,575 22 (58) 1,539
Total debt securities $ 1,619 $ 23 $ (59) $ 1,583
December 31, 2023
Trading securities $ 43 $ — $ (2) $ 41
Available-for-sale securities 1,136 26 (28) 1,134
Total debt securities $ 1,179 $ 26 $ (30) $ 1,175
9

-- 12 of 161 --

The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in
millions):
June 28, 2024 December 31, 2023
Trading
Securities Available-for-
Sale Securities Trading
Securities Available-for-
Sale Securities
Marketable securities $ 44 $ 1,169 $ 41 $ 914
Other noncurrent assets — 370 — 220
Total debt securities $ 44 $ 1,539 $ 41 $ 1,134
The contractual maturities of these available-for-sale debt securities as of June 28, 2024 were as follows (in millions):
Cost Estimated
Fair Value
Within 1 year $ 187 $ 187
After 1 year through 5 years 1,156 1,125
After 5 years through 10 years 46 56
After 10 years 186 171
Total $ 1,575 $ 1,539
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right
to call or prepay certain obligations.
The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Gross gains $ 4 $ 2 $ 5 $ 2
Gross losses (2) (1) (9) (4)
Proceeds 57 40 440 108
Captive Insurance Companies
In accordance with local insurance regulations, our consolidated captive insurance companies are required to meet and maintain
minimum solvency capital requirements. The Company elected to invest a majority of its solvency capital in a portfolio of
marketable equity and debt securities. These securities are included in the disclosures above. The Company uses one of our
consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the obligations of certain of
our European and Canadian pension plans. This captive’s solvency capital funds included total equity and debt securities of
$1,877 million and $1,643 million as of June 28, 2024 and December 31, 2023, respectively, which were classified in the line
item other noncurrent assets in our consolidated balance sheets because the assets were not available to satisfy our current
obligations.
NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
June 28,
2024 December 31,
2023
Raw materials and packaging $ 2,801 $ 2,618
Finished goods 1,615 1,449
Other 347 357
Total inventories $ 4,763 $ 4,424
10

-- 13 of 161 --

NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company’s derivative instruments that were designated and qualified as part
of a hedging relationship (in millions):
Fair Value1,2
Derivatives Designated as Hedging Instruments Balance Sheet Location1 June 28,
2024 December 31,
2023
Assets:
Foreign currency contracts Prepaid expenses and other current assets $ 232 $ 109
Foreign currency contracts Other noncurrent assets 38 13
Interest rate contracts Prepaid expenses and other current assets 7 —
Interest rate contracts Other noncurrent assets 14 50
Total assets $ 291 $ 172
Liabilities:
Foreign currency contracts Accounts payable and accrued expenses $ 20 $ 111
Foreign currency contracts Other noncurrent liabilities 46 40
Commodity contracts Accounts payable and accrued expenses 2 3
Interest rate contracts Accounts payable and accrued expenses 1 5
Interest rate contracts Other noncurrent liabilities 1,245 1,113
Total liabilities $ 1,314 $ 1,272
1 All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of
legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current
disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash
collateral. Refer to Note 16 for the net presentation of the Company’s derivative instruments.
2 Refer to Note 16 for additional information related to the estimated fair value.
The following table presents the fair values of the Company’s derivative instruments that were not designated as hedging
instruments (in millions):
Fair Value1,2
Derivatives Not Designated as Hedging Instruments Balance Sheet Location1 June 28,
2024 December 31,
2023
Assets:
Foreign currency contracts Prepaid expenses and other current assets $ 125 $ 91
Foreign currency contracts Other noncurrent assets 1 3
Commodity contracts Prepaid expenses and other current assets 6 5
Commodity contracts Other noncurrent assets 1 —
Other derivative instruments Prepaid expenses and other current assets 1 4
Total assets $ 134 $ 103
Liabilities:
Foreign currency contracts Accounts payable and accrued expenses $ 43 $ 106
Foreign currency contracts Other noncurrent liabilities 12 3
Commodity contracts Accounts payable and accrued expenses 63 62
Commodity contracts Other noncurrent liabilities 4 1
Other derivative instruments Accounts payable and accrued expenses — 4
Total liabilities $ 122 $ 176
1 All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of
legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current
disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash
collateral. Refer to Note 16 for the net presentation of the Company’s derivative instruments.
2 Refer to Note 16 for additional information related to the estimated fair value.
11

-- 14 of 161 --

Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of
investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating
immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral for
substantially all of our transactions. To mitigate pre-settlement risk, minimum credit standards become more stringent as the
duration of the derivative financial instrument increases. In addition, the Company’s master netting agreements reduce credit
risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of
credit risk, we enter into derivative transactions with a portfolio of financial institutions. Furthermore, for certain derivative
financial instruments, the Company has agreements with counterparties that require collateral to be exchanged based on
changes in the fair value of the instruments. The Company classifies collateral payments and receipts as investing cash flows
when the collateral account is in an asset position and as financing cash flows when the collateral account is in a liability
position. As a result of these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions
caused by fluctuations in foreign currency exchange rates, commodity prices or interest rates. The changes in the fair values of
derivatives designated as cash flow hedges are recorded in accumulated other comprehensive income (loss) (“AOCI”) and are
reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same
period the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are
immediately reclassified from AOCI into earnings. The maximum length of time for which the Company hedges its exposure to
the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our U.S. dollar net cash inflows
from sales outside the United States and U.S. dollar net cash outflows from procurement activities will be adversely affected by
fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase foreign currency options and
collars (principally euro, British pound and Japanese yen) to hedge certain portions of forecasted cash flows denominated in
foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future
foreign currency cash flows is partially offset by gains in the fair value of the derivative instruments. Conversely, when the U.S.
dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in the fair
value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the
Company’s foreign currency cash flow hedging program were $9,199 million and $9,408 million as of June 28, 2024 and
December 31, 2023, respectively.
The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt
and other monetary assets or liabilities due to fluctuations in foreign currency exchange rates. For this hedging program, the
Company recognizes in earnings each period the changes in carrying values of these foreign currency denominated assets and
liabilities due to fluctuations in exchange rates. The changes in fair values of the cross-currency swap derivatives are recorded
in AOCI with an immediate reclassification into earnings for the changes in fair values attributable to fluctuations in foreign
currency exchange rates. The total notional values of derivatives that were designated as cash flow hedges for the Company’s
foreign currency denominated assets and liabilities were $557 million and $958 million as of June 28, 2024 and December 31,
2023, respectively.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to
mitigate the price risk associated with forecasted purchases of materials used in our manufacturing process. These derivative
instruments were designated as part of the Company’s commodity cash flow hedging program. The objective of this hedging
program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional
values of derivatives that were designated and qualified for this program were $28 million and $54 million as of June 28, 2024
and December 31, 2023, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. We manage our risk related to interest rate
fluctuations through the use of derivative financial instruments. From time to time, the Company has entered into interest rate
swap agreements and has designated these instruments as part of the Company’s interest rate cash flow hedging program. The
objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company’s
future interest payments. The total notional values of derivatives that were designated and qualified for this program were
$1,250 million and $750 million as of June 28, 2024 and December 31, 2023, respectively.
12

-- 15 of 161 --

The following tables present the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had
on other comprehensive income (“OCI”), AOCI and earnings (in millions):
Gain (Loss)
Recognized
in OCI Location of Gain (Loss) Recognized in Income
Gain (Loss)
Reclassified from
AOCI into Income
Three Months Ended June 28, 2024
Foreign currency contracts $ 160 Net operating revenues $ (1)
Foreign currency contracts 9 Cost of goods sold 6
Foreign currency contracts — Interest expense (1)
Foreign currency contracts (9) Other income (loss) — net 2
Commodity contracts (3) Cost of goods sold (2)
Interest rate contracts 1 Interest expense —
Total $ 158 $ 4
Three Months Ended June 30, 2023
Foreign currency contracts $ (22) Net operating revenues $ (7)
Foreign currency contracts 13 Cost of goods sold 4
Foreign currency contracts — Interest expense (1)
Foreign currency contracts 22 Other income (loss) — net 3
Commodity contracts (9) Cost of goods sold (3)
Total $ 4 $ (4)
Gain (Loss)
Recognized
in OCI Location of Gain (Loss) Recognized in Income
Gain (Loss)
Reclassified from
AOCI into Income
Six Months Ended June 28, 2024
Foreign currency contracts $ 208 Net operating revenues $ (18)
Foreign currency contracts 20 Cost of goods sold 9
Foreign currency contracts — Interest expense (2)
Foreign currency contracts (24) Other income (loss) — net (26)
Commodity contracts (2) Cost of goods sold (3)
Interest rate contracts 2 Interest expense —
Total $ 204 $ (40)
Six Months Ended June 30, 2023
Foreign currency contracts $ (58) Net operating revenues $ (6)
Foreign currency contracts 17 Cost of goods sold 8
Foreign currency contracts — Interest expense (2)
Foreign currency contracts 9 Other income (loss) — net 3
Commodity contracts (11) Cost of goods sold (6)
Total $ (43) $ (3)
As of June 28, 2024, the Company estimates that it will reclassify into earnings during the next 12 months net gains of
$132 million from the pretax amount recorded in AOCI as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair
value of fixed-rate debt that result from fluctuations in benchmark interest rates. The Company also uses cross-currency interest
rate swaps to hedge the changes in the fair value of foreign currency denominated debt relating to fluctuations in foreign
currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value
hedges and the offsetting changes in the fair values of the hedged items are recognized in earnings. As a result, any difference is
reflected in earnings as ineffectiveness. When a derivative is no longer designated as a fair value hedge for any reason,
including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that
time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately
if the hedged item has matured or has been extinguished. The total notional values of derivatives that were designated and
13

-- 16 of 161 --

qualified as fair value hedges of this type were $12,898 million and $13,693 million as of June 28, 2024 and December 31,
2023, respectively.
The following tables summarize the pretax impact that changes in the fair values of derivatives designated as fair value hedges
had on earnings (in millions):
Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Three Months Ended
June 28,
2024 June 30,
2023
Interest rate contracts Interest expense $ (19) $ (102)
Fixed-rate debt Interest expense 20 131
Net impact of fair value hedging instruments $ 1 $ 29
Hedging Instruments and Hedged Items Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Six Months Ended
June 28,
2024 June 30,
2023
Interest rate contracts Interest expense $ (164) $ 106
Fixed-rate debt Interest expense 167 (91)
Net impact of fair value hedging instruments $ 3 $ 15
The following table summarizes the amounts recorded in our consolidated balance sheets related to hedged items in fair value
hedging relationships (in millions):
Cumulative Amount of Fair Value Hedging Adjustments1
Carrying Values of
Hedged Items Included in the Carrying Values
of Hedged Items
Remaining for Which Hedge
Accounting Has Been
Discontinued
Balance Sheet Location of Hedged Items June 28,
2024 December 31,
2023 June 28,
2024 December 31,
2023 June 28,
2024 December 31,
2023
Current maturities of long-term debt $ — $ 552 $ — $ 1 $ — $ —
Long-term debt 11,767 12,186 (1,258) (1,135) 146 162
1 Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rate fluctuations.
In June 2023, the Company amended the terms of its interest rate swap agreements to implement a forward-looking interest rate
based on the Secured Overnight Financing Rate in place of the London Interbank Offered Rate. Since the interest rate swap
agreements were affected by reference rate reform, the Company applied the expedients and exceptions provided to preserve
the past presentation of its derivatives without de-designating the existing hedging relationships. All amendments to interest rate
swap agreements were executed with the existing counterparties and did not change the notional amounts, maturity dates or
other critical terms of the hedging relationships.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial
instrument, to protect the value of our net investments in a number of foreign operations. For derivative financial instruments
that are designated and qualify as hedges of net investments in foreign operations, the changes in the fair values of the
derivative financial instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset
the changes in the values of the net investments being hedged. For non-derivative financial instruments that are designated and
qualify as hedges of net investments in foreign operations, the changes in the carrying values of the designated portions of the
non-derivative financial instruments due to fluctuations in foreign currency exchange rates are recorded in net foreign currency
translation adjustments. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the
period of change.
14

-- 17 of 161 --

The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as
net investment hedges (in millions):
Notional Values Gain (Loss) Recognized in OCI
as of Three Months Ended Six Months Ended
June 28,
2024 December 31,
2023 June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Foreign currency contracts $ 360 $ 150 $ 22 $ (1) $ 24 $ (1)
Foreign currency denominated debt 12,609 12,437 85 (80) 357 (234)
Total $ 12,969 $ 12,587 $ 107 $ (81) $ 381 $ (235)
The Company reclassified a gain of $3 million related to net investment hedges from AOCI into earnings during the six months
ended June 28, 2024. The Company did not reclassify any gains or losses during the three months ended June 28, 2024 nor the
three and six months ended June 30, 2023. In addition, the Company did not have any ineffectiveness related to net investment
hedges during the three and six months ended June 28, 2024 and June 30, 2023. The cash inflows and outflows associated with
the Company’s derivative contracts designated as net investment hedges are classified in the line item other investing activities
in our consolidated statement of cash flows.
Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that have been designated and qualify for hedge accounting, the Company also uses certain
derivatives as economic hedges of foreign currency, interest rate and commodity exposure. Although these derivatives were not
designated and/or did not qualify for hedge accounting, they are effective economic hedges. The changes in the fair values of
economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency
exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. The changes in the fair
values of economic hedges used to offset those monetary assets and liabilities are immediately recognized in earnings in the line
item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges
to minimize the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related
to certain acquisition and divestiture activities. The changes in the fair values of economic hedges used to offset the variability
in U.S. dollar net cash flows are immediately recognized in earnings in the line items net operating revenues, cost of goods sold
or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives
related to our foreign currency economic hedges were $7,570 million and $6,989 million as of June 28, 2024 and December 31,
2023, respectively.
The Company uses interest rate contracts as economic hedges to minimize exposure to changes in the fair value of fixed-rate
debt that result from fluctuations in benchmark interest rates. As of June 28, 2024 and December 31, 2023, we did not have any
interest rate contracts used as economic hedges.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of
materials used in the manufacturing process and vehicle fuel. The changes in the fair values of these economic hedges are
immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or selling, general and
administrative expenses in our consolidated statement of income, as applicable. The total notional values of derivatives related
to our economic hedges of this type were $303 million and $325 million as of June 28, 2024 and December 31, 2023,
respectively.
The following tables present the pretax impact that changes in the fair values of derivatives not designated as hedging
instruments had on earnings (in millions):
Derivatives Not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Three Months Ended
June 28,
2024 June 30,
2023
Foreign currency contracts Net operating revenues $ 58 $ (10)
Foreign currency contracts Cost of goods sold (22) 23
Foreign currency contracts Other income (loss) — net (96) 11
Commodity contracts Cost of goods sold (49) (84)
Other derivative instruments Selling, general and administrative expenses 6 1
Total $ (103) $ (59)
15

-- 18 of 161 --

Derivatives Not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Six Months Ended
June 28,
2024 June 30,
2023
Foreign currency contracts Net operating revenues $ 119 $ (17)
Foreign currency contracts Cost of goods sold (8) 51
Foreign currency contracts Other income (loss) — net (58) —
Commodity contracts Cost of goods sold (68) (130)
Other derivative instruments Selling, general and administrative expenses 12 4
Total $ (3) $ (92)
NOTE 7: SUPPLY CHAIN FINANCE PROGRAM
Our current payment terms with the majority of our suppliers are 120 days. Two global financial institutions offer a voluntary
supply chain finance (“SCF”) program, which enables our suppliers, at their sole discretion, to sell their receivables from the
Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating and thus may be more
beneficial to them. The SCF program is available to suppliers of goods and services included in cost of goods sold and selling,
general and administrative expenses in our consolidated statement of income. The Company and our suppliers agree on
contractual terms for the goods and services we procure, including prices, quantities and payment terms, regardless of whether
the supplier elects to participate in the SCF program. The suppliers sell goods or services, as applicable, to the Company and
issue the associated invoices to the Company based on the agreed-upon contractual terms. Then, if they are participating in the
SCF program, our suppliers sell their invoices to the financial institutions. Our suppliers’ voluntary participation in the SCF
program has no bearing on our payment terms. No guarantees are provided by the Company or any of our subsidiaries under the
SCF program. We have no economic interest in a supplier’s decision to participate in the SCF program, and we have no direct
financial relationship with the financial institutions, as it relates to the SCF program. Accordingly, amounts due to our suppliers
that elected to participate in the SCF program are included in the line item accounts payable and accrued expenses in our
consolidated balance sheet. All activity related to amounts due to suppliers that elected to participate in the SCF program is
reflected within the operating activities section of our consolidated statement of cash flows. As of June 28, 2024 and
December 31, 2023, the amount of obligations outstanding that the Company has confirmed as valid to the financial institutions
under the SCF program was $1,352 million and $1,421 million, respectively.
NOTE 8: DEBT AND BORROWING ARRANGEMENTS
Loans and notes payable consist primarily of commercial paper issued in the United States. As of June 28, 2024 and
December 31, 2023, we had $3,502 million and $4,209 million, respectively, in outstanding commercial paper borrowings.
During 2024, the Company issued fixed interest rate U.S. dollar- and euro-denominated debt of $3,000 million and
€1,000 million, respectively, with maturity dates ranging from 2032 to 2064 and interest rates ranging from 3.125% to 5.400%.
The carrying value of this debt as of June 28, 2024 was $4,017 million.
NOTE 9: COMMITMENTS AND CONTINGENCIES
Guarantees
As of June 28, 2024, we were contingently liable for guarantees of indebtedness owed by third parties of $811 million, of which
$84 million was related to variable interest entities. Our guarantees are primarily related to third-party customers, bottlers and
vendors and have arisen through the normal course of business. These guarantees have various terms, and none of these
guarantees is individually significant. These amounts represent the maximum potential future payments that we could be
required to make under the guarantees. However, management has concluded that the likelihood of any significant amounts
being paid by our Company under these guarantees is not probable.
Concentrations of Credit Risk
We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our
operations.
Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine
that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has
also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no
16

-- 19 of 161 --

estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result
of currently pending legal proceedings (excluding tax audit claims) will not have a material adverse effect on the Company
taken as a whole.
Tax Audits
The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. These uncertain tax
matters may result in the assessment of additional taxes.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the United States Internal
Revenue Service (“IRS”) seeking approximately $3.3 billion of additional federal income tax for years 2007 through 2009. In
the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from certain of its
foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in
certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS
rules governing transfer pricing require arm’s-length pricing of transactions between related parties such as the Company’s U.S.
parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on
an arm’s-length methodology for determining the amount of U.S. taxable income that the U.S. parent company would report as
compensation from its foreign licensees. The Company and the IRS memorialized this accord in a closing agreement resolving
that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances
or relevant federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed
penalties by the IRS for using the agreed-upon tax calculation methodology that the Company and the IRS agreed would be
used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five
successive audit cycles for tax years 1996 through 2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007
through 2009 tax years in favor of an entirely different methodology, without prior notice to the Company. Using the new tax
calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent company from its foreign licensees
for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet
to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination
that forecloses to a company any and all alternative means for resolution of a tax dispute. As a result of the IRS’ designation of
the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly imposed tax assessment and pay
the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation
designation, preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015,
challenging the tax adjustments enumerated in the Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of
$135 million. The Company obtained a summary judgment in its favor on a different matter related to Mexican foreign tax
credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in
April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed
with the Company that dividends previously paid by the foreign licensees to the U.S. parent company in reliance upon the
Closing Agreement should continue to be allowed to offset royalties, including those that would become payable to the
Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion (together with
the original Tax Court opinion, “Opinions”), siding with the IRS in concluding both that certain U.S. tax regulations (known as
the blocked-income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the
Company’s licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v.
Commissioner (February 9, 2023) controlled as to the validity of those regulations.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating
income earned by the Company’s foreign licensees to increase the Company’s U.S. tax. Moreover, the Company believes that
the retroactive imposition of such tax liability using a calculation methodology different from that previously agreed upon by
the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its
17

-- 20 of 161 --

claims on appeal and vigorously defend its position. In addition, for its litigation with the IRS and for purposes of its appeal of
the Tax Court decision, the Company is currently evaluating the implications of several significant administrative law cases
recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled Chevron U.S.A., Inc. v.
NRDC (“Chevron”). Since 1984, Chevron had required that courts defer to agency interpretations of statutes and agency action.
In Ohio v. EPA and Garland v. Cargill, two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to
rule on agency interpretations and actions without the deference previously required by Chevron.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-
step evaluation process prescribed by Accounting Standards Codification 740, Accounting for Income Taxes. In doing so, we
consulted with outside advisors, and we reviewed and considered relevant laws, rules, and regulations, including, but not
limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert
our various well-founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal
merits of the Company’s tax positions, that it is more likely than not the Company’s tax positions will ultimately be sustained
on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the methodology
asserted by the IRS and affirmed in the Opinions (“Tax Court Methodology”), that could be applied by the courts upon final
resolution of the litigation. Based on the required probability analysis, we determined the methodologies we believe the federal
courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we recorded a tax reserve
of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as
the different tax treatment applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in
reliance upon the Closing Agreement, that would be recharacterized as royalties in accordance with the Opinions and the
Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is
unchanged as of June 28, 2024. However, we updated our calculation of the methodologies we believe the federal courts could
ultimately order to be used in calculating the Company’s tax. As a result of the application of the required probability analysis
to these updated calculations and the accrual of interest through the current reporting period, we updated our tax reserve as of
June 28, 2024 to $456 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is
possible that some portion or all of the adjustment proposed by the IRS and sustained by the Tax Court could ultimately be
upheld. In that event, the Company would likely be subject to significant additional liabilities for tax years 2007 through 2009,
and potentially also for subsequent years, which could have a material adverse impact on the Company’s financial position,
results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign
licensees potentially covered within the scope of the Opinions, assuming such methodology were to be ultimately upheld by the
courts, and the IRS were to decide to apply that methodology to subsequent years, with consent of the federal courts. This
impact would include taxes and interest accrued through December 31, 2023 for the 2007 through 2009 litigated tax years and
for subsequent tax years from 2010 through 2023. The calculations incorporated the estimated impact of correlative adjustments
to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the
potential aggregate incremental tax and interest liability could be approximately $16 billion as of December 31, 2023.
Additional income tax and interest would continue to accrue until the time any such potential liability, or portion thereof, were
to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three and six
months ended June 28, 2024 would increase the potential aggregate incremental tax and interest liability by approximately
$500 million and $1.0 billion, respectively. We currently project the continued application of the Tax Court Methodology in
future years, assuming similar facts and circumstances as of December 31, 2023, would result in an incremental annual tax
liability that would increase the Company’s effective tax rate by approximately 3.5%.
The Company and the IRS are now in the process of agreeing on the tax impacts of the Opinions. Subsequent to the completion
of this process, the Tax Court will render a decision in the case. The Company will have 90 days thereafter to file a notice of
appeal to the U.S. Court of Appeals for the Eleventh Circuit. The IRS will then seek to collect any additional tax related to the
2007 through 2009 tax years reflected in the Tax Court decision (and interest thereon). The Company expects to pay such
amounts at some point between the issuance of the Tax Court decision and the date the amounts are due pursuant to the notice
of collection from the IRS. The Company currently estimates that the payment to be made at that time related to the 2007
through 2009 tax years, which is included in the above estimate of the potential aggregate incremental tax and interest liability,
would be approximately $6.0 billion (including interest accrued through June 28, 2024), plus any additional interest accrued
through the time of payment. Some or all of this amount, plus accrued interest, would be refunded if the Company were to
prevail on appeal.
18

-- 21 of 161 --

Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general,
we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our
self-insured retentions to reduce the Company’s risk of catastrophic loss. Our reserves for the Company’s self-insured losses are
estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on
our claims history. Our self-insurance reserves totaled $175 million and $197 million as of June 28, 2024 and December 31,
2023, respectively.
NOTE 10: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a
component of shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI
attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet as part of the line item
equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
June 28,
2024 December 31,
2023
Net foreign currency translation adjustments $ (14,077) $ (12,726)
Accumulated net gains (losses) on derivatives 13 (154)
Unrealized net gains (losses) on available-for-sale debt securities (23) (1)
Adjustments to pension and other postretirement benefit liabilities (1,371) (1,394)
Accumulated other comprehensive income (loss) $ (15,458) $ (14,275)
The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola
Company and noncontrolling interests (in millions):
Six Months Ended June 28, 2024
Shareowners of
The Coca-Cola Company Noncontrolling
Interests Total
Consolidated net income $ 5,588 $ (2) $ 5,586
Other comprehensive income:
Net foreign currency translation adjustments (1,351) 34 (1,317)
Net gains (losses) on derivatives1 167 — 167
Net change in unrealized gains (losses) on available-for-sale debt
securities2 (22) — (22)
Net change in pension and other postretirement benefit liabilities 23 — 23
Total comprehensive income (loss) $ 4,405 $ 32 $ 4,437
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
19

-- 22 of 161 --

The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of
equity method investees’ OCI (in millions):
Three Months Ended June 28, 2024 Before-Tax
Amount Income Tax After-Tax
Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period $ (1,109) $ 127 $ (982)
Gains (losses) on intra-entity transactions that are of a long-term investment nature (170) — (170)
Gains (losses) on net investment hedges arising during the period1 107 (27) 80
Net foreign currency translation adjustments $ (1,172) $ 100 $ (1,072)
Derivatives:
Gains (losses) arising during the period $ 156 $ (35) $ 121
Reclassification adjustments recognized in net income (4) 1 (3)
Net gains (losses) on derivatives1 $ 152 $ (34) $ 118
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period $ (38) $ 13 $ (25)
Reclassification adjustments recognized in net income (2) — (2)
Net change in unrealized gains (losses) on available-for-sale debt securities2 $ (40) $ 13 $ (27)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period $ 4 $ 6 $ 10
Reclassification adjustments recognized in net income 23 (6) 17
Net change in pension and other postretirement benefit liabilities $ 27 $ — $ 27
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company $ (1,033) $ 79 $ (954)
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Six Months Ended June 28, 2024 Before-Tax
Amount Income Tax After-Tax
Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period $ (1,143) $ 92 $ (1,051)
Reclassification adjustments recognized in net income 103 — 103
Gains (losses) on intra-entity transactions that are of a long-term investment nature (688) — (688)
Gains (losses) on net investment hedges arising during the period1 381 (96) 285
Net foreign currency translation adjustments $ (1,347) $ (4) $ (1,351)
Derivatives:
Gains (losses) arising during the period $ 183 $ (46) $ 137
Reclassification adjustments recognized in net income 40 (10) 30
Net gains (losses) on derivatives1 $ 223 $ (56) $ 167
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period $ (38) $ 13 $ (25)
Reclassification adjustments recognized in net income 4 (1) 3
Net change in unrealized gains (losses) on available-for-sale debt securities2 $ (34) $ 12 $ (22)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period $ (9) $ (2) $ (11)
Reclassification adjustments recognized in net income 45 (11) 34
Net change in pension and other postretirement benefit liabilities $ 36 $ (13) $ 23
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company $ (1,122) $ (61) $ (1,183)
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
20

-- 23 of 161 --

Three Months Ended June 30, 2023 Before-Tax
Amount Income Tax After-Tax
Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period $ 300 $ (63) $ 237
Gains (losses) on intra-entity transactions that are of a long-term investment nature 151 — 151
Gains (losses) on net investment hedges arising during the period1 (81) 20 (61)
Net foreign currency translation adjustments $ 370 $ (43) $ 327
Derivatives:
Gains (losses) arising during the period $ (31) $ 3 $ (28)
Reclassification adjustments recognized in net income 4 (1) 3
Net gains (losses) on derivatives1 $ (27) $ 2 $ (25)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period $ 4 $ (3) $ 1
Reclassification adjustments recognized in net income (1) 1 —
Net change in unrealized gains (losses) on available-for-sale debt securities2 $ 3 $ (2) $ 1
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period $ (11) $ (4) $ (15)
Reclassification adjustments recognized in net income 22 (5) 17
Net change in pension and other postretirement benefit liabilities $ 11 $ (9) $ 2
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company $ 357 $ (52) $ 305
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Six Months Ended June 30, 2023 Before-Tax
Amount Income Tax After-Tax
Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period $ 737 $ (154) $ 583
Reclassification adjustments recognized in net income 101 — 101
Gains (losses) on intra-entity transactions that are of a long-term investment nature 443 — 443
Gains (losses) on net investment hedges arising during the period1 (235) 59 (176)
Net foreign currency translation adjustments $ 1,046 $ (95) $ 951
Derivatives:
Gains (losses) arising during the period $ (107) $ 10 $ (97)
Reclassification adjustments recognized in net income 3 (1) 2
Net gains (losses) on derivatives1 $ (104) $ 9 $ (95)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period $ 13 $ (6) $ 7
Reclassification adjustments recognized in net income 2 — 2
Net change in unrealized gains (losses) on available-for-sale debt securities2 $ 15 $ (6) $ 9
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period $ (16) $ (6) $ (22)
Reclassification adjustments recognized in net income 44 (9) 35
Net change in pension and other postretirement benefit liabilities $ 28 $ (15) $ 13
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company $ 985 $ (107) $ 878
1 Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
2 Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
21

-- 24 of 161 --

The following table presents the amounts and line items in our consolidated statements of income where adjustments
reclassified from AOCI into income were recorded (in millions):
Amount Reclassified from AOCI
into Income
Description of AOCI Component Financial Statement Line Item Three Months Ended
June 28, 2024 Six Months Ended
June 28, 2024
Foreign currency translation adjustments:
Divestitures, deconsolidations and other1 Other income (loss) — net $ — $ 103
Income before income taxes — 103
Income taxes — —
Consolidated net income $ — $ 103
Derivatives:
Foreign currency contracts Net operating revenues $ 1 $ 18
Foreign currency contracts and commodity contracts Cost of goods sold (4) (6)
Foreign currency contracts Interest expense 1 2
Foreign currency contracts Other income (loss) — net (2) 26
Income before income taxes (4) 40
Income taxes 1 (10)
Consolidated net income $ (3) $ 30
Available-for-sale debt securities:
Sale of debt securities Other income (loss) — net $ (2) $ 4
Income before income taxes (2) 4
Income taxes — (1)
Consolidated net income $ (2) $ 3
Pension and other postretirement benefit liabilities:
Divestitures, deconsolidations and other2 Other income (loss) — net $ (1) $ (3)
Recognized net actuarial loss (gain) Other income (loss) — net 24 49
Recognized prior service cost (credit) Other income (loss) — net — (1)
Income before income taxes 23 45
Income taxes (6) (11)
Consolidated net income $ 17 $ 34
1 Related to the refranchising of our bottling operations in the Philippines and Bangladesh and the sale of our ownership interest in an equity
method investee in Thailand. Refer to Note 2.
2 Primarily related to the refranchising of our bottling operations in the Philippines and Bangladesh. Refer to Note 2.
22

-- 25 of 161 --

NOTE 11: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable
to shareowners of The Coca-Cola Company and equity attributable to noncontrolling interests (in millions):
Shareowners of The Coca-Cola Company
Three Months Ended June 28, 2024
Common
Shares
Outstanding Total Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss) Common
Stock Capital
Surplus Treasury
Stock
Non-
controlling
Interests
March 29, 2024 4,308 $ 27,946 $ 74,868 $ (14,504) $ 1,760 $ 19,321 $ (55,016) $ 1,517
Comprehensive income (loss) — 1,505 2,411 (954) — — — 48
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.485 per share) — (2,090) (2,090) — — — — —
Dividends paid to noncontrolling
interests — (7) — — — — — (7)
Purchases of treasury stock (3) (156) — — — — (156) —
Impact related to stock-based
compensation plans 4 213 — — — 147 66 —
June 28, 2024 4,309 $ 27,411 $ 75,189 $ (15,458) $ 1,760 $ 19,468 $ (55,106) $ 1,558
Shareowners of The Coca-Cola Company
Six Months Ended June 28, 2024
Common
Shares
Outstanding Total Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss) Common
Stock Capital
Surplus Treasury
Stock
Non-
controlling
Interests
December 31, 2023 4,308 $ 27,480 $ 73,782 $ (14,275) $ 1,760 $ 19,209 $ (54,535) $ 1,539
Comprehensive income (loss) — 4,437 5,588 (1,183) — — — 32
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.97 per share) — (4,181) (4,181) — — — — —
Dividends paid to noncontrolling
interests — (9) — — — — — (9)
Divestitures, deconsolidations and
other — (4) — — — — — (4)
Purchases of treasury stock (13) (777) — — — — (777) —
Impact related to stock-based
compensation plans 14 465 — — — 259 206 —
June 28, 2024 4,309 $ 27,411 $ 75,189 $ (15,458) $ 1,760 $ 19,468 $ (55,106) $ 1,558
23

-- 26 of 161 --

Shareowners of The Coca-Cola Company
Three Months Ended June 30, 2023
Common
Shares
Outstanding Total Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss) Common
Stock Capital
Surplus Treasury
Stock
Non-
controlling
Interests
March 31, 2023 4,325 $ 26,868 $ 72,137 $ (14,322) $ 1,760 $ 18,889 $ (53,247) $ 1,651
Comprehensive income (loss) — 2,751 2,547 305 — — — (101)
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.46 per share) — (1,989) (1,989) — — — — —
Dividends paid to noncontrolling
interests — (9) — — — — — (9)
Acquisition of interests held by
noncontrolling owners — (22) — — — (20) — (2)
Purchases of treasury stock (4) (230) — — — — (230) —
Impact related to stock-based
compensation plans 3 183 — — — 124 59 —
June 30, 2023 4,324 $ 27,552 $ 72,695 $ (14,017) $ 1,760 $ 18,993 $ (53,418) $ 1,539
Shareowners of The Coca-Cola Company
Six Months Ended June 30, 2023
Common
Shares
Outstanding Total Reinvested
Earnings
Accumulated
Other
Comprehensive
Income (Loss) Common
Stock Capital
Surplus Treasury
Stock
Non-
controlling
Interests
December 31, 2022 4,328 $ 25,826 $ 71,019 $ (14,895) $ 1,760 $ 18,822 $ (52,601) $ 1,721
Comprehensive income (loss) — 6,362 5,654 878 — — — (170)
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.92 per share) — (3,978) (3,978) — — — — —
Dividends paid to noncontrolling
interests — (13) — — — — — (13)
Acquisition of interests held by
noncontrolling owners — (22) — — — (20) — (2)
Purchases of treasury stock (16) (979) — — — — (979) —
Impact related to stock-based
compensation plans 12 356 — — — 194 162 —
Other activities — — — — — (3) — 3
June 30, 2023 4,324 $ 27,552 $ 72,695 $ (14,017) $ 1,760 $ 18,993 $ (53,418) $ 1,539
NOTE 12: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended June 28, 2024, the Company recorded other operating charges of $1,370 million. These charges
primarily consisted of $1,337 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, $32 million related to the Company’s productivity and
reinvestment program and $3 million for the amortization of noncompete agreements related to the BA Sports Nutrition, LLC
(“BodyArmor”) acquisition in 2021. These charges were partially offset by a net benefit of $2 million related to a revision of
management’s estimates for tax litigation expense.
During the six months ended June 28, 2024, the Company recorded other operating charges of $2,943 million. These charges
primarily consisted of $2,102 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife, $760 million related to the impairment of our BodyArmor trademark and
$68 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included
$7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $7 million
for the amortization of noncompete agreements related to the BodyArmor acquisition. These charges were partially offset by a
net benefit of $1 million related to a revision of management’s estimates for tax litigation expense.
During the three months ended June 30, 2023, the Company recorded other operating charges of $1,338 million. These charges
primarily consisted of $1,262 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with the fairlife acquisition, $35 million related to the discontinuation of certain manufacturing operations in Asia
24

-- 27 of 161 --

Pacific and $24 million related to the Company’s productivity and reinvestment program. In addition, other operating charges
included $8 million related to the restructuring of our North America operating unit, $6 million related to tax litigation expense
and $3 million for the amortization of noncompete agreements related to the BodyArmor acquisition.
During the six months ended June 30, 2023, the Company recorded other operating charges of $1,449 million. These charges
primarily consisted of $1,324 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with the fairlife acquisition, $51 million related to the Company’s productivity and reinvestment program and
$35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating
charges included $26 million related to the restructuring of our North America operating unit, $7 million for the amortization of
noncompete agreements related to the BodyArmor acquisition and $6 million related to tax litigation expense.
Refer to Note 2 for additional information on the refranchising of our bottling operations in certain territories in India. Refer to
Note 9 for additional information on the tax litigation. Refer to Note 13 for additional information on the Company’s
restructuring initiatives. Refer to Note 16 for additional information on the fairlife acquisition and the BodyArmor impairment.
Refer to Note 17 for the impact these charges had on our operating segments and Corporate.
Other Nonoperating Items
Equity Income (Loss) — Net
During the three and six months ended June 28, 2024, the Company recorded net charges of $24 million and $49 million,
respectively. During the three and six months ended June 30, 2023, the Company recorded net charges of $2 million and
$84 million, respectively. These amounts represent the Company’s proportionate share of significant operating and
nonoperating items recorded by certain of our equity method investees. Refer to Note 17 for the impact these items had on our
operating segments and Corporate.
Other Income (Loss) — Net
During the three months ended June 28, 2024, the Company recognized a net gain of $50 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-
sale debt securities and an other-than-temporary impairment charge of $34 million related to an equity method investee in Latin
America.
During the six months ended June 28, 2024, the Company recognized net gains of $599 million and $290 million related to the
refranchising of our bottling operations in the Philippines and certain territories in India, respectively. The Company also
recognized a net gain of $516 million related to the sale of our ownership interest in an equity method investee in Thailand.
Additionally, the Company recognized a net gain of $228 million related to realized and unrealized gains and losses on equity
securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. These gains were
partially offset by an other-than-temporary impairment charge of $34 million related to an equity method investee in Latin
America and a loss of $7 million related to post-closing adjustments for the refranchising of our bottling operations in Vietnam
in 2023.
During the three months ended June 30, 2023, the Company recognized a net gain of $127 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-
sale debt securities.
During the six months ended June 30, 2023, the Company recognized a net gain of $439 million related to the refranchising of
our bottling operations in Vietnam. Additionally, the Company recognized a net gain of $240 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-
sale debt securities.
Refer to Note 2 for additional information on the refranchising of our bottling operations as well as the sale of our ownership
interest in an equity method investee in Thailand. Refer to Note 4 for additional information on equity and debt securities. Refer
to Note 16 for additional information on the other-than-temporary impairment charge. Refer to Note 17 for the impact these
items had on our operating segments and Corporate.
NOTE 13: RESTRUCTURING
Productivity and Reinvestment Program
In February 2012, the Company announced a productivity and reinvestment program designed to strengthen our brands and
reinvest our resources to drive long-term profitable growth. The program was expanded multiple times, with the last expansion
occurring in April 2017. The remaining initiatives included in this program, which are primarily designed to further simplify
and standardize our organization, will be completed in 2024.
25

-- 28 of 161 --

During the three and six months ended June 28, 2024, the Company incurred expenses of $32 million and $68 million,
respectively, and during the three and six months ended June 30, 2023 incurred expenses of $24 million and $51 million,
respectively, related to our productivity and reinvestment program. These expenses primarily included internal and external
costs associated with the implementation of the program’s initiatives and were recorded in the line item other operating charges
in our consolidated statements of income. Refer to Note 17 for the impact these expenses had on our operating segments and
Corporate. The Company has incurred total pretax expenses of $4,361 million related to this program since it commenced.
North America Operating Unit Restructuring
In November 2022, the Company announced a restructuring program for our North America operating unit designed to better
align its operating structure with its customers and bottlers. The evolved operating structure brought together all bottler-related
components (franchise leadership, commercial leadership, digital, governance and technical innovation) and helped streamline
how we work. During the three and six months ended June 30, 2023, the Company incurred expenses of $8 million and
$26 million, respectively, related to this program. These expenses primarily included severance costs and were recorded in the
line item other operating charges in our consolidated statements of income. The Company has incurred total pretax expenses of
$65 million related to this program since it commenced. This restructuring program was complete as of December 31, 2023.
NOTE 14: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost or income for our pension and other postretirement benefit plans consisted of the following (in
millions):
Pension Plans Other Postretirement
Benefit Plans
Three Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Service cost $ 26 $ 23 $ 1 $ 1
Interest cost 77 81 5 7
Expected return on plan assets1 (117) (119) (2) (3)
Amortization of prior service cost (credit) 1 1 (1) (1)
Amortization of net actuarial loss (gain) 25 24 (1) (2)
Net periodic benefit cost (income) $ 12 $ 10 $ 2 $ 2
1 The weighted-average expected long-term rates of return on plan assets used in computing 2024 net periodic benefit cost (income) were
7.00% for pension plans and 4.50% for other postretirement benefit plans.
Pension Plans Other Postretirement
Benefit Plans
Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Service cost $ 53 $ 47 $ 2 $ 2
Interest cost 154 162 9 14
Expected return on plan assets1 (235) (238) (4) (7)
Amortization of prior service cost (credit) 1 1 (2) (2)
Amortization of net actuarial loss (gain) 51 48 (2) (3)
Net periodic benefit cost (income) $ 24 $ 20 $ 3 $ 4
1 The weighted-average expected long-term rates of return on plan assets used in computing 2024 net periodic benefit cost (income) were
7.00% for pension plans and 4.50% for other postretirement benefit plans.
All of the amounts in the tables above, other than service cost, were recorded in the line item other income (loss) — net in our
consolidated statements of income. During the six months ended June 28, 2024, the Company contributed $16 million to our
pension trusts, offset by a $44 million transfer of surplus international plan assets from pension trusts to general assets of the
Company. We anticipate making additional contributions of approximately $19 million during the remainder of 2024. The
Company contributed $23 million to our pension trusts during the six months ended June 30, 2023.
NOTE 15: INCOME TAXES
The Company recorded income taxes of $627 million (20.7% effective tax rate) and $359 million (12.5% effective tax rate)
during the three months ended June 28, 2024 and June 30, 2023, respectively. The Company recorded income taxes of
26

-- 29 of 161 --

$1,314 million (19.0% effective tax rate) and $1,299 million (18.7% effective tax rate) during the six months ended June 28,
2024 and June 30, 2023, respectively.
The Company’s effective tax rates for the three and six months ended June 28, 2024 and June 30, 2023 vary from the statutory
U.S. federal tax rate of 21.0% primarily due to the tax impact of significant operating and nonoperating items, as described in
Note 12, along with the tax benefits of having significant earnings generated outside of the United States and significant
earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than
the statutory U.S. federal tax rate.
The Company’s effective tax rates for the three and six months ended June 28, 2024 included $119 million and $60 million,
respectively, of net tax expense related to various discrete tax items, including the resolution of certain foreign tax matters.
The Company’s effective tax rates for the three and six months ended June 30, 2023 included $120 million and $125 million,
respectively, of net tax benefits related to various discrete tax items, including a change in tax law in a certain foreign
jurisdiction.
On November 18, 2020, the Tax Court issued the Opinion regarding the Company’s 2015 litigation with the IRS involving
transfer pricing tax adjustments in which it predominantly sided with the IRS. On November 8, 2023, the Tax Court issued a
supplemental opinion, siding with the IRS in concluding both that the blocked-income regulations apply to the Company’s
operations and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as to the validity
of those regulations. The Company strongly disagrees with the Opinions and intends to vigorously defend its position. Refer to
Note 9.
NOTE 16: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
June 28, 2024 Level 1 Level 2 Level 3 Other3 Netting
Adjustment 4 Fair Value
Measurements
Assets:
Equity securities with readily determinable values1 $ 1,890 $ 150 $ 6 $ 88 $ — $ 2,134
Debt securities1 — 1,583 — — — 1,583
Derivatives2 — 425 — — (317) 6 108 8
Total assets $ 1,890 $ 2,158 $ 6 $ 88 $ (317) $ 3,825
Liabilities:
Contingent consideration liability $ — $ — $ 5,119 5 $ — $ — $ 5,119
Derivatives2 2 1,434 — — (1,377) 7 59 8
Total liabilities $ 2 $ 1,434 $ 5,119 $ — $ (1,377) $ 5,178
1 Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt
securities.
2 Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
3 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been
categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative
positions and also cash collateral held or placed with the same counterparties. There were no amounts subject to legally enforceable master
netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 6.
5 Represents the fair value of the remaining milestone payment related to our acquisition of fairlife in 2020, which is contingent on fairlife
achieving certain financial targets through 2024 and, if achieved, is payable in 2025. This milestone payment is based on agreed-upon
formulas related to fairlife’s operating results, the resulting value of which is not subject to a ceiling. The fair value was determined using
discounted cash flow analyses. We are required to remeasure this liability to fair value quarterly, with any changes in the fair value recorded
in income until the final milestone payment is made.
6 The Company is obligated to return $4 million in cash collateral it has netted against its derivative position.
7 The Company has the right to reclaim $1,065 million in cash collateral it has netted against its derivative position.
8 The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $54 million in the
line item prepaid expenses and other current assets, $54 million in the line item other noncurrent assets, and $59 million in the line item
other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
27

-- 30 of 161 --

December 31, 2023 Level 1 Level 2 Level 3 Other3 Netting
Adjustment 4 Fair Value
Measurements
Assets:
Equity securities with readily determinable values1 $ 1,727 $ 188 $ 6 $ 85 $ — $ 2,006
Debt securities1 — 1,172 3 — — 1,175
Derivatives2 — 275 — — (222) 6 53 8
Total assets $ 1,727 $ 1,635 $ 9 $ 85 $ (222) $ 3,234
Liabilities:
Contingent consideration liability $ — $ — $ 3,017 5 $ — $ — $ 3,017
Derivatives2 3 1,445 — — (1,256) 7 192 8
Total liabilities $ 3 $ 1,445 $ 3,017 $ — $ (1,256) $ 3,209
1 Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt
securities.
2 Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
3 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been
categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative
positions and also cash collateral held or placed with the same counterparties. There were no amounts subject to legally enforceable master
netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 6.
5 Represents the fair value of the remaining milestone payment related to our acquisition of fairlife in 2020, which is contingent on fairlife
achieving certain financial targets through 2024 and, if achieved, is payable in 2025. This milestone payment is based on agreed-upon
formulas related to fairlife’s operating results, the resulting value of which is not subject to a ceiling. The fair value was determined using a
Monte Carlo valuation model. We are required to remeasure this liability to fair value quarterly, with any changes in the fair value recorded
in income until the final milestone payment is made. The Company made a milestone payment of $275 million during 2023.
6 The Company was obligated to return $4 million in cash collateral it had netted against its derivative position.
7 The Company had the right to reclaim $1,039 million in cash collateral it had netted against its derivative position.
8 The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $53 million in the
line item other noncurrent assets and $192 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information
related to the composition of our derivatives portfolio.
Gross realized and unrealized gains and losses on Level 3 assets and liabilities, excluding the contingent consideration liability,
were not significant for the three and six months ended June 28, 2024 and June 30, 2023.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross
transfers between levels within the hierarchy were not significant for the three and six months ended June 28, 2024 and June 30,
2023.
Nonrecurring Fair Value Measurements
During the three and six months ended June 28, 2024, the Company recorded an other-than-temporary impairment charge of
$34 million related to an equity method investee in Latin America. This impairment charge was derived using Level 3 inputs
and was primarily driven by revised projections of future operating results.
During the six months ended June 28, 2024, the Company recorded an asset impairment charge of $760 million related to our
BodyArmor trademark in North America, which was primarily driven by revised projections of future operating results and
higher discount rates resulting from changes in macroeconomic conditions since the acquisition date. The fair value of this
trademark was derived using discounted cash flow analyses based on Level 3 inputs. This charge was recorded in the line item
other operating charges in our consolidated statement of income. The remaining carrying value of the trademark is
$3,400 million.
During the three and six months ended June 30, 2023, the Company recorded an asset impairment charge of $25 million related
to the discontinuation of certain manufacturing operations in Asia Pacific. This impairment charge was derived using Level 3
inputs and was primarily driven by management’s best estimate of the potential proceeds from the disposal of the related assets.
Other Fair Value Disclosures
The carrying values of cash and cash equivalents, short-term investments, trade accounts receivable, accounts payable and
accrued expenses, and loans and notes payable approximate their fair values because of the relatively short-term maturities of
these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs based on quoted prices for
those instruments. Where quoted prices are not available, the fair value is estimated using discounted cash flows and market-
based expectations for interest rates, credit risk and the contractual terms of the debt instruments. As of June 28, 2024, the
28

-- 31 of 161 --

carrying value and fair value of our long-term debt, including the current portion, were $40,024 million and $35,137 million,
respectively. As of December 31, 2023, the carrying value and fair value of our long-term debt, including the current portion,
were $37,507 million and $33,445 million, respectively.
NOTE 17: OPERATING SEGMENTS
Information about our Company’s operations by operating segment and Corporate is as follows (in millions):
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
As of and for the Three Months
Ended June 28, 2024
Net operating revenues:
Third party $ 2,184 $ 1,650 $ 4,808 $ 1,386 $ 768 $ 1,537 $ 30 $ — $ 12,363
Intersegment 155 — 4 126 — 2 — (287) —
Total net operating revenues 2,339 1,650 4,812 1,512 768 1,539 30 (287) 12,363
Operating income (loss) 1,252 920 1,312 647 92 98 (1,689) — 2,632
Income (loss) before income taxes 1,267 887 1,324 648 94 548 (1,740) — 3,028
Identifiable operating assets 7,475 3,064 25,972 2,532 2 7,576 7,888 2 27,588 — 82,095
Investments1 402 671 15 54 — 12,751 5,214 — 19,107
As of and for the Three Months
Ended June 30, 2023
Net operating revenues:
Third party $ 2,043 $ 1,378 $ 4,365 $ 1,349 $ 765 $ 2,042 $ 30 $ — $ 11,972
Intersegment 145 — 2 218 — — — (365) —
Total net operating revenues 2,188 1,378 4,367 1,567 765 2,042 30 (365) 11,972
Operating income (loss) 1,133 797 1,216 673 78 122 (1,618) — 2,401
Income (loss) before income taxes 1,147 802 1,227 675 78 577 (1,626) — 2,880
Identifiable operating assets 7,729 2,474 26,109 2,453 2, 3 7,622 9,281 2, 3 23,368 — 79,036
Investments1 394 728 15 76 — 13,406 4,801 — 19,420
As of December 31, 2023
Identifiable operating assets $ 7,117 $ 3,149 $ 25,808 $ 2,428 2 $ 7,607 $ 9,871 2 $ 21,934 $ — $ 77,914
Investments1 389 712 15 71 — 13,639 4,963 — 19,789
1 Principally equity method investments and other investments in bottling companies.
2 Property, plant and equipment — net in India represented 14%, 10% and 12% of consolidated property, plant and equipment — net as of
June 28, 2024, June 30, 2023 and December 31, 2023, respectively.
3 Property, plant and equipment — net in the Philippines represented 10% of consolidated property, plant and equipment — net as of June 30,
2023. As of December 31, 2023, the Company’s bottling operations in the Philippines met the criteria to be classified as held for sale. Refer
to Note 2.
During the three months ended June 28, 2024, the results of our operating segments and Corporate were impacted by the
following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $1,337 million for Corporate due to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition. Refer to
Note 16.
• Operating income (loss) and income (loss) before income taxes were reduced by $32 million for Corporate due to the
Company’s productivity and reinvestment program. Refer to Note 13.
• Operating income (loss) and income (loss) before income taxes were reduced by $7 million for North America due to the
restructuring of our manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $3 million for Corporate due to charges
related to our acquisition of BodyArmor. Refer to Note 12.
• Income (loss) before income taxes was increased by $50 million for Corporate due to realized and unrealized gains and
losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt
securities. Refer to Note 4.
29

-- 32 of 161 --

• Income (loss) before income taxes was reduced by $34 million for Latin America due to an other-than-temporary
impairment charge related to an equity method investee. Refer to Note 16.
• Income (loss) before income taxes was reduced by $21 million for Bottling Investments and $3 million for Latin America
due to the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our
equity method investees.
During the three months ended June 30, 2023, the results of our operating segments and Corporate were impacted by the
following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $1,262 million for Corporate due to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition. Refer to
Note 16.
• Operating income (loss) and income (loss) before income taxes were reduced by $35 million for Asia Pacific due to the
discontinuation of certain manufacturing operations.
• Operating income (loss) and income (loss) before income taxes were reduced by $25 million for Corporate due to the
Company’s productivity and reinvestment program. Operating income (loss) and income (loss) before income taxes were
increased by $1 million for North America due to the refinement of previously established accruals related to the
Company’s productivity and reinvestment program. Refer to Note 13.
• Operating income (loss) and income (loss) before income taxes were reduced by $8 million for North America due to the
restructuring of our North America operating unit. Refer to Note 13.
• Operating income (loss) and income (loss) before income taxes were reduced by $6 million for Corporate related to tax
litigation expense. Refer to Note 9.
• Operating income (loss) and income (loss) before income taxes were reduced by $5 million for North America due to the
restructuring of our manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $3 million for Corporate due to charges
related to our acquisition of BodyArmor. Refer to Note 12.
• Income (loss) before income taxes was increased by $127 million for Corporate due to realized and unrealized gains and
losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt
securities. Refer to Note 4.
• Income (loss) before income taxes was reduced by $2 million for Bottling Investments due to the Company’s
proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Europe,
Middle East
& Africa Latin
America North
America Asia
Pacific Global
Ventures Bottling
Investments Corporate Eliminations Consolidated
Six Months Ended June 28, 2024
Net operating revenues:
Third party $ 3,960 $ 3,177 $ 8,980 $ 2,639 $ 1,498 $ 3,352 $ 57 $ — $ 23,663
Intersegment 352 — 6 342 — 4 — (704) —
Total net operating revenues 4,312 3,177 8,986 2,981 1,498 3,356 57 (704) 23,663
Operating income (loss) 2,332 1,862 1,757 1,301 147 254 (2,880) — 4,773
Income (loss) before income taxes 2,356 1,834 1,779 1,306 150 972 (1,497) — 6,900
Six Months Ended June 30, 2023
Net operating revenues:
Third party $ 3,874 $ 2,764 $ 8,267 $ 2,534 $ 1,472 $ 3,986 $ 55 $ — $ 22,952
Intersegment 338 — 4 404 — 2 — (748) —
Total net operating revenues 4,212 2,764 8,271 2,938 1,472 3,988 55 (748) 22,952
Operating income (loss) 2,268 1,650 2,249 1,236 129 261 (2,025) — 5,768
Income (loss) before income taxes 2,289 1,657 2,268 1,098 135 1,081 (1,595) — 6,933
30

-- 33 of 161 --

During the six months ended June 28, 2024, the results of our operating segments and Corporate were impacted by the
following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $2,102 million for Corporate due to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition. Refer to
Note 16.
• Operating income (loss) and income (loss) before income taxes were reduced by $760 million for North America due to
the impairment of our BodyArmor trademark. Refer to Note 16.
• Operating income (loss) and income (loss) before income taxes were reduced by $68 million for Corporate due to the
Company’s productivity and reinvestment program. Refer to Note 13.
• Operating income (loss) and income (loss) before income taxes were reduced by $10 million for North America due to the
restructuring of our manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $7 million for Corporate due to
transaction costs related to the refranchising of our bottling operations in certain territories in India. Refer to Note 2.
• Operating income (loss) and income (loss) before income taxes were reduced by $7 million for Corporate due to charges
related to our acquisition of BodyArmor. Refer to Note 12.
• Income (loss) before income taxes was increased by $599 million for Corporate due to the refranchising of our bottling
operations in the Philippines. Refer to Note 2.
• Income (loss) before income taxes was increased by $516 million for Corporate related to the sale of our ownership
interest in an equity method investee in Thailand. Refer to Note 2.
• Income (loss) before income taxes was increased by $290 million for Corporate due to the refranchising of our bottling
operations in certain territories in India, including the impact of post-closing adjustments. Refer to Note 2.
• Income (loss) before income taxes was increased by $228 million for Corporate due to realized and unrealized gains and
losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt
securities. Refer to Note 4.
• Income (loss) before income taxes was reduced by $44 million for Bottling Investments, $3 million for Latin America and
$2 million for Corporate due to the Company’s proportionate share of significant operating and nonoperating items
recorded by certain of our equity method investees.
• Income (loss) before income taxes was reduced by $34 million for Latin America due to an other-than-temporary
impairment charge related to an equity method investee. Refer to Note 16.
• Income (loss) before income taxes was reduced by $7 million for Corporate related to post-closing adjustments for the
refranchising of our bottling operations in Vietnam. Refer to Note 2.
During the six months ended June 30, 2023, the results of our operating segments and Corporate were impacted by the
following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $1,324 million for Corporate due to the
remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition. Refer to
Note 16.
• Operating income (loss) and income (loss) before income taxes were reduced by $52 million for Corporate due to the
Company’s productivity and reinvestment program. Operating income (loss) and income (loss) before income taxes were
increased by $1 million for North America due to the refinement of previously established accruals related to the
Company’s productivity and reinvestment program. Refer to Note 13.
• Operating income (loss) and income (loss) before income taxes were reduced by $35 million for Asia Pacific due to the
discontinuation of certain manufacturing operations.
• Operating income (loss) and income (loss) before income taxes were reduced by $26 million for North America due to the
restructuring of our North America operating unit. Refer to Note 13.
• Operating income (loss) and income (loss) before income taxes were reduced by $11 million for North America due to the
restructuring of our manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $7 million for Corporate due to charges
related to our acquisition of BodyArmor. Refer to Note 12.
31

-- 34 of 161 --

• Operating income (loss) and income (loss) before income taxes were reduced by $6 million for Corporate related to tax
litigation expense. Refer to Note 9.
• Income (loss) before income taxes was increased by $439 million for Corporate due to the refranchising of our bottling
operations in Vietnam. Refer to Note 2.
• Income (loss) before income taxes was increased by $240 million for Corporate due to realized and unrealized gains and
losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt
securities. Refer to Note 4.
• Income (loss) before income taxes was reduced by $140 million for Asia Pacific and was increased by $56 million for
Bottling Investments due to the Company’s proportionate share of significant operating and nonoperating items recorded
by certain of our equity method investees.
32

-- 35 of 161 --

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola
Company and all entities included in our consolidated financial statements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Equity Method Investments and Indefinite-Lived Intangible Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the
countries and territories in which we operate, particularly in developing and emerging markets. Refer to the headings “Item 1A.
Risk Factors” in Part I and “Our Business — Challenges and Risks” in Part II of our Annual Report on Form 10-K for the year
ended December 31, 2023, as well as the heading “Operations Review” below for additional information related to our present
business environment. As a result, management must make numerous assumptions, which involve a significant amount of
judgment, when performing impairment tests of equity method investments and indefinite-lived intangible assets in various
regions around the world. The performance of impairment tests involves critical accounting estimates. These estimates require
significant management judgment and include inherent uncertainties. Factors that management must estimate include, among
others, the economic lives of the assets, sales volume, pricing, royalty rates, cost of raw materials, delivery costs, long-term
growth rates, discount rates, marketing spending, foreign currency exchange rates, tax rates, capital spending and proceeds from
the sale of assets. The variability of these factors depends on a number of conditions, and thus our accounting estimates may
change from period to period. These factors are even more difficult to estimate when global financial markets are highly
volatile. As these factors are often interdependent and may not change in isolation, we do not believe it is practicable or
meaningful to present the impact of changing a single factor.
In November 2021, the Company acquired the remaining 85% ownership interest in, and now owns 100% of, BA Sports
Nutrition, LLC (“BodyArmor”), which offers a line of sports performance and hydration beverages. During 2021, in
conjunction with acquiring the remaining ownership interest, we recognized a noncash gain of $834 million resulting from the
remeasurement of our previously held equity interest in BodyArmor to fair value. The Company allocated $4.2 billion of the
$5.6 billion purchase price to the BodyArmor trademark. During the three months ended March 29, 2024, the operating results
related to the trademark were lower than expected. Therefore, the Company revised its projections of the future operating
results related to the trademark which triggered the need to update its impairment analysis. As a result, the Company concluded
that the fair value of the trademark was less than its carrying value and recorded an impairment charge of $760 million. The
decrease in fair value was primarily driven by the revised projections of future operating results as well as higher discount rates
resulting from changes in macroeconomic conditions since the acquisition date. If the near-term operating results of this
trademark do not achieve our revised financial projections, or if the macroeconomic conditions change causing the discount rate
to increase without an offsetting increase in the operating results, it is likely that we would be required to recognize an
additional impairment charge. Management will continue to monitor the fair value of this trademark in future periods.
OPERATIONS REVIEW
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting
for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions.
Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company’s operating performance, from time to time, we engage in buying and
selling ownership interests in bottling partners and other manufacturing operations. In addition, we periodically acquire brands
and their related operations or enter into license agreements for certain brands to supplement our beverage offerings. These
items impact our operating results and certain key metrics used by management in assessing the Company’s performance.
Unit case volume growth is a key metric used by management to evaluate the Company’s performance because it measures
demand for our products at the consumer level. The Company’s unit case volume represents the number of unit cases (or unit
case equivalents) of Company beverage products directly or indirectly sold by the Company and its bottling partners to
customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers. Refer to the
heading “Beverage Volume” below.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances
expressed in unit case equivalents) sold by, or used in finished products sold by, the Company to its bottling partners or other
customers. For Costa non-ready-to-drink beverage products, concentrate sales volume represents the amount of beverages,
primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to
customers or consumers. Refer to the heading “Beverage Volume” below.
33

-- 36 of 161 --

When we analyze our net operating revenues, we generally consider the following factors: (1) volume growth (concentrate sales
volume or unit case volume, as applicable); (2) changes in price, product and geographic mix; (3) foreign currency exchange
rate fluctuations; and (4) acquisitions and divestitures (including structural changes as defined below), as applicable. Refer to
the heading “Net Operating Revenues” below. The Company sells concentrates and syrups to both consolidated and
unconsolidated bottling partners. The ownership structure of our bottling partners impacts the timing of recognizing concentrate
revenue and concentrate sales volume. When we sell concentrates or syrups to our consolidated bottling partners, we do not
recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products
manufactured from the concentrates or syrups to a third party. When we sell concentrates or syrups to our unconsolidated
bottling partners, we recognize the concentrate revenue and concentrate sales volume when the concentrates or syrups are sold
to the bottling partner. The subsequent sale of the finished products manufactured from the concentrates or syrups to a third
party does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we account for an
unconsolidated bottling partner as an equity method investment, we eliminate the intercompany profit related to concentrate
sales, to the extent of our ownership interest, until the equity method investee has sold finished products manufactured from the
concentrates or syrups to a third party. We typically report unit case volume when finished products manufactured from the
concentrates or syrups are sold to a third party, regardless of our ownership interest in the bottling partner, if any.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of
acquisitions and divestitures. Typically, structural changes do not impact the Company’s unit case volume or concentrate sales
volume on a consolidated basis or at the geographic operating segment level. We report unit case volume for all sales of
Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume
reported by our Bottling Investments operating segment is generally impacted by structural changes because it only includes the
unit case volume of our consolidated bottling operations. Refer to Note 2 of Notes to Consolidated Financial Statements for
additional information on the Company’s divestitures.
“Acquired brands” refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case
volume or recognized concentrate sales volume related to acquired brands in periods prior to the closing of a transaction.
Therefore, the unit case volume and concentrate sales volume related to an acquired brand are incremental to prior year volume.
We generally do not consider the acquisition of a brand to be a structural change.
“Licensed brands” refers to brands not owned by the Company but for which we hold certain rights, generally including, but not
limited to, distribution rights, and from which we derive an economic benefit when the related products are sold. Typically, the
Company has not reported unit case volume or recognized concentrate sales volume related to a licensed brand in periods prior
to the beginning of the term of a license agreement. Therefore, in the year that a license agreement is entered into, the unit case
volume and concentrate sales volume related to a licensed brand are incremental to prior year volume. We generally do not
consider the licensing of a brand to be a structural change.
In May 2023, the Company acquired certain brands in Asia Pacific. The impact of acquiring these brands has been included in
acquisitions and divestitures in our analysis of net operating revenues on a consolidated basis as well as for the Asia Pacific
operating segment for the three and six months ended June 28, 2024. Additionally, in January 2023, the Company refranchised
our bottling operations in Vietnam. The impact of this refranchising has been included as a structural change in our analysis of
net operating revenues on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for
the six months ended June 28, 2024. In January and February 2024, the Company refranchised our bottling operations in certain
territories in India, and in February 2024, the Company refranchised our bottling operations in Bangladesh and the Philippines.
The impact of each of these refranchisings has been included as a structural change in our analysis of net operating revenues on
a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for the three and six months
ended June 28, 2024.
Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and
(2) concentrate sales. As used in this report, “unit case” means a unit of measurement equal to 192 U.S. fluid ounces of finished
beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink beverage products,
which are primarily measured in number of transactions; and “unit case volume” means the number of unit cases (or unit case
equivalents) of Company beverage products directly or indirectly sold by the Company and its bottling partners to customers or
consumers. Unit case volume primarily consists of beverage products bearing Company trademarks. Also included in unit case
volume are certain brands licensed to, or distributed by, our Company, and brands owned by Coca-Cola system bottlers for
which our Company provides marketing support and from the sale of which we derive an economic benefit. In addition, unit
case volume includes sales by certain joint ventures in which the Company has an ownership interest. We believe unit case
volume is one of the indicators of the underlying strength of the Coca-Cola system because it measures demand for our
products at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the
Company from its bottling partners and distributors. Concentrate sales volume represents the amount of concentrates, syrups,
34

-- 37 of 161 --

source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished beverages
sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products, concentrate
sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in
unit case equivalents), sold by the Company to customers or consumers. Unit case volume and concentrate sales volume growth
rates are not necessarily equal during any given period. Factors such as seasonality, bottlers’ inventory practices, supply point
changes, timing of price increases, new product introductions and changes in product mix can create differences between unit
case volume and concentrate sales volume growth rates. In addition to these items, the impact of unit case volume from certain
joint ventures in which the Company has an ownership interest, but to which the Company does not sell concentrates, syrups,
source waters or powders/minerals, may give rise to differences between unit case volume and concentrate sales volume growth
rates.
Information about our volume growth worldwide and for each of our operating segments is as follows:
Percent Change 2024 versus 2023
Three Months Ended
June 28, 2024 Six Months Ended
June 28, 2024
Unit Cases1,2,3 Concentrate
Sales4 Unit Cases1,2,3 Concentrate
Sales4
Worldwide 2% 5% 6 2% 1% 6
Europe, Middle East & Africa — 5 1 —
Latin America 5 9 4 4
North America (1) (1) (1) —
Asia Pacific 3 5 7 1 4 7
Global Ventures 3 3 2 2
Bottling Investments (27) 5 N/A (17) 5 N/A
1 Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
2 Geographic and Global Ventures operating segment data reflects unit case volume growth for all bottlers, both consolidated and
unconsolidated, and distributors in the applicable geographic areas. Global Ventures operating segment data also reflects unit case volume
growth for Costa retail stores.
3 Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by
comparing the average daily sales in each of the corresponding periods. Average daily sales are the unit cases sold during the period divided
by the number of days in the period.
4 Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in
unit case equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers and is not based
on average daily sales. For Costa non-ready-to-drink beverage products, concentrate sales volume represents the amount of beverages,
primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or
consumers and is not based on average daily sales. Each of our quarters, other than the fourth quarter, ends on the Friday closest to the last
day of the corresponding quarterly calendar period. As a result, the first quarter of 2024 had one less day when compared to the first quarter
of 2023, and the fourth quarter of 2024 will have two additional days when compared to the fourth quarter of 2023.
5 After considering the impact of structural changes, unit case volume for Bottling Investments for both the three and six months ended
June 28, 2024 grew 7%.
6 After considering the impact of structural changes, worldwide concentrate sales volume for the three and six months ended June 28, 2024
grew 6% and 2%, respectively.
7 After considering the impact of structural changes, concentrate sales volume for Asia Pacific for the three and six months ended June 28,
2024 grew 7% and 3%, respectively.
Unit Case Volume
Although a significant portion of our Company’s net operating revenues is not based directly on unit case volume, we believe
unit case volume performance is one of the indicators of the underlying strength of the Coca-Cola system because it measures
demand for our products at the consumer level.
Three Months Ended June 28, 2024 versus Three Months Ended June 30, 2023
Unit case volume in Europe, Middle East and Africa was even, which included 5% growth in water, sports, coffee and tea, and
1% growth in sparkling flavors, offset by a 1% decline in Trademark Coca-Cola and a 3% decline in juice, value-added dairy
and plant-based beverages. The operating segment reported an increase in unit case volume of 5% in the Africa operating unit,
offset by declines of 1% in the Europe operating unit and 2% in the Eurasia and Middle East operating unit.
Unit case volume in Latin America increased 5%, which included 6% growth in Trademark Coca-Cola, 5% growth in water,
sports, coffee and tea, and 1% growth in both sparkling flavors and juice, value-added dairy and plant-based beverages. The
35

-- 38 of 161 --

operating segment’s volume performance included 6% growth in Mexico and 12% growth in Brazil, partially offset by a
decline of 18% in Argentina.
Unit case volume in North America decreased 1%, which included a 5% decline in water, sports, coffee and tea, a 1% decline in
Trademark Coca-Cola and a 2% decline in sparkling flavors, partially offset by 4% growth in juice, value-added dairy and
plant-based beverages.
Unit case volume in Asia Pacific increased 3%, which included 8% growth in sparkling flavors and 4% growth in both
Trademark Coca-Cola and juice, value-added dairy and plant-based beverages, partially offset by a 4% decline in water, sports,
coffee and tea. The operating segment’s volume performance included 15% growth in the India and Southwest Asia operating
unit and 5% growth in both the ASEAN and South Pacific operating unit and Japan and South Korea operating unit, partially
offset by a decline in unit case volume of 7% in the Greater China and Mongolia operating unit.
Unit case volume for Global Ventures increased 3%, driven by growth in energy drinks, partially offset by a 7% decline in
water, sports, coffee and tea, and a 2% decline in juice, value-added dairy and plant-based beverages.
Unit case volume for Bottling Investments decreased 27%, driven by the impact of refranchising our bottling operations in the
Philippines, Bangladesh and certain territories in India.
Six Months Ended June 28, 2024 versus Six Months Ended June 30, 2023
Unit case volume in Europe, Middle East and Africa increased 1%, which included 7% growth in water, sports, coffee and tea,
and 1% growth in sparkling flavors, partially offset by a 1% decline in juice, value-added dairy and plant-based beverages. Unit
case volume in Trademark Coca-Cola was even. The operating segment reported an increase in unit case volume of 7% in the
Africa operating unit, partially offset by declines of 2% in the Eurasia and Middle East operating unit and 1% in the Europe
operating unit.
Unit case volume in Latin America increased 4%, which included 6% growth in Trademark Coca-Cola, 5% growth in water,
sports, coffee and tea, and 1% growth in sparkling flavors. Unit case volume in juice, value-added dairy and plant-based
beverages was even. The operating segment’s volume performance included 5% growth in Mexico and 10% growth in Brazil,
partially offset by a 21% decline in Argentina.
Unit case volume in North America decreased 1%, which included a 5% decline in water, sports, coffee and tea, and a 1%
decline in sparkling flavors, partially offset by 4% growth in juice, value-added dairy and plant-based beverages. Unit case
volume in Trademark Coca-Cola was even.
Unit case volume in Asia Pacific increased 1%, which included 4% growth in sparkling flavors, 3% growth in Trademark
Coca-Cola and 2% growth in juice, value-added dairy and plant-based beverages, partially offset by a 7% decline in water,
sports, coffee and tea. The operating segment’s volume performance included 10% growth in the India and Southwest Asia
operating unit, 6% growth in the ASEAN and South Pacific operating unit and 3% growth in the Japan and South Korea
operating unit, partially offset by a decline in unit case volume of 9% in the Greater China and Mongolia operating unit.
Unit case volume for Global Ventures increased 2%, driven by growth in energy drinks, partially offset by a 6% decline in
water, sports, coffee and tea. Unit case volume in juice, value-added dairy and plant-based beverages was even.
Unit case volume for Bottling Investments decreased 17%, driven by the impact of refranchising our bottling operations in the
Philippines, Bangladesh and certain territories in India.
Concentrate Sales Volume
During the three months ended June 28, 2024, worldwide concentrate sales volume increased 5% and unit case volume
increased 2% compared to the three months ended June 30, 2023. During the six months ended June 28, 2024, worldwide
concentrate sales volume increased 1% and unit case volume increased 2% compared to the six months ended June 30, 2023.
Concentrate sales volume growth is calculated based on the amount sold during the reporting periods, which is impacted by the
number of days. Conversely, unit case volume growth is calculated based on average daily sales, which is not impacted by the
number of days in the reporting periods. The differences between concentrate sales volume and unit case volume growth rates
for the operating segments were primarily due to the timing of concentrate shipments. In addition, the first quarter of 2024 had
one less day when compared to the first quarter of 2023, which also contributed to the differences between concentrate sales
volume and unit case volume growth rates on a consolidated basis and for the individual operating segments during the six
months ended June 28, 2024. We expect the differences between concentrate sales volume and unit case volume growth rates to
lessen over the remainder of the year.
36

-- 39 of 161 --

Net Operating Revenues
Three Months Ended June 28, 2024 versus Three Months Ended June 30, 2023
During the three months ended June 28, 2024, net operating revenues were $12,363 million, compared to $11,972 million
during the three months ended June 30, 2023, an increase of $391 million, or 3%.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in
net operating revenues on a consolidated basis and for each of our operating segments:
Percent Change 2024 versus 2023
Volume1 Price, Product &
Geographic Mix Foreign Currency
Fluctuations
Acquisitions &
Divestitures2 Total
Consolidated 6% 9% (6) % (5) % 3%
Europe, Middle East & Africa 5 24 (23) — 7
Latin America 9 19 (9) — 20
North America (1) 11 — — 10
Asia Pacific 7 (3) (6) (2) (4)
Global Ventures 3 (2) — — —
Bottling Investments 7 7 (2) (37) (25)
Note: Certain rows may not add due to rounding.
1 Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our
geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact
of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating
revenues attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily
sales) in each of the corresponding periods after considering the impact of structural changes, if any. Our Bottling Investments operating
segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer
to the heading “Beverage Volume” above.
2 Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate
sales volumes.
“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as pricing actions
taken by the Company and, where applicable, our bottling partners; the mix of categories, products and packages sold; and the
mix of channels and geographic territories where the sales occurred. Management believes that providing investors with price,
product and geographic mix enhances their understanding about the combined impact that these items had on the Company’s
net operating revenues. The impact of price, product and geographic mix is calculated by subtracting the change in net
operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and
acquisitions and divestitures from the total change in net operating revenues. Management uses this measure in making
financial, operating and planning decisions and in evaluating the Company’s performance.
Price, product and geographic mix had a 9% favorable impact on our consolidated net operating revenues. Price, product and
geographic mix was impacted by a variety of factors and events including, but not limited to, the following:
• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing primarily in Nigeria,
Türkiye and Zimbabwe, and favorable category mix;
• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina;
• North America — favorable pricing initiatives and favorable category mix, partially offset by unfavorable channel mix;
• Asia Pacific — unfavorable geographic and category mix, partially offset by favorable pricing initiatives;
• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and
• Bottling Investments — favorable pricing initiatives across most markets and favorable package and category mix,
partially offset by unfavorable geographic mix.
37

-- 40 of 161 --

Fluctuations in foreign currency exchange rates unfavorably impacted our consolidated net operating revenues by 6%. This
unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine
peso, Nigerian naira, Zimbabwean dollar and Turkish lira, which had an unfavorable impact on our Latin America; Europe,
Middle East and Africa; and Bottling Investments operating segments. The unfavorable impact of a stronger U.S. dollar
compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar compared to certain other
foreign currencies, including the Mexican peso and British pound, which had a favorable impact on our Latin America, Global
Ventures and Europe, Middle East and Africa operating segments. Refer to the heading “Liquidity, Capital Resources and
Financial Position — Foreign Exchange” below.
“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the
Company considers to be structural changes. The impact of acquisitions and divestitures is the difference between the change in
net operating revenues and the change in what our net operating revenues would have been if we removed the net operating
revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable.
Management believes that quantifying the impact that acquisitions and divestitures had on the Company’s net operating
revenues provides investors with useful information to enhance their understanding of the Company’s net operating revenue
performance by improving their ability to compare our period-to-period results. Management considers the impact of
acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired
Brands and Newly Licensed Brands” above for additional information related to acquisitions and divestitures.
Six Months Ended June 28, 2024 versus Six Months Ended June 30, 2023
During the six months ended June 28, 2024, net operating revenues were $23,663 million, compared to $22,952 million during
the six months ended June 30, 2023, an increase of $711 million, or 3%.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in
net operating revenues on a consolidated basis and for each of our operating segments:
Percent Change 2024 versus 2023
Volume1 Price, Product &
Geographic Mix Foreign Currency
Fluctuations
Acquisitions &
Divestitures2 Total
Consolidated 2% 11% (6) % (4) % 3%
Europe, Middle East & Africa — 23 (21) — 2
Latin America 4 21 (10) — 15
North America — 9 — — 9
Asia Pacific 3 2 (5) 1 1
Global Ventures 2 (2) 1 — 2
Bottling Investments 7 6 (3) (26) (16)
Note: Certain rows may not add due to rounding.
1 Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our
geographic operating segments and our Global Ventures operating segment (expressed in unit case equivalents) after considering the impact
of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating
revenues attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily
sales) in each of the corresponding periods after considering the impact of structural changes, if any. Our Bottling Investments operating
segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural changes, if any. Refer
to the heading “Beverage Volume” above.
2 Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate
sales volumes.
Price, product and geographic mix had an 11% favorable impact on our consolidated net operating revenues. Price, product and
geographic mix was impacted by a variety of factors and events including, but not limited to, the following:
• Europe, Middle East and Africa — favorable pricing initiatives, including inflationary pricing primarily in Nigeria,
Türkiye and Zimbabwe, and favorable geographic mix;
• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by unfavorable
category mix;
• North America — favorable pricing initiatives and favorable category mix, partially offset by unfavorable channel mix;
• Asia Pacific — favorable pricing initiatives and favorable package mix, partially offset by unfavorable geographic mix;
38

-- 41 of 161 --

• Global Ventures — unfavorable product mix, partially offset by favorable pricing initiatives; and
• Bottling Investments — favorable pricing initiatives across most markets and favorable package mix, partially offset by
unfavorable geographic mix.
Fluctuations in foreign currency exchange rates unfavorably impacted our consolidated net operating revenues by 6%. This
unfavorable impact was primarily due to a stronger U.S. dollar compared to certain foreign currencies, including the Argentine
peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen, which had an unfavorable impact on our Latin
America; Europe, Middle East and Africa; Asia Pacific; and Bottling Investments operating segments. The unfavorable impact
of a stronger U.S. dollar compared to the currencies listed above was partially offset by the impact of a weaker U.S. dollar
compared to certain other foreign currencies, including the Mexican peso and British pound, which had a favorable impact on
our Latin America, Global Ventures and Europe, Middle East and Africa operating segments. Refer to the heading “Liquidity,
Capital Resources and Financial Position — Foreign Exchange” below.
Net operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency
exchange rate fluctuations; and acquisitions and divestitures. The size and timing of acquisitions and divestitures are not
consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency
exchange rate fluctuations will have an unfavorable impact on our full year 2024 net operating revenues.
Gross Profit Margin
Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit
margin provides investors with useful information related to the profitability of our business prior to considering all of the
selling, general and administrative expenses and other operating charges incurred. Management uses this measure in making
financial, operating and planning decisions and in evaluating the Company’s performance.
Our gross profit margin increased to 61.1% for the three months ended June 28, 2024, compared to 59.0% for the three months
ended June 30, 2023. Our gross profit margin increased to 61.8% for the six months ended June 28, 2024, compared to 59.8%
for the six months ended June 30, 2023. These increases were primarily due to the impact of favorable pricing initiatives and
the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories in India, partially offset by the
unfavorable impact of foreign currency exchange rate fluctuations and higher commodity costs.
Selling, General and Administrative Expenses
The following table sets forth the components of selling, general and administrative expenses (in millions):
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Selling and distribution expenses $ 609 $ 682 $ 1,230 $ 1,336
Advertising expenses 1,400 1,219 2,561 2,284
Stock-based compensation expense 72 62 140 120
Other operating expenses 1,468 1,358 2,969 2,766
Selling, general and administrative expenses $ 3,549 $ 3,321 $ 6,900 $ 6,506
During the three and six months ended June 28, 2024, selling, general and administrative expenses increased $228 million, or
7%, and increased $394 million, or 6%, respectively, versus the prior year. The increases were primarily due to higher
advertising expenses, partially offset by a decrease in selling and distribution expenses. The decrease in selling and distribution
expenses was primarily due to the refranchising of our bottling operations in the Philippines, Bangladesh and certain territories
in India. During both the three and six months ended June 28, 2024, foreign currency exchange rate fluctuations decreased
selling, general and administrative expenses by 5%.
As of June 28, 2024, we had $363 million of total unrecognized compensation cost related to nonvested stock-based
compensation awards granted under our plans, which we expect to recognize over a weighted-average period of 1.8 years as
stock-based compensation expense. This expected cost does not include the impact of any future stock-based compensation
awards.
39

-- 42 of 161 --

Other Operating Charges
Other operating charges incurred by operating segment and Corporate were as follows (in millions):
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Europe, Middle East & Africa $ — $ — $ — $ —
Latin America — — — —
North America — 7 760 25
Asia Pacific — 35 — 35
Global Ventures — — — —
Bottling Investments — — — —
Corporate 1,370 1,296 2,183 1,389
Total $ 1,370 $ 1,338 $ 2,943 $ 1,449
During the three months ended June 28, 2024, the Company recorded other operating charges of $1,370 million. These charges
primarily consisted of $1,337 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, $32 million related to the Company’s productivity and
reinvestment program, and $3 million for the amortization of noncompete agreements related to the BodyArmor acquisition.
These charges were partially offset by a net benefit of $2 million related to a revision of management’s estimates for tax
litigation expense.
During the six months ended June 28, 2024, the Company recorded other operating charges of $2,943 million. These charges
primarily consisted of $2,102 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with our acquisition of fairlife, $760 million related to the impairment of our BodyArmor trademark and
$68 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included
$7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India and $7 million
for the amortization of noncompete agreements related to the BodyArmor acquisition. These charges were partially offset by a
net benefit of $1 million related to a revision of management’s estimates for tax litigation expense.
During the three months ended June 30, 2023, the Company recorded other operating charges of $1,338 million. These charges
primarily consisted of $1,262 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with the fairlife acquisition, $35 million related to the discontinuation of certain manufacturing operations in Asia
Pacific and $24 million related to the Company’s productivity and reinvestment program. In addition, other operating charges
included $8 million related to the restructuring of our North America operating unit, $6 million related to tax litigation expense
and $3 million for the amortization of noncompete agreements related to the BodyArmor acquisition.
During the six months ended June 30, 2023, the Company recorded other operating charges of $1,449 million. These charges
primarily consisted of $1,324 million related to the remeasurement of our contingent consideration liability to fair value in
conjunction with the fairlife acquisition, $51 million related to the Company’s productivity and reinvestment program and
$35 million related to the discontinuation of certain manufacturing operations in Asia Pacific. In addition, other operating
charges included $26 million related to the restructuring of our North America operating unit, $7 million for the amortization of
noncompete agreements related to the BodyArmor acquisition and $6 million related to tax litigation expense.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling
operations in certain territories in India. Refer to Note 9 of Notes to Consolidated Financial Statements for additional
information on the tax litigation. Refer to Note 13 of Notes to Consolidated Financial Statements for additional information on
the Company’s restructuring initiatives. Refer to Note 16 of Notes to Consolidated Financial Statements for additional
information on the fairlife acquisition and the BodyArmor impairment. Refer to Note 17 of Notes to Consolidated Financial
Statements for the impact these charges had on our operating segments and Corporate.
40

-- 43 of 161 --

Operating Income and Operating Margin
Information about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Europe, Middle East & Africa 47.6% 47.2% 48.9% 39.3%
Latin America 35.0 33.2 39.0 28.6
North America 49.9 50.6 36.8 39.0
Asia Pacific 24.5 28.0 27.2 21.4
Global Ventures 3.5 3.3 3.1 2.3
Bottling Investments 3.7 5.1 5.3 4.5
Corporate (64.2) (67.4) (60.3) (35.1)
Total 100.0% 100.0% 100.0% 100.0%
Operating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating
margin provides investors with useful information related to the profitability of our business after considering all of the selling,
general and administrative expenses and other operating charges incurred. Management uses this measure in making financial,
operating and planning decisions and in evaluating the Company’s performance.
Information about our operating margin on a consolidated basis and for each of our operating segments and Corporate is as
follows:
Three Months Ended Six Months Ended
June 28,
2024 June 30,
2023 June 28,
2024 June 30,
2023
Consolidated 21.3% 20.1% 20.2% 25.1%
Europe, Middle East & Africa 57.4 55.4 58.9 58.5
Latin America 55.8 57.9 58.6 59.7
North America 27.3 27.9 19.6 27.2
Asia Pacific 46.6 49.8 49.3 48.8
Global Ventures 12.1 10.2 9.8 8.8
Bottling Investments 6.4 6.0 7.6 6.6
Corporate * * * *
* Calculation is not meaningful.
Three Months Ended June 28, 2024 versus Three Months Ended June 30, 2023
During the three months ended June 28, 2024, operating income was $2,632 million, compared to $2,401 million during the
three months ended June 30, 2023, an increase of $231 million, or 10%. The increase was driven by an increase in concentrate
sales volume of 6% and favorable pricing initiatives. These items were partially offset by the impact of refranchising our
bottling operations in the Philippines, Bangladesh and certain territories in India; higher commodity costs; higher selling,
general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact
of 16%.
Fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 16% due to a stronger
U.S. dollar compared to certain foreign currencies, including the Argentine peso, Zimbabwean dollar and Turkish lira, which
had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Bottling Investments operating
segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the
impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Mexican peso, which had a favorable
impact on our Latin America operating segment. Refer to the heading “Liquidity, Capital Resources and Financial Position —
Foreign Exchange” below.
The Europe, Middle East and Africa operating segment reported operating income of $1,252 million and $1,133 million for the
three months ended June 28, 2024 and June 30, 2023, respectively. The increase in operating income was primarily driven by
concentrate sales volume growth of 5% and favorable pricing initiatives, partially offset by higher commodity costs, increased
marketing spending, higher operating expenses and an unfavorable foreign currency exchange rate impact of 22%.
41

-- 44 of 161 --

Latin America reported operating income of $920 million and $797 million for the three months ended June 28, 2024 and
June 30, 2023, respectively. The increase in operating income was primarily driven by an increase in concentrate sales volume
of 9% and favorable pricing initiatives, partially offset by increased marketing spending, higher operating expenses and an
unfavorable foreign currency exchange rate impact of 13%.
Operating income for North America for the three months ended June 28, 2024 and June 30, 2023 was $1,312 million and
$1,216 million, respectively. The increase in operating income was primarily driven by favorable pricing initiatives, partially
offset by a decline in concentrate sales volume of 1%, higher commodity costs, increased marketing spending and higher
operating expenses.
Asia Pacific’s operating income for the three months ended June 28, 2024 and June 30, 2023 was $647 million and
$673 million, respectively. The decrease in operating income was primarily driven by higher commodity costs, increased
marketing spending, the impact of acquired brands and structural changes, and an unfavorable foreign currency exchange rate
impact of 7%, partially offset by an increase in concentrate sales volume of 7% and lower other operating charges.
Global Ventures’ operating income for the three months ended June 28, 2024 and June 30, 2023 was $92 million and
$78 million, respectively. The increase in operating income was primarily driven by concentrate sales volume growth of 3%,
decreased marketing spending and a favorable foreign currency exchange rate impact of 1%, partially offset by higher operating
expenses.
Bottling Investments’ operating income for the three months ended June 28, 2024 and June 30, 2023 was $98 million and
$122 million, respectively. The decrease in operating income was primarily driven by the impact of refranchising our bottling
operations in the Philippines, Bangladesh and certain territories in India; higher commodity costs; higher operating expenses;
and an unfavorable foreign currency exchange rate impact of 3%, partially offset by unit case volume growth of 7% and
favorable pricing initiatives.
Corporate’s operating loss for the three months ended June 28, 2024 and June 30, 2023 was $1,689 million and $1,618 million,
respectively. Operating loss in 2024 increased as a result of higher other operating charges primarily due to the remeasurement
of our contingent consideration liability to fair value in conjunction with the fairlife acquisition, partially offset by a favorable
foreign currency exchange rate impact of 1%. Refer to Note 16 of Notes to Consolidated Financial Statements for additional
information on the fairlife acquisition.
Six Months Ended June 28, 2024 versus Six Months Ended June 30, 2023
During the six months ended June 28, 2024, operating income was $4,773 million, compared to $5,768 million during the six
months ended June 30, 2023, a decrease of $995 million, or 17%. The decrease was driven by the impact of refranchising our
bottling operations in the Philippines, Bangladesh and certain territories in India; higher commodity costs; higher selling,
general and administrative expenses; higher other operating charges; and an unfavorable foreign currency exchange rate impact
of 11%. These items were partially offset by an increase in concentrate sales volume of 2% and favorable pricing initiatives.
Fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% due to a stronger
U.S. dollar compared to certain foreign currencies, including the Argentine peso, Zimbabwean dollar and Turkish lira, which
had an unfavorable impact on our Latin America; Europe, Middle East and Africa; and Bottling Investments operating
segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially offset by the
impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Mexican peso, which had a favorable
impact on our Latin America operating segment. Refer to the heading “Liquidity, Capital Resources and Financial Position —
Foreign Exchange” below.
The Europe, Middle East and Africa operating segment reported operating income of $2,332 million and $2,268 million for the
six months ended June 28, 2024 and June 30, 2023, respectively. The increase in operating income was primarily driven by
favorable pricing initiatives, partially offset by higher commodity costs, increased marketing spending, higher operating
expenses and an unfavorable foreign currency exchange rate impact of 18%.
Latin America reported operating income of $1,862 million and $1,650 million for the six months ended June 28, 2024 and
June 30, 2023, respectively. The increase in operating income was primarily driven by concentrate sales volume growth of 4%
and favorable pricing initiatives, partially offset by higher commodity costs, increased marketing spending, higher operating
expenses and an unfavorable foreign currency exchange rate impact of 10%.
Operating income for North America for the six months ended June 28, 2024 and June 30, 2023 was $1,757 million and
$2,249 million, respectively. The decrease in operating income was primarily driven by higher commodity costs, increased
marketing spending, higher operating expenses and higher other operating charges due to the impairment of our BodyArmor
trademark, partially offset by favorable pricing initiatives. Refer to Note 16 of Notes to Consolidated Financial Statements for
additional information on the impairment of our BodyArmor trademark.
42

-- 45 of 161 --

Asia Pacific’s operating income for the six months ended June 28, 2024 and June 30, 2023 was $1,301 million and
$1,236 million, respectively. The increase in operating income was primarily driven by concentrate sales volume growth of 3%,
favorable pricing initiatives, lower other operating charges, and the impact of acquired brands and structural changes, partially
offset by higher commodity costs, increased marketing spending and an unfavorable foreign currency exchange rate impact of
4%.
Global Ventures’ operating income for the six months ended June 28, 2024 and June 30, 2023 was $147 million and
$129 million, respectively. The increase in operating income was primarily driven by concentrate sales volume growth of 2%
and a favorable foreign currency exchange rate impact of 1%, partially offset by increased marketing spending and higher
operating expenses.
Bottling Investments’ operating income for the six months ended June 28, 2024 and June 30, 2023 was $254 million and
$261 million, respectively. The decrease in operating income was primarily driven by the impact of refranchising our bottling
operations in the Philippines, Bangladesh and certain territories in India, higher commodity costs, increased marketing
spending, higher operating expenses and an unfavorable foreign currency exchange rate impact of 3%, partially offset by unit
case volume growth of 7% and favorable pricing initiatives.
Corporate’s operating loss for the six months ended June 28, 2024 and June 30, 2023 was $2,880 million and $2,025 million,
respectively. Operating loss in 2024 increased as a result of increased marketing spending, higher operating expenses and
higher other operating charges primarily due to the remeasurement of our contingent consideration liability to fair value in
conjunction with the fairlife acquisition. Refer to Note 16 of Notes to Consolidated Financial Statements for additional
information on the fairlife acquisition.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have
an unfavorable impact on our full year 2024 operating income.
Interest Income
During the three months ended June 28, 2024, interest income was $275 million, compared to $224 million during the three
months ended June 30, 2023, an increase of $51 million, or 23%. During the six months ended June 28, 2024, interest income
was $521 million, compared to $392 million during the six months ended June 30, 2023, an increase of $129 million, or 33%.
The increases were primarily driven by higher average investment balances on our Corporate and certain international
investments.
Interest Expense
During the three months ended June 28, 2024, interest expense was $418 million, compared to $374 million during the three
months ended June 30, 2023, an increase of $44 million, or 12%. During the six months ended June 28, 2024, interest expense
was $800 million, compared to $746 million during the six months ended June 30, 2023, an increase of $54 million, or 7%. The
increases were primarily due to the impact of higher debt balances and higher interest rates on derivative instruments compared
to the prior year.
Equity Income (Loss) — Net
Three Months Ended June 28, 2024 versus Three Months Ended June 30, 2023
During the three months ended June 28, 2024, equity income was $537 million, compared to equity income of $538 million
during the three months ended June 30, 2023, a decrease of $1 million. The decrease reflects, among other items, the impact of
the sale of our ownership interest in certain of our equity method investees, a $22 million increase in net charges resulting from
the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method
investees and an unfavorable foreign currency exchange rate impact. These unfavorable impacts were partially offset by the
impact of more favorable operating results reported by certain of our equity method investees in the current year.
Six Months Ended June 28, 2024 versus Six Months Ended June 30, 2023
During the six months ended June 28, 2024, equity income was $891 million, compared to equity income of $813 million
during the six months ended June 30, 2023, an increase of $78 million, or 10%. The increase reflects, among other items, the
impact of more favorable operating results reported by certain of our equity method investees in the current year and a
$35 million decrease in net charges resulting from the Company’s proportionate share of significant operating and nonoperating
items recorded by certain of our equity method investees. These items were partially offset by the impact of the sale of our
ownership interests in certain of our equity method investees and an unfavorable foreign currency exchange rate impact.
43

-- 46 of 161 --

Other Income (Loss) — Net
Three Months Ended June 28, 2024 versus Three Months Ended June 30, 2023
During the three months ended June 28, 2024, other income (loss) — net was income of $2 million. The Company recognized a
net gain of $50 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well
as realized gains and losses on available-for-sale debt securities, dividend income of $48 million and income of $13 million
related to the non-service cost components of net periodic benefit cost. Other income (loss) — net also included net foreign
currency exchange losses of $64 million, an other-than-temporary impairment charge of $34 million related to an equity method
investee in Latin America and $29 million of costs related to our trade accounts receivable factoring program.
During the three months ended June 30, 2023, other income (loss) — net was income of $91 million. The Company recognized
a net gain of $127 million related to realized and unrealized gains and losses on equity securities and trading debt securities as
well as realized gains and losses on available-for-sale debt securities, recognized net foreign currency exchange losses of
$96 million, and recorded $20 million of costs related to our trade accounts receivable factoring program. Additionally, other
income (loss) — net included dividend income of $62 million and income of $12 million related to the non-service cost
components of net periodic benefit cost.
Refer to Note 4 of Notes to Consolidated Financial Statements for additional information on equity and debt securities. Refer to
Note 14 of Notes to Consolidated Financial Statements for additional information on net periodic benefit cost or income. Refer
to Note 16 of Notes to Consolidated Financial Statements for additional information on the other-than-temporary impairment
charge. Refer to Note 17 of Notes to Consolidated Financial Statements for the impact that certain of these items had on our
operating segments and Corporate.
Six Months Ended June 28, 2024 versus Six Months Ended June 30, 2023
During the six months ended June 28, 2024, other income (loss) — net was income of $1,515 million. The Company
recognized net gains of $599 million and $290 million related to the refranchising of our bottling operations in the Philippines
and certain territories in India, respectively. The Company also recognized a net gain of $516 million related to the sale of our
ownership interest in an equity method investee in Thailand. Additionally, the Company recognized a net gain of $228 million
related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and
losses on available-for-sale debt securities, dividend income of $73 million and income of $28 million related to the non-service
cost components of net periodic benefit cost. Other income (loss) — net also included net foreign currency exchange losses of
$132 million, $51 million of costs related to our trade accounts receivable factoring program, an other-than-temporary
impairment charge of $34 million related to an equity method investee in Latin America and a loss of $7 million related to post-
closing adjustments for the refranchising of our bottling operations in Vietnam in 2023.
During the six months ended June 30, 2023, other income (loss) — net was income of $706 million. The Company recognized a
net gain of $439 million related to the refranchising of our bottling operations in Vietnam. The Company recognized a net gain
of $240 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as
realized gains and losses on available-for-sale debt securities, recognized net foreign currency exchange losses of $120 million,
and recorded $31 million of costs related to our trade accounts receivable factoring program. Additionally, other income (loss)
— net included dividend income of $128 million and income of $25 million related to the non-service cost components of net
periodic benefit cost.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on the refranchising of our bottling
operations as well as the sale of our ownership interest in an equity method investee in Thailand. Refer to Note 4 of Notes to
Consolidated Financial Statements for additional information on equity and debt securities. Refer to Note 14 of Notes to
Consolidated Financial Statements for additional information on net periodic benefit cost or income. Refer to Note 16 of Notes
to Consolidated Financial Statements for additional information on the other-than-temporary impairment charge. Refer to Note
17 of Notes to Consolidated Financial Statements for the impact that certain of these items had on our operating segments and
Corporate.
Income Taxes
The Company recorded income taxes of $627 million (20.7% effective tax rate) and $359 million (12.5% effective tax rate)
during the three months ended June 28, 2024 and June 30, 2023, respectively. The Company recorded income taxes of
$1,314 million (19.0% effective tax rate) and $1,299 million (18.7% effective tax rate) during the six months ended June 28,
2024 and June 30, 2023, respectively.
44

-- 47 of 161 --

The Company’s effective tax rates for the three and six months ended June 28, 2024 and June 30, 2023 vary from the statutory
U.S. federal tax rate of 21.0% primarily due to the tax impact of significant operating and nonoperating items, as described in
Note 12 of Notes to Consolidated Financial Statements, along with the tax benefits of having significant earnings generated
outside of the United States and significant earnings generated in investments accounted for under the equity method, both of
which are generally taxed at rates lower than the statutory U.S. federal tax rate.
The Company’s effective tax rates for the three and six months ended June 28, 2024 included $119 million and $60 million,
respectively, of net tax expense related to various discrete tax items, including the resolution of certain foreign tax matters.
The Company’s effective tax rates for the three and six months ended June 30, 2023 included $120 million and $125 million,
respectively, of net tax benefits related to various discrete tax items, including a change in tax law in a certain foreign
jurisdiction.
On November 18, 2020, the U.S. Tax Court (“Tax Court”) issued an opinion (“Opinion”) regarding the Company’s 2015
litigation with the United States Internal Revenue Service (“IRS”) involving transfer pricing tax adjustments in which it
predominantly sided with the IRS. On November 8, 2023, the Tax Court issued a supplemental opinion (together with the
original Tax Court opinion, “Opinions”), siding with the IRS in concluding both that the blocked-income regulations apply to
the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as
to the validity of those regulations. The Company strongly disagrees with the Opinions and intends to vigorously defend its
position. Refer to Note 9 of Notes to Consolidated Financial Statements for additional information on the tax litigation.
At the end of each quarter, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year.
This estimate reflects, among other items, our best estimate of operating results and foreign currency exchange rates. Based on
enacted tax laws, as well as our current interpretation of recently issued regulations, the Company’s effective tax rate in 2024 is
expected to be 19.0% before considering the potential impact of any significant operating and nonoperating items that may
affect our effective tax rate. This rate does not include the impact of the ongoing tax litigation with the IRS, if the Company
were not to prevail.
Many jurisdictions have enacted legislation and adopted policies resulting from the Organization for Economic Co-operation
and Development’s (“OECD”) Anti-Base Erosion and Profit Shifting project. The OECD is currently coordinating a two-
pillared project on behalf of the G20 and other participating countries which would grant additional taxing rights over profits
earned by multinational enterprises to the countries in which their products are sold and services rendered. Pillar One would
allow countries to reallocate a portion of profits earned by multinational businesses with an annual global revenue exceeding
€20 billion and a profit margin of over 10% to applicable market jurisdictions. While the OECD issued draft language for the
international implementation of Pillar One in October 2023, both the substantive rules and implementation process remain
under discussion at the OECD so the timetable for any implementation remains uncertain.
In December 2021, the OECD issued Pillar Two model rules which would establish a global per-country minimum tax of 15%,
and the European Union has approved a directive requiring member states to incorporate similar provisions into their respective
domestic laws. The directive requires the rules to initially become effective for fiscal years starting on or after December 31,
2023. While it is uncertain whether the United States will enact legislation to adopt Pillar Two, numerous countries have
enacted legislation, or have indicated their intent to adopt legislation, to implement certain aspects of Pillar Two effective
January 1, 2024, with general implementation of the remaining global minimum tax rules by January 1, 2025. The OECD and
implementing countries are expected to continue to make further revisions to their legislation and release additional guidance.
The Company will continue to monitor developments to determine any potential impact in the countries in which we operate.
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION
We believe our ability to generate cash flows from operating activities is one of the fundamental strengths of our business.
Refer to the heading “Cash Flows from Operating Activities” below. The Company does not typically raise capital through the
issuance of stock. Instead, we use debt financing to lower our overall cost of capital and increase our return on shareowners’
equity. Refer to the heading “Cash Flows from Financing Activities” below. We have a history of borrowing funds both
domestically and internationally at reasonable interest rates, and we expect to be able to continue to borrow funds at reasonable
rates over the long term. Our debt financing also includes the use of a commercial paper program. We currently have the ability
to borrow funds in this market at levels that are consistent with our debt financing strategy, and we expect to continue to be able
to do so in the future. The Company regularly reviews its optimal mix of short-term and long-term debt.
The Company’s cash, cash equivalents, short-term investments and marketable securities totaled $19.0 billion as of June 28,
2024. In addition to these funds, our commercial paper program, and our ability to issue long-term debt, we had $4.6 billion in
unused backup lines of credit for general corporate purposes as of June 28, 2024. These backup lines of credit expire at various
times through 2028.
45

-- 48 of 161 --

Our current payment terms with the majority of our suppliers are 120 days. Two global financial institutions offer a voluntary
supply chain finance program which enables our suppliers, at their sole discretion, to sell their receivables from the Company to
these financial institutions on a non-recourse basis at a rate that leverages our credit rating and thus may be more beneficial to
them. We do not believe there is a risk that our payment terms will be shortened in the near future. Refer to Note 7 of Notes to
Consolidated Financial Statements for additional information.
The Company has a trade accounts receivable factoring program in certain countries. Under this program, we can elect to sell
trade accounts receivables to unaffiliated financial institutions at a discount. In these factoring arrangements, for ease of
administration, the Company collects customer payments related to the factored receivables and remits those payments to the
financial institutions. The Company sold $10,021 million and $7,197 million of trade accounts receivables under this program
during the six months ended June 28, 2024 and June 30, 2023, respectively. The costs of factoring such receivables were
$51 million and $31 million for the six months ended June 28, 2024 and June 30, 2023, respectively. The cash received from
the financial institutions is reflected within the operating activities section of our consolidated statement of cash flows.
Our current capital allocation priorities are as follows: investing wisely to support our business operations, continuing to grow
our dividend payment, enhancing our beverage portfolio and capabilities through consumer-centric acquisitions, and using
excess cash to repurchase shares over time. We currently expect 2024 capital expenditures to be approximately $2.2 billion.
During 2024, we expect to repurchase shares to offset dilution resulting from employee stock-based compensation. During
2025, we expect to pay the remaining milestone payment related to the acquisition of fairlife. Refer to Note 16 of Notes to
Consolidated Financial Statements for additional information on the milestone payment for fairlife.
We are currently in litigation with the IRS for tax years 2007 through 2009. On November 18, 2020, the Tax Court issued the
Opinion in which it predominantly sided with the IRS. On November 8, 2023, the Tax Court issued a supplemental opinion,
siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-income regulations) that address
the effect of certain Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the
Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v. Commissioner (February 9, 2023) controlled as to
the validity of those regulations. The Company strongly disagrees with the IRS’ positions and the portions of the Opinions
affirming such positions and intends to vigorously defend our positions utilizing every available avenue of appeal. While the
Company believes that it is more likely than not that we will ultimately prevail in this litigation upon appeal, it is possible that
all, or some portion of, the adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In the
event that all of the adjustments proposed by the IRS were to be ultimately upheld for tax years 2007 through 2009 and the IRS,
with the consent of the federal courts, were to decide to apply the underlying methodology (“Tax Court Methodology”) to the
subsequent years up to and including 2023, the Company currently estimates that the potential aggregate incremental tax and
interest liability could be approximately $16 billion as of December 31, 2023. Additional income tax and interest would
continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the
impact of the continued application of the Tax Court Methodology for the three and six months ended June 28, 2024 would
increase the potential aggregate incremental tax and interest liability by approximately $500 million and $1.0 billion,
respectively. The Company and the IRS are now in the process of agreeing on the tax impacts of the Opinions. Subsequent to
the completion of this process, the Tax Court will render a decision in the case. The Company will have 90 days thereafter to
file a notice of appeal to the U.S. Court of Appeals for the Eleventh Circuit. The IRS will then seek to collect any additional tax
related to the 2007 through 2009 tax years reflected in the Tax Court decision (and interest thereon). The Company expects to
pay such amounts at some point between the issuance of the Tax Court decision and the date the amounts are due pursuant to
the notice of collection from the IRS and expects this to occur by the end of 2024. The Company currently estimates that the
payment to be made at that time related to the 2007 through 2009 tax years, which is included in the above estimate of the
potential aggregate incremental tax and interest liability, would be approximately $6.0 billion (including interest accrued
through June 28, 2024), plus any additional interest accrued through the time of payment. Some or all of this amount, plus
accrued interest, would be refunded if the Company were to prevail on appeal. Refer to Note 9 of Notes to Consolidated
Financial Statements for additional information on the tax litigation.
While we believe it is more likely than not that we will prevail in the tax litigation discussed above, we are confident that,
between our ability to generate cash flows from operating activities and our ability to borrow funds at reasonable interest rates,
we can manage the range of possible outcomes in the final resolution of the matter.
Based on all of the aforementioned factors, the Company believes its current liquidity position is strong and will continue to be
sufficient to fund our operating activities and cash commitments for investing and financing activities for the foreseeable future.
46

-- 49 of 161 --

Cash Flows from Operating Activities
Net cash provided by operating activities during the six months ended June 28, 2024 and June 30, 2023 was $4,113 million and
$4,629 million, respectively, a decrease of $516 million, or 11%. This decrease was primarily driven by an unfavorable impact
due to foreign currency exchange rate fluctuations, higher tax payments and additional annual incentive payments in the current
year due to improved business performance in the prior year. In addition, the decrease was impacted by the timing of
concentrate sales and marketing payments, and the prior year impact of working capital initiatives. These items were partially
offset by strong cash operating results, a dividend payment from an equity method investee in Thailand, payments in the prior
year resulting from the buildup of inventory to manage potential supply chain disruptions, and $167 million of the $275 million
milestone payment for fairlife in the prior year. Refer to Note 16 of Notes to Consolidated Financial Statements for additional
information on the milestone payment for fairlife.
Cash Flows from Investing Activities
Net cash provided by investing activities during the six months ended June 28, 2024 was $997 million, and net cash used in
investing activities during the six months ended June 30, 2023 was $766 million.
Purchases of Investments and Proceeds from Disposals of Investments
During the six months ended June 28, 2024, purchases of investments were $3,827 million and proceeds from disposals of
investments were $2,662 million, resulting in a net cash outflow of $1,165 million. During the six months ended June 30, 2023,
purchases of investments were $2,103 million and proceeds from disposals of investments were $1,608 million, resulting in a
net cash outflow of $495 million. This activity primarily represents the purchases of, and proceeds from the disposals of,
investments in marketable securities and short-term investments that were made as part of the Company’s overall cash
management strategy. Also included in this activity are purchases of, and proceeds from the disposals of, investments held by
our captive insurance companies. Refer to Note 4 of Notes to Consolidated Financial Statements for additional information on
our investments.
Proceeds from Disposals of Businesses, Equity Method Investments and Nonmarketable Securities
During the six months ended June 28, 2024 and June 30, 2023, proceeds from disposals of businesses, equity method
investments and nonmarketable securities were $2,907 million and $320 million, respectively. The activity during the six
months ended June 28, 2024 primarily related to sales of our ownership interests in certain equity method investees and the
refranchising of certain of our bottling operations. The activity during the six months ended June 30, 2023 primarily related to
sales of our ownership interests in certain equity method investees. Refer to Note 2 of Notes to Consolidated Financial
Statements.
Purchases of Property, Plant and Equipment
Purchases of property, plant and equipment during the six months ended June 28, 2024 and June 30, 2023 were $792 million
and $615 million, respectively.
Other Investing Activities
During the six months ended June 28, 2024 and June 30, 2023, the total cash inflow was $127 million and $44 million,
respectively. The activity during the six months ended June 28, 2024 included the collection of $69 million of deferred
proceeds related to the refranchising of our bottling operations in Vietnam.
Cash Flows from Financing Activities
Net cash used in financing activities during the six months ended June 28, 2024 and June 30, 2023 was $532 million and
$998 million, respectively.
Loans, Notes Payable and Long-Term Debt
During the six months ended June 28, 2024, the Company had issuances of debt of $6,832 million, which included
$2,677 million of issuances of commercial paper and short-term debt with maturities greater than 90 days and long-term debt
issuances of $4,155 million, net of related discounts and issuance costs.
The Company made payments of debt of $4,734 million during the six months ended June 28, 2024, which included
$1,117 million of net payments of commercial paper and short-term debt with maturities of 90 days or less, payments of
$2,450 million related to commercial paper and short-term debt with maturities greater than 90 days and payments of long-term
debt of $1,167 million. Refer to Note 8 of Notes to Consolidated Financial Statements for additional information.
During the six months ended June 30, 2023, the Company had issuances of debt of $4,638 million, which included $733 million
of net issuances of commercial paper and short-term debt with maturities of 90 days or less, $3,892 million of issuances of
47

-- 50 of 161 --

commercial paper and short-term debt with maturities greater than 90 days, and long-term debt issuances of $13 million, net of
related discounts and issuance costs.
The Company made payments of debt of $2,366 million during the six months ended June 30, 2023, which included payments
of $2,188 million related to commercial paper and short-term debt with maturities greater than 90 days and payments of long-
term debt of $178 million.
On December 31, 2021, the United Kingdom’s Financial Conduct Authority, the governing body responsible for regulating the
London Interbank Offered Rate (“LIBOR”), ceased to publish certain LIBOR reference rates. However, other LIBOR reference
rates, including U.S. dollar overnight, 1-month, 3-month, 6-month and 12-month maturities, continued to be published through
June 2023. As a result of the discontinuation of LIBOR, we have amended our LIBOR-referencing agreements to either
reference the Secured Overnight Financing Rate or include mechanics for selecting an alternative rate. Refer to Note 6 of Notes
to Consolidated Financial Statements for additional information on our hedging activities.
Issuances of Stock
The issuances of stock during the six months ended June 28, 2024 and June 30, 2023 were related to the exercise of stock
options by employees.
Purchases of Stock for Treasury
During the six months ended June 28, 2024, the total cash outflow for treasury stock purchases was $874 million. The
Company repurchased 12.9 million shares of common stock under the share repurchase plan authorized by our Board of
Directors. These shares were repurchased at an average cost of $60.38 per share, for a total cost of $777 million. In addition to
shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the
Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap
exercises of employee stock options and/or the vesting of restricted stock issued to employees. The net impact of the
Company’s issuances of stock and share repurchases during the six months ended June 28, 2024 resulted in a net cash outflow
of $437 million.
During the six months ended June 30, 2023, the total cash outflow for treasury stock purchases was $1,084 million. The
Company repurchased 16.1 million shares of common stock under the share repurchase plan authorized by our Board of
Directors. These shares were repurchased at an average cost of $60.94 per share, for a total cost of $980 million. In addition to
shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the
Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap
exercises of employee stock options and/or the vesting of restricted stock issued to employees. The net impact of the
Company’s issuances of stock and share repurchases during the six months ended June 30, 2023 resulted in a net cash outflow
of $725 million.
Dividends
During the six months ended June 28, 2024 and June 30, 2023, the Company paid dividends of $2,184 million and
$2,089 million, respectively. As a result of the timing of our quarterly reporting periods as well as our dividend payment dates,
the Company paid substantially all of the 2023 and 2024 second quarterly dividends in the third quarter of each year.
Our Board of Directors approved the Company’s regular quarterly dividend of $0.485 per share at its July 2024 meeting. This
dividend is payable on October 1, 2024 to shareowners of record as of the close of business on September 13, 2024.
Other Financing Activities
During the six months ended June 28, 2024 and June 30, 2023, the total cash outflow for other financing activities was
$9 million and $456 million, respectively. The cash outflow during the six months ended June 30, 2023 included $108 million
of the $275 million milestone payment for fairlife. Additionally, the cash outflow during the six months ended June 30, 2023
included payments totaling $311 million of the purchase price of BodyArmor, which included amounts originally held back for
indemnification obligations. Refer to Note 16 of Notes to Consolidated Financial Statements for additional information on the
milestone payment for fairlife.
Foreign Exchange
Our international operations are subject to certain opportunities and risks, including currency fluctuations and governmental
actions. We closely monitor our operations in each country and seek to adopt appropriate strategies that are responsive to
changing economic and political environments as well as to fluctuations in currencies.
Due to the geographic diversity of our operations, weakness in some currencies may be offset by strength in other currencies
over time. Our foreign currency management program is designed to mitigate, over time, a portion of the potentially
unfavorable impact of exchange rate fluctuations on our net income. Taking into account the effects of our hedging activities,
48

-- 51 of 161 --

the impact of fluctuations in foreign currency exchange rates decreased our operating income for the three and six months
ended June 28, 2024 by 16% and 11%, respectively.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have
an unfavorable impact on operating income and cash flows from operating activities through the end of the year.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have no material changes to the disclosures on this matter made in our Annual Report on Form 10-K for the year ended
December 31, 2023.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and
the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and
procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of the
end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer
concluded that the Company’s disclosure controls and procedures were effective as of June 28, 2024.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the quarter ended June 28, 2024
that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial
reporting.
49

-- 52 of 161 --

Part II. Other Information
Item 1. Legal Proceedings
Information regarding reportable legal proceedings is contained in Part I, “Item 3. Legal Proceedings” in our Annual Report
on Form 10-K for the year ended December 31, 2023. The following updates and restates the description of the previously
reported U.S. Federal Income Tax Dispute matter and describes a new environmental matter. Management believes that,
except as disclosed in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a
result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.
U.S. Federal Income Tax Dispute
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the United States Internal
Revenue Service (“IRS”) seeking approximately $3.3 billion of additional federal income tax for years 2007 through 2009. In
the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from certain of its
foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in
certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS
rules governing transfer pricing require arm’s-length pricing of transactions between related parties such as the Company’s U.S.
parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on
an arm’s-length methodology for determining the amount of U.S. taxable income that the U.S. parent company would report as
compensation from its foreign licensees. The Company and the IRS memorialized this accord in a closing agreement resolving
that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances
or relevant federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed
penalties by the IRS for using the agreed-upon tax calculation methodology that the Company and the IRS agreed would be
used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five
successive audit cycles for tax years 1996 through 2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007
through 2009 tax years in favor of an entirely different methodology, without prior notice to the Company. Using the new tax
calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent company from its foreign licensees
for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet
to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination
that forecloses to a company any and all alternative means for resolution of a tax dispute. As a result of the IRS’ designation of
the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly imposed tax assessment and pay
the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation
designation, preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015,
challenging the tax adjustments enumerated in the Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of
$135 million. The Company obtained a summary judgment in its favor on a different matter related to Mexican foreign tax
credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in
April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed
with the Company that dividends previously paid by the foreign licensees to the U.S. parent company in reliance upon the
Closing Agreement should continue to be allowed to offset royalties, including those that would become payable to the
Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion (together with
the original Tax Court opinion, “Opinions”), siding with the IRS in concluding both that certain U.S. tax regulations (known as
the blocked-income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the
Company’s licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v.
Commissioner (February 9, 2023) controlled as to the validity of those regulations.
50

-- 53 of 161 --

The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating
income earned by the Company’s foreign licensees to increase the Company’s U.S. tax. Moreover, the Company believes that
the retroactive imposition of such tax liability using a calculation methodology different from that previously agreed upon by
the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its
claims on appeal and vigorously defend its position. In addition, for its litigation with the IRS and for purposes of its appeal of
the Tax Court decision, the Company is currently evaluating the implications of several significant administrative law cases
recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled Chevron U.S.A., Inc. v.
NRDC (“Chevron”). Since 1984, Chevron had required that courts defer to agency interpretations of statutes and agency action.
In Ohio v. EPA and Garland v. Cargill, two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to
rule on agency interpretations and actions without the deference previously required by Chevron.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-
step evaluation process prescribed by Accounting Standards Codification 740, Accounting for Income Taxes. In doing so, we
consulted with outside advisors, and we reviewed and considered relevant laws, rules, and regulations, including, but not
limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert
our various well-founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal
merits of the Company’s tax positions, that it is more likely than not the Company’s tax positions will ultimately be sustained
on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the methodology
asserted by the IRS and affirmed in the Opinions (“Tax Court Methodology”), that could be applied by the courts upon final
resolution of the litigation. Based on the required probability analysis, we determined the methodologies we believe the federal
courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we recorded a tax reserve
of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as
the different tax treatment applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in
reliance upon the Closing Agreement, that would be recharacterized as royalties in accordance with the Opinions and the
Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is
unchanged as of June 28, 2024. However, we updated our calculation of the methodologies we believe the federal courts could
ultimately order to be used in calculating the Company’s tax. As a result of the application of the required probability analysis
to these updated calculations and the accrual of interest through the current reporting period, we updated our tax reserve as of
June 28, 2024 to $456 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is
possible that some portion or all of the adjustment proposed by the IRS and sustained by the Tax Court could ultimately be
upheld. In that event, the Company would likely be subject to significant additional liabilities for tax years 2007 through 2009,
and potentially also for subsequent years, which could have a material adverse impact on the Company’s financial position,
results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign
licensees potentially covered within the scope of the Opinions, assuming such methodology were to be ultimately upheld by the
courts, and the IRS were to decide to apply that methodology to subsequent years, with consent of the federal courts. This
impact would include taxes and interest accrued through December 31, 2023 for the 2007 through 2009 litigated tax years and
for subsequent tax years from 2010 through 2023. The calculations incorporated the estimated impact of correlative adjustments
to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the
potential aggregate incremental tax and interest liability could be approximately $16 billion as of December 31, 2023.
Additional income tax and interest would continue to accrue until the time any such potential liability, or portion thereof, were
to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three and six
months ended June 28, 2024 would increase the potential aggregate incremental tax and interest liability by approximately
$500 million and $1.0 billion, respectively. We currently project the continued application of the Tax Court Methodology in
future years, assuming similar facts and circumstances as of December 31, 2023, would result in an incremental annual tax
liability that would increase the Company’s effective tax rate by approximately 3.5%.
The Company and the IRS are now in the process of agreeing on the tax impacts of the Opinions. Subsequent to the completion
of this process, the Tax Court will render a decision in the case. The Company will have 90 days thereafter to file a notice of
appeal to the U.S. Court of Appeals for the Eleventh Circuit. The IRS will then seek to collect any additional tax related to the
2007 through 2009 tax years reflected in the Tax Court decision (and interest thereon). The Company expects to pay such
amounts at some point between the issuance of the Tax Court decision and the date the amounts are due pursuant to the notice
of collection from the IRS. The Company currently estimates that the payment to be made at that time related to the 2007
through 2009 tax years, which is included in the above estimate of the potential aggregate incremental tax and interest liability,
would be approximately $6.0 billion (including interest accrued through June 28, 2024), plus any additional interest accrued
51

-- 54 of 161 --

through the time of payment. Some or all of this amount, plus accrued interest, would be refunded if the Company were to
prevail on appeal.
Environmental Matter
On June 20, 2024, the Mayor and City Council of Baltimore filed a lawsuit against the Company and several unrelated parties
in the Circuit Court for Baltimore City, Maryland, concerning the environmental impacts of plastic packaging on the city’s
lands and waterways. The complaint asserts claims for (a) violations of various state statutes and local ordinances that prohibit
littering or improper dumping of waste on public or private property; (b) unfair, abusive or deceptive trade practices; (c)
trespass upon city property; (d) design defects; (e) public nuisance; (f) failure to warn; and (g) negligence. The complaint seeks
injunctive relief, compensatory damages and punitive damages but does not specify an amount of damages sought. The
Company believes it has strong defenses to the claims.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item
1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, which could materially affect
our business, financial condition or future results. The risks described in this report and in our Annual Report on Form 10-K are
not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem
to be immaterial, could also materially adversely affect our business, financial condition or future results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three
months ended June 28, 2024 by the Company or any “affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3)
under the Securities Exchange Act of 1934, as amended (“Exchange Act”):
Period Total Number of
Shares Purchased1
Average
Price Paid
Per Share
Total Number of
Shares Purchased as
Part of the Publicly
Announced Plan2
Maximum Number
of Shares That May
Yet Be Purchased
Under the Publicly
Announced Plan
March 30, 2024 through April 26, 2024 832,000 $ 59.65 832,000 91,666,097
April 27, 2024 through May 24, 2024 713,782 62.61 713,100 90,952,997
May 25, 2024 through June 28, 2024 971,300 63.01 971,300 89,981,697
Total 2,517,082 $ 61.79 2,516,400
1 The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the 2019 Plan described in footnote 2 below and (2)
shares surrendered, if any, to the Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-
called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
2 In February 2019, the Company publicly announced that our Board of Directors had authorized a plan (“2019 Plan”) for the Company to
purchase up to 150 million shares of our common stock. This column discloses the number of shares purchased, if any, pursuant to the 2019
Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading plans meeting the requirements of
Rule 10b5-1 under the Exchange Act).
Item 5. Other Information
During the fiscal quarter ended June 28, 2024, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange
Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is
defined in Item 408 of Regulation S-K, except as follows:
Jennifer K. Mann, Executive Vice President and President, North America operating unit, adopted a Rule 10b5-1 trading
arrangement on May 22, 2024 for the potential exercise of vested stock options and the associated sale of up to 129,268 shares
of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is May 31, 2025.
This trading plan was adopted during an open trading window.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with
information regarding their terms and are not intended to provide any other factual or disclosure information about the
Company or the other parties to the agreements. The agreements contain representations, warranties, covenants and conditions
by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been
made solely for the benefit of the other parties to the applicable agreement and:
52

-- 55 of 161 --

• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of
the parties if those statements prove to be inaccurate;
• may have been qualified by disclosures that were made to the other party in connection with the negotiation of the
applicable agreement, which disclosures are not necessarily reflected in the agreement;
• may apply standards of materiality in a way that is different from what may be viewed as material to you or other
investors; and
• were made only as of the date of the applicable agreement, or such other date or dates as may be specified in the
agreement, and are subject to more recent developments.
Accordingly, these representations, warranties, covenants and conditions may not describe the actual state of affairs as of the
date they were made or at any other time. Additional information about the Company may be found elsewhere in this report and
the Company’s other public filings, which are available without charge through the Securities and Exchange Commission’s
website at http://www.sec.gov.
EXHIBIT INDEX
Exhibit No.
(With regard to applicable cross-references in the list of exhibits below, the Company’s Current, Quarterly and Annual
Reports are filed with the Securities and Exchange Commission (“SEC”) under File No. 001-02217; and Coca-Cola
Refreshments USA, LLC’s (formerly known as Coca-Cola Refreshments USA, Inc. and Coca-Cola Enterprises Inc.) Current,
Quarterly and Annual Reports are filed with the SEC under File No. 001-09300).
3.1 Certificate of Incorporation of the Company, including Amendment of Certificate of Incorporation, dated July 27,
2012 — incorporated herein by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the
quarter ended September 28, 2012.
3.2 By-Laws of the Company, as amended and restated through October 19, 2023 — incorporated herein by reference to
Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on October 20, 2023.
4.1 As permitted by the rules of the SEC, the Company has not filed certain instruments defining the rights of holders of
long-term debt of the Company or consolidated subsidiaries under which the total amount of securities authorized
does not exceed 10% of the total assets of the Company and its consolidated subsidiaries. The Company agrees to
furnish to the SEC, upon request, a copy of any omitted instrument.
4.2 Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust
Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to
Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.3 First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of
April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust
Company, as trustee — incorporated herein by reference to Exhibit 4.2 to the Company’s Current Report on
Form 8-K filed on May 25, 2017.
4.4 Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of
April 26, 1988, as amended, between the Company and Deutsche Bank Trust Company Americas, as successor to
Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.3 of the Company’s Current
Report on Form 8-K filed on May 25, 2017.
4.5 Form of Note for 1.875% Notes due 2026 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Registration Statement on Form 8-A filed on September 19, 2014.
4.6 Form of Note for 1.125% Notes due 2027 — incorporated herein by reference to Exhibit 4.7 to the Company’s
Registration Statement on Form 8-A filed on March 6, 2015.
4.7 Form of Note for 1.625% Notes due 2035 — incorporated herein by reference to Exhibit 4.8 to the Company’s
Registration Statement on Form 8-A filed on March 6, 2015.
4.8 Form of Note for 1.100% Notes due 2036 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Registration Statement on Form 8-A filed on September 2, 2016.
4.9 Form of Note for 2.900% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on May 25, 2017.
4.10 Form of Note for 0.750% Notes due 2026 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on March 8, 2019.
4.11 Form of Note for 1.250% Notes due 2031 — incorporated herein by reference to Exhibit 4.7 to the Company’s
Current Report on Form 8-K filed on March 8, 2019.
4.12 Form of Note for 1.750% Notes due 2024 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on September 9, 2019.
4.13 Form of Note for 2.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on September 9, 2019.
53

-- 56 of 161 --

4.14 Form of Note for 3.375% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on March 25, 2020.
4.15 Form of Note for 3.450% Notes due 2030 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on March 25, 2020.
4.16 Form of Note for 4.125% Notes due 2040 — incorporated herein by reference to Exhibit 4.7 to the Company’s
Current Report on Form 8-K filed on March 25, 2020.
4.17 Form of Note for 4.200% Notes due 2050 — incorporated herein by reference to Exhibit 4.8 to the Company’s
Current Report on Form 8-K filed on March 25, 2020.
4.18 Form of Note for 1.450% Notes due 2027 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on May 4, 2020.
4.19 Form of Note for 1.650% Notes due 2030 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on May 4, 2020.
4.20 Form of Note for 2.500% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on May 4, 2020.
4.21 Form of Note for 2.600% Notes due 2050 — incorporated herein by reference to Exhibit 4.7 to the Company’s
Current Report on Form 8-K filed on May 4, 2020.
4.22 Form of Note for 2.750% Notes due 2060 — incorporated herein by reference to Exhibit 4.8 to the Company’s
Current Report on Form 8-K filed on May 4, 2020.
4.23 Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on September 18, 2020.
4.24 Form of Note for 0.375% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on September 18, 2020.
4.25 Form of Note for 0.800% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on September 18, 2020.
4.26 Form of Note for 1.000% Notes due 2028 — incorporated herein by reference to Exhibit 4.7 to the Company’s
Current Report on Form 8-K filed on September 18, 2020.
4.27 Form of Note for 1.375% Notes due 2031 — incorporated herein by reference to Exhibit 4.8 to the Company’s
Current Report on Form 8-K filed on September 18, 2020.
4.28 Form of Note for 2.500% Notes due 2051 — incorporated herein by reference to Exhibit 4.9 to the Company’s
Current Report on Form 8-K filed on September 18, 2020.
4.29 Form of Note for 1.500% Notes due 2028 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on March 5, 2021.
4.30 Form of Note for 2.000% Notes due 2031 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on March 5, 2021.
4.31 Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on March 9, 2021.
4.32 Form of Note for 0.500% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on March 9, 2021.
4.33 Form of Note for 1.000% Notes due 2041 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on March 9, 2021.
4.34 Form of Note for 2.250% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on May 5, 2021.
4.35 Form of Note for 2.875% Notes due 2041 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on May 5, 2021.
4.36 Form of Note for 3.000% Notes due 2051 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on May 5, 2021.
4.37 Form of Note for 0.950% Notes due 2036 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on May 6, 2021.
4.38 Form of Note for 0.400% Notes due 2030 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on May 17, 2021.
4.39 Form of Note for 5.000% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on May 13, 2024.
4.40 Form of Note for 5.300% Notes due 2054 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on May 13, 2024.
4.41 Form of Note for 5.400% Notes due 2064 — incorporated herein by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K filed on May 13, 2024.
54

-- 57 of 161 --

4.42 Form of Note for 3.125% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s
Current Report on Form 8-K filed on May 14, 2024.
4.43 Form of Note for 3.500% Notes due 2044 — incorporated herein by reference to Exhibit 4.5 to the Company’s
Current Report on Form 8-K filed on May 14, 2024.
4.44 Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust
Company Americas, as trustee — incorporated herein by reference to Exhibit 4.1 to Coca-Cola Refreshments USA,
Inc.’s Current Report on Form 8-K dated July 30, 1991.
4.45 First Supplemental Indenture, dated as of January 29, 1992, to the Indenture, dated as of July 30, 1991, between
Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust Company Americas, as trustee — incorporated herein
by reference to Exhibit 4.01 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-K dated January 29,
1992.
4.46 Second Supplemental Indenture, dated as of June 22, 2017, to the Indenture, dated as of July 30, 1991, as amended,
among Coca-Cola Refreshments USA, Inc., the Company and Deutsche Bank Trust Company Americas, as trustee
— incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on June
3, 2017.
4.47 Third Supplemental Indenture, dated as of July 5, 2017, to the Indenture, dated as of July 30, 1991, as amended,
among Coca-Cola Refreshments USA, Inc., the Company and Deutsche Bank Trust Company Americas, as trustee
— incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on July 6,
2017.
10.1 Letter, dated May 1, 2024, from the Company to Erin “Ellie” May — incorporated herein by reference to Exhibit
10.1 to the Company’s Form 8-K filed on May 2, 2024.
10.2 The Coca-Cola Company 2024 Equity Plan — incorporated herein by reference to Exhibit 10.2 to the Company’s
Form 8-K filed on May 2, 2024.
10.3 Form of Performance Share Agreement for grants under the 2024 Equity Plan, as adopted May 1, 2024.
10.4 Form of Restricted Stock Unit Agreement for grants under the 2024 Equity Plan, as adopted May 1, 2024.
10.5 Form of Stock Option Agreement for grants under the 2024 Equity Plan, as adopted May 1, 2024.
31.1 Rule 13a-14(a)/15d-14(a) Certification, executed by James Quincey, Chairman of the Board of Directors and Chief
Executive Officer of The Coca-Cola Company.
31.2 Rule 13a-14(a)/15d-14(a) Certification, executed by John Murphy, President and Chief Financial Officer of The
Coca-Cola Company.
32.1 Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United
States Code (18 U.S.C. Section 1350), executed by James Quincey, Chairman of the Board of Directors and Chief
Executive Officer of The Coca-Cola Company, and by John Murphy, President and Chief Financial Officer of The
Coca-Cola Company.
101 The following financial information from The Coca-Cola Company’s Quarterly Report on Form 10-Q for the quarter
ended June 28, 2024, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Consolidated
Statements of Income for the three and six months ended June 28, 2024 and June 30, 2023; (ii) Consolidated
Statements of Comprehensive Income for the three and six months ended June 28, 2024 and June 30, 2023; (iii)
Consolidated Balance Sheets as of June 28, 2024 and December 31, 2023; (iv) Consolidated Statements of Cash
Flows for the six months ended June 28, 2024 and June 30, 2023; and (v) Notes to Consolidated Financial
Statements.
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the iXBRL document and included
in Exhibit 101).
55

-- 58 of 161 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
THE COCA-COLA COMPANY
(Registrant)
/s/ ERIN MAY
Date: July 29, 2024 Erin May
Senior Vice President, Controller and Chief Accounting Officer
(On behalf of the Registrant)
56

-- 59 of 161 --

Award Notification – Performance Share
Congratulations [INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the
Company) granted you an award (your Award) under The Coca-Cola Company 2024 Equity Plan, as
amended from time to time (the Plan). Your Award is a great opportunity to share in the long-term
success of the Company and contribute to its future growth.
This document provides details of the key terms of your Award. Your Award is subject to the formal rules
of the Plan, plus the additional terms and conditions (including country specific terms) as set out in a
document called the “Additional Terms”. The Additional Terms is available to review as part of the Award
acceptance process. The Plan is available in the Documents section of the Morgan Stanley at Work®
website. This Award Notification (including the appendices), the Plan and the Additional Terms together
form your Award Agreement. You are being asked to confirm that you understand and agree to be bound
by these documents as part of the Award acceptance process, so we recommend you read them
carefully.
Type of Award Performance Award (sometimes called Performance Share Units) -This is a
conditional right to receive $0.25 par value common stock of the Company (Stock)
in the future. You will not receive the Stock (or have any shareholder rights) unless
your Award vests.
Target number
of shares of
Stock subject
to your Award
[INSERT]
Continuing
employment Your Award is subject to your continuing employment, as set out in the
Employment Events Appendix to this document and the Plan.
Performance
conditions Performance conditions apply to your Award, which are set out in the Performance
Criteria Appendix to this document. The performance conditions must be met in
order for your Award to vest.
Performance
period [INSERT]
The performance conditions are measured during this period. See the
Performance Criteria Appendix for more details.
Details of Award
Exhibit 10.3

-- 60 of 161 --

Date your
Award
normally vests
[INSERT DATE], or if later when the performance conditions are certified.
When your Award vests, you become entitled to the Stock subject to your Award.
You do not need to purchase that Stock - it is delivered automatically to you.
The number of shares of Stock that vest will be calculated based upon the target
number of shares of Stock set forth above and the provisions of the Performance
Criteria Appendix.
The number of shares of Stock that vest will normally be delivered to you as soon
as administratively possible following vesting, unless a different timing for
delivering the Stock applies under the Employment Events Appendix.
Your Award will generally be settled in Shares, except where the appendices to
this Award Notification apply and specify otherwise.
You are liable for any tax, fees and costs due on vesting, which may be withheld.
Remember: your Award will only vest if and to the extent that all of the terms and
conditions of your Award are satisfied. To the extent that your Award does not vest,
it will be forfeited.
Prohibited
Activities If you engage in certain activities (called Prohibited Activities), your Award will be
forfeited and you will be required to pay back any gain from your Award. Refer to
the Prohibited Activities Appendix to this document.
Malus and
clawback Your Award is subject to additional malus and clawback provisions which means
your Award will be subject to reduction, cancellation, repayment or forfeiture in the
circumstances set out in the Additional Terms.
Details of Award
Finally, certain data privacy provisions apply to you in connection with your Award, as set out in the Data
Privacy Appendix to this document.
In the event of any conflict between this Award Notification (including the appendices), the Additional
Terms and the Plan, the Plan takes precedence.
Action required!
If you wish to accept your Award, you must accept it using the Morgan Stanley at Work ® website by
[INSERT DATE/TIME]. If you fail to do so by this deadline, then the Company may declare your Award
grant null and void at any time. If this happens, your Award will be forfeited, and you will have no right to
the underlying Stock. Acceptance of this award will constitute acknowledgement of and consent to the
updated Annual Incentive and Long-Term Incentive design and mix of awards.
Interpretation
The appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning
given in the Plan, unless otherwise specified. For the purposes of the Prohibited Activities Appendix, references to your employer
include your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current
local employing entity or former local employing entity and the Company (where applicable). References to the Committee mean
The Talent and Compensation Committee of the Board of Directors of the Company, unless otherwise specified.

-- 61 of 161 --

Employment Events Appendix – Performance Share
The table below sets out the impact to your Award (if any) upon certain employment events. The terms of
the table below apply to vested and unvested portions of an Award equally, unless otherwise stated.
Except as otherwise specified herein, all other terms and conditions of your Award continue to apply.
Disability Whether your employment with the Company or a Subsidiary terminates because
of Disability or whether you remain employed, there is no impact to your Award.
Death Any Award that has not been accepted terminates immediately upon your death
and may not be transferred to your heirs.
If you die while employed with the Company or a Subsidiary, your Award
immediately vests, and your estate will be paid, within 90 days after your death, a
cash amount equal to the value of (1) the target number of shares of Stock subject
to the Award, if you die before the end of the performance period, or (2) the shares
of Stock earned, if you die after the end of the performance period. The value shall
be determined based on the closing price of the Stock on the date of death (or in
the case of a non-trading day, the next trading day).
Leave of
absences1 If you are on (1) US military leave, (2) a Company-paid leave of absence (meaning
paid under Company payroll), or (3) an unpaid leave of absence (approved
pursuant to a published Company policy available to all employees covered under
the policy) of 12 months or less, there is no impact to your Award.
For all other leaves of absence not specified in the paragraph above, including all
approved unpaid leaves that extend beyond 12 months:
• any portion of your Award that is unvested is immediately forfeited1; or
• if the Committee identifies a valid business interest in doing otherwise, it
may specify what provisions it deems appropriate at its sole discretion
(provided that the Committee shall have no obligation to consider any such
matters).
Transfer If you transfer (1) between the Company and any Subsidiary or, (2) at the
Committee’s discretion, to an Affiliate that is not a Subsidiary, there is no impact to
your Award.
Event Impact to your Award
1 If an approved unpaid leave of absence extends beyond 12 months, the portion of your Award that is unvested as of the end of
the 12th month is forfeited.

-- 62 of 161 --

Termination2 A. If your employment with the Company or a Subsidiary terminates after attaining
age 60:
• Awards held less than 12 months are immediately forfeited, and
• there is no impact on Awards held at least 12 months.
B. If your employment with the Company or a Subsidiary terminates involuntarily
for any reason other than for cause within one year after a Change in Control,
your Award will be treated as described in the Plan.
C. If your employment with the Company or a Subsidiary terminates prior to
attaining age 60 (or after attaining age 60 and your award would be forfeited
under paragraph A) because of (1) an involuntarily termination due to a
reduction in workforce, internal reorganization, or job elimination and you sign a
release of all claims and, if requested, an agreement on confidentiality and
competition, or (2) you participate in a Company or Subsidiary-sponsored
voluntary separation program:
• if any portion of your Award normally vests within 10 months after your
termination date, there is no impact to that portion of your Award, and
• all other Awards, or portions thereof, are immediately forfeited.
D. If your employment (1) with the Company or a Subsidiary terminates for any
other reason, or (2) with an Affiliate (that is not a Subsidiary) terminates for any
reason , your Award is immediately forfeited.
Notwithstanding anything herein, if your employment with an Affiliate terminates
and you immediately become employed by the Company or a Subsidiary, there
is no impact on your Award.
Event Impact to your Award
For the purposes of your Award, you are deemed to have terminated employment on the date you are no
longer actively providing services to the relevant entity or entities, regardless of the reasons for
termination and whether or not later found to be invalid or in breach of your employment agreement, if
any, or employment laws in the jurisdiction where you are employed. The Committee has exclusive
discretion to decide when you are considered to be no longer actively providing services for the purposes
of your Award. However, you will not be considered to be actively providing services during any
contractual notice period or any period of “garden leave” or similar period mandated under employment
laws in the jurisdiction where you are employed or in your employment agreement, if any, unless the
Committee decides otherwise.
2 This would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award. If
your employer no longer meets the definition of “Affiliate”, you are deemed to have terminated employment for the purposes of the
Plan.

-- 63 of 161 --

Prohibited Activities Appendix
1. Engaging in Prohibited Activity
1.1 Timing
Section 1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5
(Types of Prohibited Activity) below) at any time during the term of your Award or within one year
after the later of:
1.1.1 the termination of your employment with the Company, your employer or any Affiliate; and
1.1.2 the last date of vesting or exercise of all or any portion of your Award.
1.2 Implications
If this section 1.2 applies:
1.2.1 your Award will immediately terminate, be forfeited and (if relevant) cease to be
exercisable; and
1.2.2 within 10 days after receiving written notice from the Company that this section applies,
you must pay in cash to the Company:
(i) any and all gains associated with any previous vesting or exercise of all or any
portion of your Award; and
(ii) interest calculated from the time of the notice until the date of repayment to the
Company.
2. Implications for settled Awards
2.1 Calculation of gain
For the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any
portion of your Award will be calculated as:
2.1.1 where your Award is in the form of an Option, the closing price per share of Stock on the
date of exercise as reported on the New York Stock Exchange Composite Transactions
listing minus the exercise price per share of Stock, multiplied by the number of shares of
Stock over which the Award was exercised;
2.1.2 where your Award is in the form of Restricted Stock Units or Performance Share Units,
the closing price per share of Stock on the date of vesting as reported on the New York
Stock Exchange Composite Transactions listing, multiplied by the number of shares of
Stock that vested; and
2.1.3 where your Award is in the form of Performance Cash, the gross amount of the cash
payment that vested.

-- 64 of 161 --

3. Alternative payment
3.1 Return of Stock
If all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable
for any reason by any court with jurisdiction:
3.1.1 you will transfer to the Company all of the shares of Stock that you acquired on vesting or
exercise of your Award that you still hold (and if your Award is an Option, the Company
will pay to you the exercise price you paid for that Stock in exchange); and
3.1.2 where you have already sold, transferred or disposed of any shares of Stock you
acquired on vesting or exercise of your Award, you must pay to the Company:
(i) any and all gains associated with each sale, transfer or disposal; and
(ii) interest calculated from the date of each sale, transfer or disposal until the date
of repayment to the Company.
3.2 Calculation of gain
For the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in
each case be calculated as the closing price per share of Stock on the date of the sale, transfer
or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus,
where your Award is an Option, the exercise price per share of Stock), multiplied by the number
of shares of Stock sold, transferred or disposed of.
4. Interest
Any interest payable under this Prohibited Activities Appendix will be calculated using the
weighted prime rate at SunTrust Bank, Atlanta.
5. Types of Prohibited Activity
The term Prohibited Activity includes any and all of the following:
5.2 Disparagement
Making any statement, written or verbal, in any forum or media, or taking any action in
disparagement of the Company, your employer and/or any Affiliate, including but not limited to
negative references to the Company or its products, services, corporate policies, or current or
former officers or employees, customers, suppliers, or business partners or associates.
5.2 Publicity
Publishing any opinion, fact, or material, delivering any lecture or address, participating in the
making of any film, radio broadcast or television transmission, or communicating with any
representative of the media relating to confidential matters regarding the business or affairs of the
Company, your employer and/or any Affiliate which you were involved with during your
employment.

-- 65 of 161 --

5.3 Disclosure of a Trade Secret
Failure to hold in confidence any and all Trade Secrets of the Company that came into your
knowledge during your employment with the Company, your employer and/or any Affiliate, or
disclosing, publishing, or making use of, at any time, such Trade Secrets.
For these purposes, Trade Secret means any technical or non-technical data, formula, pattern,
compilation, program, device, method, technique, drawing, process, financial data, financial plan,
product plan, list of actual or potential customers or suppliers or other information similar to any of
the foregoing, which:
5.3.1 derives economic value, actual or potential, from not being generally known to and not
being readily ascertainable by proper means by other persons who can derive economic
value from its disclosure or use; and
5.3.2 is the subject of efforts that are reasonable under the circumstances to maintain its
secrecy.
5.4 Disclosure of Confidential Information
Failure to hold in confidence all Confidential Information of the Company, your employer and/or
any Affiliate that came into your knowledge during your employment with the Company, your
employer or any Affiliate, or disclosing, publishing, or making use of such Confidential
Information.
For these purposes, Confidential Information means any data or information, other than Trade
Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)), that is valuable to the
Company and not generally known to the public or to competitors of the Company.
5.5 Failing to return materials
Your failure, in the event of your termination of employment for any reason, promptly to deliver to
the Company all memoranda, notes, records, manuals or other documents, including all copies of
such materials and all documentation prepared or produced in connection therewith, containing
Trade Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential
Information (as defined in section 5.4 (Disclosure of Confidential Information)) regarding the
Company’s business, whether made or compiled by you or furnished to you by virtue of your
employment with the Company, your employer or any Affiliate, or failure promptly to deliver to the
Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office
equipment, and other property furnished to you by virtue of your employment with the Company,
your employer or any Affiliate.
5.6 Competing
Rendering services for any organization which, or engaging directly or indirectly in any business
which, in the sole judgment of the Committee or the Chief Executive Officer of the Company or
any senior officer designated by the Committee, is or becomes competitive with the Company.
Notwithstanding the preceding sentence, this Section 5.6 will not be applicable for any employee
living or working in California.

-- 66 of 161 --

5.7 Solicitation
Soliciting or attempting to solicit for employment, for or on behalf of any corporation, partnership,
or other business entity, any employee of the Company, your employer or an Affiliate with whom
you had professional interaction during the last twelve months of your employment with the
Company, your employer or the Affiliate.
5.8 Violation of Company policies
Violating any written policies of the Company or your employer applicable to you, including,
without limitation, The Coca-Cola Company Global Insider Trading Compliance Policy.
6. Release
You may be released from the effects of this Prohibited Activities Appendix if the Committee
determines in its sole discretion that such action is in the best interest of the Company and its
stockholders.
7. Other rights apply
Nothing in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or
otherwise limiting the Company’s right under applicable state or local law or any prior agreement
you have signed or made with the Company regarding trade secrets, confidential information, or
intellectual property.

-- 67 of 161 --

Data Privacy Appendix
1. General
1.1 Introduction
This Data Privacy Appendix sets out certain data privacy provisions that apply to you in
connection with your Award.
1.2 Meaning of Data
For the purposes of this Data Privacy Appendix, Data means personal information that directly or
indirectly identifies you, including: your name, home address and telephone number, your date of
birth, your government identification number, your salary information, nationality, job title and
employment location, any shares or directorships you hold or held in the Company or any Affiliate,
details of your Award and any equity or cash awards or any other entitlements to stock or cash
granted (regardless of whether or not exercised, vested or settled, and including any cancelled or
forfeited awards), any information necessary to process your Award or any other award (e.g. your
mailing address for a check payment or bank account wire transfer information), any other
information necessary to process mandatory tax withholding and reporting and/or, where
applicable, your employment or service termination date and the reason for the termination.
2. For Award recipients not located in the EEA or UK
This section applies if you reside anywhere in the world except the European Economic Area
(EEA) or the United Kingdom (UK). By accepting your Award, you confirm the following:
2.1 Consent
You voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data
by and between the Company, your employer or any Affiliate for the purpose of implementing,
administering, and managing your participation in the Plan.
2.2 Data collected
You understand that the Company and its Affiliates may hold Data for the exclusive purpose of
implementing, administering, and managing the Plan.
2.3 Purposes of collection
You understand that Data will be transferred to one or more stock or incentive plan service
providers selected by the Company, which may assist the Company with the implementation,
administration, and/or management of the Plan.
2.4 Recipients of Data
You understand that the recipients of Data may be located in the United States or elsewhere. The
Company also uses third party service providers who may assist with the implementation,
administration or management of the Plan. These service providers are bound by contract to
handle Data in a way that aligns with this Data Privacy Appendix and applicable law. If you have

-- 68 of 161 --

any questions about the local entities or services providers who may access or handle your Data,
please contact your local human resources representative.
By consenting at section 2.1 (Consent) above, you authorize the Company and any other
possible recipients that do or may assist the Company with implementing, administering or
managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other
form, for the sole purpose of implementing, administering and/or managing your participation in
the Plan.
2.5 Data retention
You understand that Data will be held only as long as is necessary to implement, administer and
manage your participation in the Plan. In some cases, your information will be retained for the
Company or your employer to comply with a legal or tax obligation.
2.6 Your rights
You understand that if you reside in certain jurisdictions, to the extent required by applicable laws,
you may, at any time and without cost:
2.6.1 request access to Data;
2.6.2 request additional information about the storage and processing of Data;
2.6.3 require any necessary amendments to Data; or
2.6.4 refuse or withdraw the consents you give by accepting the Award,
by contacting your local human resources representative in writing.
2.7 Implications of not consenting or withdrawing consent
You understand that you provide these consents on a purely voluntary basis. If you do not
consent, or if you later withdraw your consent, your employment or service contract with the
Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will
mean that the Company will not be able to grant new awards or administer or maintain any
existing awards (including this Award) under the Plan. You understand that refusing or
withdrawing your consent may affect your ability to participate in the Plan (including the right to
retain an award, such as this Award). You understand that you may contact a local human
resources representative for more information on the consequences of refusal to consent or
withdrawal of consent.
3. For Award recipients located in the EEA and/or UK
This section applies if you reside inside the United Kingdom (UK) and/or the European Economic
Area (EEA). By accepting your Award, you confirm the following:
3.1 Data collected
You understand that the your employer (acting as controller) and the Company may collect, to the
extent permissible under applicable law, Data for the exclusive purpose of implementing,
administering, and managing the Plan. The Data is collected from you, the employer, and the

-- 69 of 161 --

Company for the exclusive purpose of implementing, administering, and managing the Plan in
accordance with the terms of your Award.
3.2 Purposes of collection/processing
You acknowledge the legal basis for Data processing is performance of the contract comprising
your Award. The Data must be provided in order for you to participate in the Plan and for the
parties to your Award to perform their respective obligations as set out in your Award documents.
If you do not provide Data, you will not be able to participate in the Plan or continue to hold your
Award.
3.3 Transfers and retention of Data
You understand that your employer will transfer Data to the Company for Plan administration
purposes. The Company and your employer may also transfer your Data to other service
providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by
the Company now or in the future, to assist the Company and your employer with the
implementation, administration and/or management of your Award. You understand that recipients
of the Data may be located in a country that does not benefit from an adequacy decision issued
by the European Commission. When your information is transferred outside the EEA or the UK
(as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please
contact privacy@coca-cola.com. Your Data will be held only as long as is necessary to
implement, administer and manage your rights and obligations under the terms of your Award
documents, as well as in compliance with other laws requiring a longer retention period.
3.4 Accuracy
You understand the Company and your employer will take steps in accordance with applicable
legislation to keep Data accurate, complete and up to date.
3.5 Your rights
You understand you are entitled to:
3.5.1 have any inadequate, incomplete or incorrect Data corrected;
3.5.2 request access to your Data and additional information about the processing of that Data;
3.5.3 object to the processing of Data or have your Data erased, under certain circumstances;
and
3.5.4 subject to applicable law:
(i) restrict the processing of your Data so that it is stored but not actively processed
(e.g. while the Company assesses whether you are entitled to have Data
erased); and
(ii) receive a copy of the Data provided in connection with your Award or generated
by you, in a common machine-readable format,
and you may exercise these rights by contacting a local human resources representative.

-- 70 of 161 --

3.6 Other contacts
You understand you have the right to contact, and may lodge a complaint with, the relevant data
protection supervisory authority.
You may also contact the EU Data Protection Officer:
Coca-Cola Italia s.r.l.
Viale Edison 110
Building B
20099 Sesto San Giovanni (Milan)
Italy
DPO-Europe@coca-cola.com
4. Country specific provisions
The provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of
this Data Privacy Appendix. By accepting your Award, you confirm the following:
4.1 If you are subject to the laws of Canada
You authorize the Company, your employer, and your employer’s representatives to discuss with
and obtain all relevant information from all personnel (professional or not) involved in the
administration and operation of the Plan. You authorize your employer, the Company, any
Affiliates and any stock or incentive plan service provider that may be selected by the Company
to assist with the Plan to disclose and discuss the Plan with their respective advisors. You further
authorize your employer, the Company and any Affiliates to record this information and to keep it
in your employee file.
4.2 If you are subject to the laws of Russia
You acknowledge that you have read, understood and agree to the terms regarding the collection,
processing and transfer of data described in section 2 (For Award recipients not located in the
EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you
agree to provide an executed data privacy consent form or any similar agreements or consents
that the Company or your employer may deem necessary to obtain under the data privacy laws in
Russia, either now or in the future. You understand that you will not be able to participate in the
Plan if you fail to execute any such consent or agreement that may be requested.

-- 71 of 161 --

Awards made under
The Coca-Cola Company 2024 Equity Plan
Additional Terms
By accepting your Award you:
1. Plan Documents
Agree that you have been given all relevant information and materials regarding the terms and
conditions of your Award, which are set out in the rules of The Coca-Cola Company 2024 Equity
Plan, as amended from time to time (the Plan), your Award Notification (including any appendices
attached to it) and these Additional Terms (including the Global Appendix set out below)
(collectively, the Plan Documents).
2. Employment
2.1 Acknowledge that the grant of your Award does not form part of and does not affect or change
your employment contract or your employment relationship with your employer (which is entirely
separate from the Plan). The grant of your Award and your participation in the Plan does not
create a right to employment or continued service and will not be interpreted as forming an
employment or service contract with The Coca-Cola Company (the Company), your employer or
any Affiliate (as defined in the Plan). The Award does not impact the ability of the Company, your
employer or any Affiliate to terminate that employment or service relationship. All benefits granted
by your Award will constitute an occasional extraordinary payment and may not, in any way or for
any purpose, be considered part of your normal remuneration or constitute consideration for any
services you provide to the Company, your employer or any Affiliate, including when calculating
any other benefits.
2.2 Acknowledge that the Company’s decision to grant your Award is voluntary and discretionary, and
that you have no right to participate in the Plan. Acceptance of your Award and participation in the
Plan does not create any right to, or expectation of, future employment or service, future
participation in the Plan or the grant of future awards (on the same basis, or at all). The Company
may at any time decide to cease offering awards under the Plan, or amend, modify, suspend,
cancel or terminate the Plan and any benefits under it.
2.3 Acknowledge that you are not entitled to the exercise of any discretion under the Plan in your
favor, that decisions with respect to your Award and any future awards are at the sole discretion
of the Company and are final, binding and conclusive, and that you do not have any claim or right
of action in respect of any decision, omission, or discretion, which may in each case operate to
your disadvantage.
2.4 Agree, in consideration for and as a condition of your Award, to waive all rights which might arise
in connection with the Plan, including:
2.4.1 the right to institute any claim against the Company, your employer or any Affiliate; and
2.4.2 the right to pursue any claim that is allowed by a court,
other than the right to acquire, as relevant, $0.25 par value shares of common stock of the
Company (Stock) or cash (subject to and in accordance with the Plan).

-- 72 of 161 --

2.5 Acknowledge that you do not have any right to compensation or damages for any loss (actual or
potential) in relation to the Plan or your Award, including where it is forfeited on termination of
employment or cessation of services for any reason, whether or not lawful or in breach of
employment laws or the terms of your employment or service agreement, if any.
3. No transfer
Accept that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your
Award or any rights in respect of it, whether voluntarily or involuntarily (other than to your
personal representatives on death).
4. Modifications and additional requirements
4.1 Agree that the Company may modify any of the terms of your Award to be consistent with any
applicable law or applicable government agency regulation where, in the opinion of the Company,
that term might otherwise conflict or be inconsistent.
4.2 Agree that the Company may impose additional conditions, requirements and restrictions on your
Award, your participation in the Plan and any Stock or cash you acquire on vesting or exercise of
your Award, and that you will comply with them, including signing any additional agreements or
undertakings.
4.3 Agree to any amendment made to the Plan or any term of your Award (including an amendment
with retroactive effect) where the amendment is necessary or advisable to ensure the Plan or
your Award complies with any future law relating to plans of this nature or their administration
(including Section 409A of the U.S. Internal Revenue Code of 1986, as amended).
4.4 Agree to any amendment made to any of the terms of your Award (including rescinding your
Award entirely) to correct any error that occurred in connection with the grant or documentation of
your Award.
4.5 Acknowledge that your Award may be adjusted to reflect a change in capital structure, in
accordance with the terms of the Plan, and agree that, where your Award is over Stock and an
adjustment results in a fractional share, the fractional share may be disregarded at the
Company’s discretion.
5. Tax
5.1 Acknowledge that participating in the Plan will probably have tax consequences for you and that
all payments made with respect to your Award (including payments in Stock or cash) may be
subject to tax, social security and any similar charges in any country where you are employed,
reside, or are otherwise subject to tax (Tax).
5.2 Agree that you (or your personal representative) are ultimately responsible for and will bear any
liability for any Tax in respect of your Award and your participation in the Plan, and understand
that this liability may exceed any amounts withheld and paid on your behalf.
5.3 Acknowledge that the Company, your employer, an Affiliate, any trustee of any employee benefit
trust and any third party service provider (each, a Withholding Person) is entitled to do any, all
or a combination of the following methods (where relevant) to enable a Withholding Person to
raise an amount it considers necessary or desirable to recover the Liabilities:

-- 73 of 161 --

5.3.1 sell or procure the sale on your behalf of a sufficient number of the Stock you acquire on
vesting or exercise of your Award;
5.3.2 reduce the number of Stock you acquire on vesting or exercise of your Award accordingly
and settle the balance in cash; and
5.3.3 withhold amounts from:
(i) proceeds of sale under section 5.3.1;
(ii) the balance settled in cash under section 5.3.2; and
(iii) any other cash payments of any kind owed to you.
For these purposes, Liabilities means any obligation on the Withholding Person to pay or
account for Tax, any unpaid exercise price, any associated costs (including under section 7
(Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any
obligation of any nature whatsoever (including under a loan, the Company’s tax equalization
program or any travel or expenses policy) to the extent that the Company, the employer or any
Affiliate in its reasonable judgement determines you owe them that amount.
5.4 Agree that, for tax purposes, and where allowed by applicable law, you are deemed to have
received the full number of Stock where the number of Stock you acquire is reduced under
section 5.3.2.
5.5 Agree that, where permitted by the Company, you may elect to satisfy Tax and/or pay any
exercise price by delivering (including by attestation) Stock to the Company.
5.6 Agree that if a Withholding Person’s obligation to pay or account for Tax cannot or has not been
fully satisfied by the above methods, you must pay to the Withholding Person an amount
sufficient to enable them to discharge that obligation.
5.7 Agree to enter any tax elections for particular tax and/or social security treatment, execute any
documents, give any directions and take any action as may be requested by the Company, your
employer or any Affiliate in relation to any Liabilities.
5.8 Acknowledge that the Company, your employer and any Affiliate do not guarantee or warrant any
particular Tax treatment in relation to your Award, the cash or Stock you acquire in connection
with your Award (including any dividends on Stock), or your participation in the Plan and that they
are not under any obligation to structure the Award in a Tax favorable way or avoid adverse Tax
treatment in any jurisdiction.
5.9 Acknowledge that neither the Company, your employer nor any Affiliate will be liable for any Tax,
interest, penalties or other amounts owed by any taxpayer as a consequence of the Plan or an
Award and that any Tax information provided is for guidance purposes only.
5.10 Accept that the cash or Stock subject to your Award may only vest or be exercised (as applicable)
if satisfactory arrangements are in place to enable all Withholding Persons to obtain the funds
needed to satisfy any Liabilities.
5.11 Acknowledge that the vested (and, if applicable, exercised) Stock or cash subject to your Award
may not be delivered or paid to you unless you have complied with your obligation to pay the
Liabilities.

-- 74 of 161 --

6. Internationally mobile employees
6.1 Acknowledge that if you are a mobile employee, meaning that you are based in different
jurisdictions during the course of your employment or service that you are or may be subject to
Tax in more than one country, you are strongly encouraged to inform the Company and your
employer, and to speak with your personal tax adviser regarding the tax treatment of your
participation in the Plan.
6.2 Accept that, if you are a mobile employee, the Company or your employer may be required to
withhold for Tax in more than one jurisdiction.
6.3 Accept that if you are a “Global Mobility Associate” as defined in the Company’s Global Mobility
Policy (or the equivalent under any applicable international service policy from time to time), you
remain responsible for all Tax except where expressly stated otherwise in that policy and/or the
Company’s tax equalization program. A copy of the Company’s Global Mobility Policy is available
on the Company’s intranet.
7. Costs
Agree that you are responsible for the payment of any fees, dealing, commission or currency
conversion costs or any other costs associated with your Award, including costs associated with
the payment of any cash and the sale of any Stock.
8. Notices
8.1 Agree that any notice or other communication required in relation to your Award will be given in
writing, which may include electronic means.
8.2 Agree that any notice or other communication to be given to you in connection with your Award
may be delivered by electronic means (including by email, or through the Company or your
employer’s intranet or a share plan portal), personally delivered, or sent by ordinary post to the
principal address on file for you from time to time with the Company, your employer, an Affiliate or
the Company’s agents.
8.3 Agree that any notice or other communication to be given to the Company or its agents in
connection with your Award may be delivered or sent to its registered office or to such other place
and by such means as communicated to you by or on behalf of the Company from time to time.
8.4 Accept that notices or other communications:
8.4.1 sent electronically will be deemed to have been received immediately (if sent
during usual business hours) or at the opening of business on the next business
day (if sent outside usual business hours);
8.4.2 that are personally delivered will be deemed to have been received when left at the
relevant address (if left during usual business hours) or at the opening of business
on the next business day (if left outside usual business hours); and
8.4.3 sent by post will be deemed to have been received 24 hours after posting to a U.S.
address or 3 days after posting to an address outside the U.S.,
unless there is evidence to the contrary.

-- 75 of 161 --

8.5 Agree that all notices or communications to be given to you are given and sent at your risk and
that neither the Company, your employer nor any Affiliate has any liability in respect of any notice
or communication given or sent, nor need they be concerned to see that you actually receive it.
9. Insider trading and market abuse
9.1 Acknowledge that rules on insider trading, dealing notification requirements, and market abuse
laws may apply in relation to any actions or decisions taken relating to your Award, including in
relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment
of any Stock or cash, and the sale of any Stock. These rules, requirements and laws:
9.1.1 are separate from and in addition to the requirements that apply to you under The
Coca-Cola Company Global Insider Trading Compliance Policy; and
9.1.2 may prohibit or delay your actions or decisions.
9.2 Agree that it is your responsibility to comply with the rules, requirements and laws referred to in
section 9.1. You should consult with your personal legal adviser on these matters.
10. Currency risk
10.1 Acknowledge that if any Stock relating to your Award is traded in a currency that is not the
currency in your jurisdiction, the value of the Stock may also be affected by movements in the
exchange rate.
10.2 Agree that neither the Company, your employer nor any Affiliate is liable for any loss due to
movements in the exchange rate nor any charges imposed in relation to the conversion or
transfer of money.
11. No advice
11.1 Confirm you are accepting your Award and participating in the Plan voluntarily and understand
that the Company is not making any recommendations regarding your Award or any Stock or
cash relating to your Award.
11.2 Agree that neither the Company, your employer, any Affiliate nor any person or entity acting on
their behalf has provided you with any legal, investment, tax (including reporting) or financial
advice with respect to your participation in the Plan, your Award or any Stock or cash acquired
upon vesting or exercise of your Award. You should consult with your own suitably qualified
advisers before taking any action under the Plan.
11.3 Acknowledge that the information and materials provided do not take into account your
objectives, financial situation or needs and that if you do not understand the contents of the Plan
Documents, or you are in any doubt, you should consult an independent authorized financial
adviser.
11.4 Agree you will have no remedies for any statement, representation, assurance or warranty that is
not set out in your Plan Documents.
12. No guarantee
12.1 Acknowledge that neither the Company, your employer nor any Affiliate guarantees a specified
level of return in respect of your Award or any Stock.

-- 76 of 161 --

12.2 Acknowledge that there is a risk that any Stock relating to your Award may fall as well as rise in
value, that the future value of Stock cannot be predicted with certainty and that market forces will
impact the price of any Stock relating to your Award and, in the worst case, the market value of
the Stock may become zero. More information in relation to the Company, including its share
price, can be found at https://www.coca-colacompany.com/.
13. No public offer
13.1 Acknowledge that your Award is being offered to you in your capacity as an employee of the
Company’s group and that the offer is not intended for the general public and may not be used for
any public offer.
13.2 Acknowledge that the Company is not required to deliver any Stock or cash on settlement of your
Award before it completes, on terms to its satisfaction, any registration, listing, exemption or
qualification or other legal requirements or obtains any clearance or approval that the Company
considers is necessary or desirable, and you agree to provide any information, make any
agreements and give any representations that the Company requests as part of this process.
13.3 Agree that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse to
deliver any Stock or cash where the Company considers the delivery of Stock or cash may
conflict or be inconsistent with applicable law or applicable government agency regulation.
13.4 Acknowledge that neither the Company, your employer nor any Affiliate is under any obligation to
register, exempt or qualify, or seek clearance or approval for, your Award or any Stock or cash
that you may acquire in connection with your Award.
13.5 Acknowledge that your Award may not have been authorized or approved by any applicable
securities authorities and may have been offered pursuant to an exemption from registration in
your local jurisdiction.
13.6 Acknowledge that the regulatory bodies in your jurisdiction accept no responsibility for the
accuracy and completeness of the statements and information contained in the Plan Documents
and take no liability whatsoever for any loss arising from reliance upon the whole or any part of
the contents of those documents.
13.7 Acknowledge that a prospectus or similar offering or registration document may not have been
prepared, authorized or approved by any applicable authority in any jurisdiction outside the
United States.
14. Exchange controls and any reporting requirements
14.1 Accept that exchange control regulations and/or foreign asset reporting requirements may apply
to you in respect of your Award and/or any Stock or cash acquired in connection with your Award,
and that you are solely responsible for complying with those regulations and requirements.
14.2 Agree that neither the Company, your employer nor any Affiliate are responsible for obtaining
exchange control approval or making any reports on your behalf, nor for monitoring compliance
with those regulations and requirements and that if you fail to obtain any required exchange
control approval or make the necessary reports, neither the Company, your employer nor any
Affiliate will be liable in any way for any resulting fines or penalties. You should seek independent
professional advice if you are unsure about the obligations that apply to you as a result of your
participation in the Plan.

-- 77 of 161 --

14.3 Accept that you are solely responsible for complying with any filing, notification or reporting
requirements in respect of:
14.3.1 your participation in the Plan and/or
14.3.2 benefits received under the Plan,
as required by the local law in any jurisdiction. The Company accepts no responsibility for your
failure or delay in complying with such requirements. If you are in any doubt as to what actions
you should take, you should consult a duly authorized independent adviser.
15. General
15.1 Consent to the use of electronic communications in connection with the Plan.
15.2 Confirm that references to “employer” throughout these Additional Terms include your former
employer, where applicable.
15.3 Agree that all determinations and decisions on questions of interpretation in respect of your
Award and the Plan Documents will be made by the Company (or any committee on its behalf) in
its sole and absolute discretion. Those determinations and decisions will be final, binding and
conclusive. Any references to determinations or decisions made, or actions taken, by the
“Company” as referred to in these Additional Terms include any committee acting on its behalf.
15.4 Agree that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable
for any reason by any court in any jurisdiction then, for the purposes of that jurisdiction only:
15.4.1 such provision will be deleted; and
15.4.1 the remaining provisions will continue in full force and effect.
15.5 Agree that if the Company waives a breach of one or more provisions in the Plan Documents, this
does not constitute a waiver of any other provision of the Plan Documents, or a waiver of any
subsequent breach of the Plan Documents (by you or anyone else).
15.6 Accept that:
15.6.1 the federal laws of the United States of America and the state laws of the State of
Delaware, United States of America, govern your Plan Documents and your Award
without regard to the conflict of law provisions; and
15.6.2 the courts of the United States District Court for the District of Delaware or the Delaware
Superior Court, New Castle County have exclusive jurisdiction in respect of disputes
arising under or in connection with the Plan or your Award,
and you waive any current or future objection you may have to this choice of law and jurisdiction.
16. English language (this applies if you have received an English language version
only of any Plan Document)
16.1 Accept that you fully understand the contents of the English language version of the Plan
Documents.

-- 78 of 161 --

16.2 Acknowledge that you do not need a translation of the Plan Documents and that you are fluent
and regularly conduct business in the English language as part of your duties and responsibilities
to your employer.
17. Translations (this applies if you have received a Plan Document in a language
other than English)
17.1 Agree that if there is any conflict between the terms of the English language version of the Plan
Documents and a version in any other language, the English language version will prevail.
18. Options (this applies if your Award Notification specifies that your Award is an
Option)
18.1 Understand that, in order to exercise your Award, you will need to pay the exercise price.
18.2 Acknowledge that you will be informed of the acceptable forms and methods of paying the
exercise price when you come to exercise your Award.
19. Restricted resale (this applies if your Award is over Stock)
Acknowledge that any Stock you may acquire upon settlement of your Award may be subject to
restrictions on transfer and resale in your local jurisdiction and you agree that you will comply with
those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or
cause any of these to occur) in circumstances which constitute any type of public offering of
securities, unless an exemption applies.
20. Performance conditions (this applies if your Award Notification specifies that your
Award is subject to performance conditions)
20.1 Accept that the vesting of your Award is conditional on the satisfaction of one or more
performance conditions as set out in the Performance Criteria Appendix to your Award Notification
(the Performance Criteria) and, to the extent the Performance Criteria are not satisfied, your
Award may be forfeited.
20.2 Accept that the Performance Criteria may be altered in the circumstances specified in Section
10.2 of the Plan.
21. Malus and clawback (this applies if your Award Notification specifies that your
Award is subject to “Malus and clawback”)
21.1 Agree that any benefits you may receive with respect to your Award will be subject to reduction,
cancellation, repayment, forfeiture or recoupment if there is a determination that the vesting of, or
amount realized from, your Award was based on:
21.1.1 materially inaccurate financial statements; or
21.1.2 any other materially inaccurate performance metric criteria,
and you acknowledge that this applies regardless of whether you caused or contributed to the
material inaccuracy.
21.2 Agree that the Company may also seek to recover your Award where required by the provisions
of the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other “clawback”

-- 79 of 161 --

provision required by applicable law, regulation or listing standards, including the listing standards
of the New York Stock Exchange, and you authorize such recovery.
22. Stock ownership guidelines (this only applies if you are subject to the Company’s
stock ownership guidelines)
22.1 Accept that if you have not met the Company’s stock ownership guidelines before the applicable
compliance deadline but you are a “Section 16 officer” under the U.S. Securities Exchange Act of
1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of
your Award until you meet the relevant guidelines, except for any Stock that is sold or cash settled
to cover Tax and any exercise price.
22.2 Accept that if you have not met the guidelines by the applicable compliance deadline, you are
prohibited at all times after that compliance deadline from selling any Stock you obtain on vesting
or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax,
commissions and fees and any exercise price. Once you meet the guidelines, you can sell Stock
in excess of the guidelines.

-- 80 of 161 --

Global Appendix – Equity Awards3
1. If you are subject to the laws of the European Union
This offer is being made to selected employees as part of an employee incentive program in order
to provide an additional incentive and to encourage employee share ownership and to increase
your interest in the success of the Company. The company offering these rights is The Coca-Cola
Company. The Stock which is the subject of these rights is new or existing par value common stock
in the Company. More information in relation to the Company including the stock price can be found
at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU
Prospectus Regulation. The total maximum number of Stock which is the subject of this offer is
240,000,000.
2. If you are subject to the laws of Argentina
Neither the Award nor the underlying Stock are publicly offered or listed on any stock exchange in
Argentina.
This provision applies if your Award Notification specifies that your Award is an Option:
Depending upon the method of exercise chosen for the Option, you may be subject to
restrictions with respect to the purchase and/or remittance of U.S. dollars pursuant to Argentine
currency exchange regulations. The Company reserves the right to restrict the methods of
exercise if required or advisable to comply with Argentine laws.
3. If you are subject to the laws of Australia
The grant of Awards under the Plan is intended to comply with the provisions of the Corporations
Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000. Additional details are set
forth in the Australia Offer Document, which is available on the Morgan Stanley at Work® website.
The offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax
Assessment Act 1997(Cth). The conditions to receive such treatment are contained in the Award
Agreement.
4. If you are subject to the laws of Belgium
If your Award Notification specifies that your Award is an Option, you confirm you have read and
understood the information regarding the Belgian taxation of Options which has been separately
made available to you by email and/or on the Morgan Stanley at Work® website. You should review
this information thoroughly before accepting your Option grant.
__________________________
3. If your are subject to the laws of any of the following countries, there are no country-specific provisions for your country in this
appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador, Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico,
Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.

-- 81 of 161 --

5. If you are subject to the laws of Brazil
By accepting the Award, you agree that you are (i) making an investment decision, and (ii) the
value of the underlying Stock is not fixed and may increase or decrease in value over the vesting or
exercise period without compensation to you.
6. If you are subject to the laws of Canada
For purposes of your Award, your employment will be considered terminated and your right (if any)
to vest in any Award or exercise any Option after such termination (regardless of the reason for
such termination and whether or not later found to be invalid, unlawful or in breach of the
employment laws in the jurisdiction where you are employed or the terms of your employment
agreement, if any) will be measured as of the earlier of: (a) the date your employment with the
Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date
you receive written notice of termination from the Company or a Subsidiary or Affiliate, regardless of
any notice period or period of pay in lieu of such notice mandated under the employment laws in
the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c)
the date you are no longer employed by the Company or any of its Subsidiaries or Affiliates. You will
not be entitled to a pro-rata portion of the Award for any time before the date on which your right to
vest terminates, nor will you be entitled to any compensation for lost vesting. In the event the date
on which you are no longer actively providing services cannot be reasonably determined under the
terms of your Award, the Company, in its sole discretion, shall determine when you are no longer
employed for purposes of the Award (including whether you may still be considered employed or
actively providing services while on a leave of absence).
Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires
continued entitlement to vesting during a statutory notice period, your right to vest in the Award
under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice
period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end
of your statutory notice period, nor will you be entitled to any compensation for lost vesting.
In addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired
pursuant to the Plan will be subject to certain restrictions on resale imposed by Canadian provincial
securities laws (in general, you may not resell your Stock to Canadian purchasers). Accordingly,
you are encouraged to seek legal advice prior to any resale of the Stock.
Furthermore, notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards
granted to Canadian residents shall only be settled in Stock and shall not be settled in cash.
The following terms and conditions apply if you are resident in Quebec:
You agree that you wish the Plan Documents to be drawn up in English.
Vous confirmez que vous souhaitiez que les Documents du Plan soient rédigés en anglais
7. If you are subject to the laws of Chile
Neither the Company, the Plan nor the Stock have been registered in the Registro de Valores
(Securities Registry) or in the Registro de Valores Extranjeros (Foreign Securities Registry) of the

-- 82 of 161 --

Comisión para el Mercado Financiero de Chile (Chilean Commission for the Financial market or
CMF) and they are not subject to the control of the CMF. The Plan is governed by General
Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to
deliver public information regarding the Stock in Chile. Shares of Stock cannot be publicly offered in
Chile unless they are registered with the CMF.
Ni The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de
Valores o en el Registro de Valores Extranjeros que lleva la Comisión para el Mercado
Financiero de Chile (CMF) y ninguno de ellos está sujeto a la fiscalización de la CMF. Esta
oferta de Acciones se acoge a la Norma de Carácter General 336. Por tratarse de valores no
inscritos, el emisor de las Acciones no tiene obligación bajo la ley chilena de entregar en Chile
información pública acerca de las Acciones. Las Acciones no pueden ser ofrecidas
públicamente en Chile en tanto éstas no se inscriban en el Registro de Valores
correspondiente.
8. If you are subject to exchange control restrictions imposed by the China State
Administration of Foreign Exchange (SAFE), as determined by the Company in its
sole discretion
Notwithstanding any other provision in the Plan Documents, the following provisions apply in the
event of the termination of your employment (as interpreted in accordance with the Employment
Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your
Disability, or (2) after attaining age 55:
Awards that are Options and Awards held at least 12 months will immediately vest and will be
settled in cash. The cash amount will be determined based on the closing price of the Stock on
the date of your termination of employment (or, if a non-trading day, the next trading day) or the
exercise of your Option (if applicable) within the post-termination exercise period stated below.
Awards that are not Options and that are held less than 12 months from the date of grant are
forfeited.
Where Performance Criteria apply, the Performance Criteria will be measured over a shortened
performance period, ending at the end of the year prior to your termination of employment.
If your Award is an Option, the period over which you may exercise your Option expires upon
earlier of (1) six months from your termination of employment or (2) the Option expiration date
provided in the Plan Documents.
The Company has the discretion to arrange for the sale of any Stock issued upon settlement of
your Award, either immediately upon settlement or at any time thereafter. In any event, if you
terminate employment, you will be required to sell all Stock acquired upon settlement of the Award
within such time period as required by the Company in accordance with SAFE requirements. Any
Stock remaining in your brokerage account at the end of this period shall be sold by the broker (on
your behalf pursuant to this authorization and without further consent). In addition, any Award that
has not vested by the end of this period will then immediately be forfeited. The Company shall have
the exclusive discretion to determine when your employment has been terminated for the purposes
of the Award.

-- 83 of 161 --

You agree to sign any additional agreements, forms and/or consents that reasonably may be
requested by the Company (or the Company’s designated broker) to effectuate the sale of the
Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange
control matters noted below) and shall otherwise cooperate with the Company with respect to such
matters. You acknowledge that neither the Company nor the designated broker is under any
obligation to arrange for the sale of Stock at any particular price (it being understood that the sale
will occur in the market) and that broker’s fees and similar expenses may be incurred in any such
sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for applicable
taxes, any broker’s fees or commissions, and any similar expenses of the sale will be remitted to
you in accordance with applicable exchange control laws and regulations.
By accepting the Award, you acknowledge that you understand and agree that you are not
permitted to transfer any Stock acquired under the Plan out of your account established with the
Company’s designated broker until the Stock is sold. The limitation applies to all Stock issued to
you under the Plan, whether or not you remained employed with the Company or a Subsidiary.
You understand and agree that you will be required to immediately repatriate to China the
proceeds from the sale of any Stock acquired under the Plan and any such dividends paid on such
shares. You further understand that such repatriation proceeds may need to be effected through a
special bank account established by the Company (or a Subsidiary or Affiliate in China), and you
hereby consent and agree that any sale proceeds and cash dividends may be transferred to such
special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being
delivered to you and that no interest shall be paid with respect to funds held in such account.
The proceeds may be paid to you in U.S. dollars or local currency at the Company’s discretion. If
the proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account in
China must be established and maintained so that the proceeds may be deposited into such
account. If the proceeds are paid to you in local currency, you acknowledge that the Company
(and its Subsidiaries and Affiliates) are under no obligation to secure any particular exchange
conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in
converting the proceeds to local currency due to exchange control restrictions. You agree to bear
any currency fluctuation risk between the time the Stock is sold and the net proceeds are
converted into local currency and distributed to you. You further agree to comply with any other
requirements that may be imposed by the Company in the future in order to facilitate compliance
with exchange control requirements in China.
In addition to the vesting schedule for your Award, settlement of the Award is also conditioned on
the continued effectiveness of the Company’s registration of the Plan with SAFE (the SAFE
Registration Requirement). If or to the extent the Company is unable to maintain the registration,
no Stock for which a registration cannot be maintained shall be issued. In this case, the Company
retains the discretion to settle any Award for which the vesting schedule, but not the SAFE
Registration Requirement, has been met in cash paid through local payroll in an amount equal to
the market value of the Stock subject to the Award less any withholding for applicable taxes.
The Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost
interest or dividends or other losses that you may incur or suffer resulting from the enforcement of
the foregoing terms or otherwise from the Company’s operation and enforcement of the Plan, the

-- 84 of 161 --

Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and
requirements.
9. If you are subject to the laws of Colombia
You acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related
benefits do not constitute a component of “salary” for any legal purpose.
10. If you are subject to the laws of France
By accepting the Award, you confirm that you have read and understood the Plan Documents,
which were provided in English. You accept the terms of those Plan Documents and confirm that
you have a good knowledge of the English language.
En acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs à ce plan
d’incitation à long terme (qui vous ont été fournis en anglais) et que vous acceptez les termes
de ce plan.
11. If you are subject to the laws of Hong Kong
WARNING:
The contents of the Plan Documents have not been reviewed by any regulatory authority in Hong
Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any
of the contents of the Plan Documents, you should obtain independent professional advice.
This offer to receive an Award under the Plan (the Offer) is strictly private and only available to
eligible employees of Coca-Cola China Limited. The Offer has also not been approved by the
Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to
the public or any third-party.
No Awards granted under the Plan may be transferred or assigned, except as expressly permitted
by the Company in writing.
Sale of Stock. Any Stock received at vesting is accepted as a personal investment. In the event
that any portion of this Award vests within six months of the grant date, you agree that you will not
offer to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of
the grant date.
12. If you are subject to the laws of India
You must repatriate to India all funds resulting from the sale of Stock acquired in relation to your
Award within 90 days, and all proceeds from the receipt of any dividends within 180 days. You
should receive a foreign inward remittance certificate (FIRC) from your bank where you deposit the
foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event
that the Reserve Bank of India or your employer requests proof of repatriation.

-- 85 of 161 --

13. If you are subject to the laws of Indonesia
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to you
upon request to your local human resources representative. By accepting the grant of the Award,
you (i) confirm having read and understood the documents relating to this grant which were
provided in the English language, (ii) accept the terms of those documents accordingly, and (iii)
agree not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag,
Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when
issued).
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat
disediakan bagi anda berdasarkan permintaan kepada perwakilan sumber daya manusia lokal
anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah
membaca dan mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan
dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-dokumen tersebut, dan (iii)
setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-
Undang No. 24 Tahun 2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu
Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).
14. If you are subject to the laws of Italy
By accepting the grant of the Award, you acknowledge that you have received a copy of the Plan
Documents, you have reviewed the Plan Documents in their entirety and you fully understand and
accept all provisions of the Plan Documents. You further acknowledge that you have read and
expressly approve the following sections of the Additional Terms: section 2 (Employment); section 4
(Modifications and additional requirements); section 5 (Tax); and section 15 (General).
15. If you are subject to the laws of Mexico
By participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed
the Plan in its entirety and fully understand and accept all provisions of the Plan. You further
acknowledge that you have read and expressly approve the terms and conditions set forth in
section 2 (Employment) of the Additional Terms, in which the following is clearly described and
established: (i) your participation in the Plan does not constitute an acquired right; (ii) the Plan and
your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your
participation in the Plan is voluntary; and (iv) the Company and its Subsidiaries (as defined in the
Plan) are not responsible for any decrease in the value of the underlying Stock.
By participating in the Plan, you expressly recognize that The Coca Cola Company, with registered
offices at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA, is solely responsible for the
administration of the Plan and that your participation in the Plan and acquisition of Stock does not
constitute an employment relationship between you and the Company since you are participating in
the Plan on a wholly commercial basis. Based on the foregoing, you expressly recognize that the
Plan and the benefits that you may derive from participation in the Plan do not establish any rights
between you and the Company and do not form part of the employment conditions and/or benefits
provided by the Company and any modification of the Plan or its termination shall not constitute a
change or impairment of the terms and conditions of your employment.

-- 86 of 161 --

You further understand that your participation in the Plan is as a result of a unilateral and
discretionary decision of the Company; therefore, the Company reserves the absolute right to
amend and/or discontinue your participation at any time without any liability to you.
Finally, you hereby declare that you do not reserve any action or right to bring any claim against the
Company for any compensation or damages regarding any provision of the Plan or the benefits
derived under the Plan, and you therefore grant a full and broad release to the Company, its
Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal
representatives with respect to any claim that may arise.
Al participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el
Plan en su totalidad, y que entiende y acepta en su totalidad, todas y cada una de las
disposiciones del Plan. Asimismo reconoce que ha leído y aprueba expresamente los términos
y condiciones señalados en el párrafo titulado Naturaleza de la Oferta en el Convenio, en lo
que claramente se describe y establece lo siguiente: (i) su participación en el Plan no
constituye un derecho adquirido; (ii) el Plan y su participación en el Plan son ofrecidos por la
Compañía sobre una base completamente discrecional; (iii) su participación en el Plan es
voluntaria; y (iv) la Compañía y sus Afiliadas no son responsables de ninguna por la
disminución en el valor de las Acciones subyacentes.
Al participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con
oficinas registradas en One Coca-Cola Plaza, Atlanta, Georgia 30313, Estados Unidos de
América, es la única responsable por la administración del Plan, y que su participación en el
Plan, así como la adquisición de las Acciones, no constituye una relación laboral entre usted y
la Compañía, debido a que usted participa en el plan sobre una base completamente mercantil.
Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que
pudiera obtener por su participación en el Plan, no establecen derecho alguno entre usted y la
Compañía, y no forman parte de las condiciones y/o prestaciones laborales que la Compañía
ofrece, y que las modificaciones al Plan o su terminación, no constituirán un cambio ni
afectarán los términos y condiciones de su relación laboral.
Asimismo usted entiende que su participación en el Plan es el resultado de una decisión
unilateral y discrecional de la Compañía; por lo tanto, la Compañía se reserva el derecho
absoluto de modificar y/o suspender su participación en cualquier momento, sin que usted
incurra en responsabilidad alguna.
Finalmente, usted declara que no se reserva acción o derecho alguno para interponer
reclamación alguna en contra de la Compañía, por concepto de compensación o daños
relacionados con cualquier disposición del Plan o de los beneficios derivados del Plan, y por lo
tanto, usted libera total y ampliamente de toda responsabilidad a la Compañía, a sus Afiliadas,
sucursales, oficinas de representación, sus accionistas, funcionarios, agentes o representantes
legales, con respecto a cualquier reclamación que pudiera surgir.
The Stock underlying your Award has not been registered with the National Register of Securities
maintained by the Mexican Banking and Securities Commission and may not be offered or sold
publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials
are addressed to you only because of your existing relationship with the Company and its
Subsidiaries and may not be reproduced or copied in any form. The offer contained in these

-- 87 of 161 --

materials is addressed solely to the present employees of the Company and its Subsidiaries in
Mexico and any rights under the Plan may not be assigned or transferred. The Stock underlying
your Award will be offered pursuant to a private placement exception under the Mexican Securities
Law.
16. If you are subject to the laws of New Zealand
You are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with
the terms of the Plan Documents. The Stock, if issued, will give you a stake in the ownership of the
Company. You may receive a return if dividends are paid.
If the Company runs into financial difficulties and is wound up, you will be paid only after all
creditors and holders of preference shares (if any) have been paid. You may lose some or all of
your investment, if any.
New Zealand law normally requires people who offer financial products to give information to
investors before they invest. This information is designed to help investors to make an informed
decision. The usual rules do not apply to this offer because it is made under an employee share
scheme. As a result, you may not be given all the information usually required. You will also have
fewer other legal protections for this investment. You are advised to ask questions, read all
documents carefully, and seek independent financial advice before committing.
The Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under
the Plan, you may be able to sell the Stock on the New York Stock Exchange if there are interested
buyers. You may get less than you invested. The price will depend on the demand for the Stock.
For information on risk factors impacting the Company’s business that may affect the value of the
Stock, you should refer to the risk factors discussion on the Company’s Annual Report on Form 10-
K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange
Commission and are available online at www.sec.gov, as well as on the Company’s “Investor
Relations” website at https://investors.coca-colacompany.com/.
17. If you are subject to the laws of Peru
The grant of the Award is considered a private offering in Peru; therefore, it is not subject to
registration in Peru. For more information concerning the offer, please refer to the Plan Documents
and any other materials or documentation made available by the Company. For more information
regarding the Company, please refer to the Company’s Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are
available at www.sec.gov, as well as the Company’s “Investor Relations” website at https://
investors.coca-colacompany.com/.
By accepting the Award, you acknowledge that the Award is being granted ex gratia with the
purpose of rewarding you.
18. If you are subject to the laws of Philippines
The following wording is hereby made a part of the Plan Documents:

-- 88 of 161 --

The securities being offered or sold under the Plan have not been registered with the Philippine
Securities and Exchange Commission under the Philippine Securities Regulation Code. Any
future offer or sale of the securities in the Philippines is subject to registration requirements
under the Securities Regulation Code unless such offer or sale qualifies as an exempt
transaction.
This applies if your Award Notification specifies that your Award is an Option:
Notwithstanding any terms or conditions of the Plan Documents, you acknowledge and agree
that you will be restricted to the cashless sell-all method of exercise. To complete a cashless
sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise
of the Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and
brokerage fees or commissions; and (iii) remit the balance in cash to you. You will not be
permitted to hold the Stock after exercise. Depending on the development of local laws, the
Company reserves the right to modify the methods of exercising the Option and, in its sole
discretion, to permit cash exercise, cashless sell-to cover exercise or any other method of
exercise and payment of Liabilities permitted under the Plan.
19. If you are subject to the laws of Russia
Information contained in the Plan Documents does not constitute an advertisement of any
securities in Russia and must not be passed on to third parties or otherwise be made publicly
available in Russia. The Awards and the Stock to be granted under the Plan have not been and will
not be registered in Russia and are not intended for 'placement' or 'circulation' in Russia.
20. If you are subject to the laws of Singapore
You acknowledge that the Plan Documents have not been registered as a prospectus with the
Monetary Authority of Singapore. Accordingly, the Plan Documents and any other document or
material in connection with the offer or sale, or invitation for subscription or purchase of the Stock
may not be circulated or distributed, nor may the Stock be offered or sold, or be made the subject
of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore
other than pursuant to, and in accordance with the conditions of, an exemption under any provision
(other than Section 280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures
Act, Chapter 289 of Singapore.
The Awards under the Plan are prescribed capital markets products (as defined in the Securities
and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as
defined in MAS Notices SFA 04-N12 and FAA-N16).
21. If you are subject to the laws of South Africa
By accepting the Award, you agree to immediately notify your employer of the amount of any
income realized upon exercise or vesting of the Award. If you fail to advise your employer of the
income realized upon exercise or vesting of the Award, then you may be liable for a fine. You
personally will be responsible for paying the difference between the actual tax liability and the
amount withheld by the Company or your employer.

-- 89 of 161 --

The documents listed below are available for your review on the Company’s website at https://
investors.coca-colacompany.com/ and the Company’s intranet:
1. The Company’s most recent annual financial statements; and
2. The Company’s most recent Plan prospectus.
A copy of the above-listed documents will be sent to you free of charge on written request to Global
Equity, The Coca-Cola Company, at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA. You
should read these materials carefully before making a decision whether to participate in the Plan.
22. If you are subject to the laws of Spain
By accepting the Award, you acknowledge that you consent to participation in the Plan and have
received a copy of the Plan Documents. Except as otherwise provided in the Plan Documents,
termination of your employment for any reason (including for the reasons listed below) will
automatically result in the forfeiture of any unvested Awards; in particular, you understand and
agree that such Awards will be forfeited without entitlement to the underlying Stock or to any
amount as indemnification in the event of a termination of your employment prior to vesting by
reason of, including, but not limited to, resignation, disciplinary dismissal with or without cause,
individual or collective layoff with or without cause, material modification of employment under
Article 41 of the Worker’s Statute, relocation under Article 40 of the Worker’s Statute, Article 50 of
the Worker’s Statute, Article 10.3 of Royal Decree 1382/1985 and unilateral withdrawal by your
employer.
Furthermore, you understand that the Company has unilaterally, gratuitously, and in its sole
discretion decided to grant Awards under the Plan to individuals who may be employees of the
Company's group throughout the world. The decision is a limited decision that is entered into upon
the express assumption and condition that any grant will not bind the Company or any Subsidiary
(as defined in the Plan) or Affiliate, other than to the extent set forth in the Plan Documents.
Consequently, you understand that the Awards are offered on the assumption and condition that the
Awards and any Stock acquired under the Plan are not part of any employment contract (either with
the Company or any Subsidiary or Affiliate), and shall not be considered a mandatory benefit, salary
for any purposes (including severance compensation), or any other right whatsoever. In addition,
you understand that this offer would not be made but for the assumptions and conditions referred to
above; thus, you acknowledge and freely accept that, should any or all of the assumptions be
mistaken or should any of the conditions not be met for any reason, then any grant of or right to the
Award shall be null and void.
23. If you are subject to the laws of Sweden
The following provision supplements section 5 (Tax) of the Additional Terms:
Without limiting the authority of any Withholding Person to satisfy their withholding obligations
for Tax as set forth in section 5 (Tax) of the Additional Terms, by accepting the grant of the
Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable
to you to satisfy Tax, regardless of whether the Withholding Person has an obligation to
withhold such Tax.

-- 90 of 161 --

24. If you are subject to the laws of Switzerland
The offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a
prospectus under the Swiss Financial Services Act (FinSA) because such offering by the Company
is made exclusively to current or former members of the board of directors, members of the
management board or employees of the Company, the employer and its Affiliates. The Plan
Documents do not constitute a prospectus pursuant to FinSA, and no such prospectus has been or
will be prepared for or in connection with the offering of the Plan.
25. If you are subject to the laws of Turkey
Under Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The
shares are currently traded on the New York Stock Exchange, which is located outside of Turkey,
under the ticker symbol “KO” and the Stock may be sold through this exchange.
You acknowledge that any activity related to investments in foreign securities (e.g. the sale of
Stock) should be conducted through a bank or financial intermediary institution licensed by the
Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You
are solely responsible for complying with this requirement and should consult with a personal legal
advisor for further information regarding any obligations in this respect.
26. If you are subject to the laws of the United Arab Emirates
The Awards are granted under the Plan only to select employees of the Company's group and are
in the nature of providing employee equity incentives in the United Arab Emirates. The Plan
Documents are intended for distribution only to such employees and must not be delivered to, or
relied on by, any other person. Prospective purchasers of the securities offered should conduct
their own due diligence on the securities. If you do not understand the contents of the Plan
Documents, you should consult an authorized financial adviser. The Emirates Securities and
Commodities Authority has no responsibility for reviewing or verifying any documents in connection
with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic
Development has approved the Plan Documents nor taken steps to verify the information set out
herein, and has no responsibility for such documents.
27. If you are subject to the laws of the United Kingdom
This offer is being made to selected employees as part of an employee incentive program in order
to provide an additional incentive and to encourage employee share ownership and to increase
your interest in the success of the Company. The company offering these rights is The Coca-Cola
Company. The Stock which is the subject of these rights is new or existing par value common stock
in the Company. More information in relation to the Company including the stock price can be found
at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial
Services and Markets Act 2000 (as amended, supplemented or substituted by any UK legislation
enacted in connection with the UK’s exit from the European Union). The total maximum number of
Stock which is the subject of this offer is 240,000,000.

-- 91 of 161 --

28. If you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or
Vietnam
The Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your
Award. Instead, the Company reserves the right to make a payment to you in cash upon exercise or
vesting of your Award. Any references to the issuance of shares or Stock in any documents related
to the Award shall not be applicable in these circumstances.

-- 92 of 161 --

Award Notification – Restricted Stock Unit
Congratulations [INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the
Company) granted you an award (your Award) under The Coca-Cola Company 2024 Equity Plan, as
amended from time to time (the Plan). Your Award is a great opportunity to share in the long-term
success of the Company and contribute to its future growth.
This document provides details of the key terms of your Award. Your Award is subject to the formal rules
of the Plan, plus the additional terms and conditions (including country specific terms) as set out in a
document called the “Additional Terms”. The Additional Terms is available to review as part of the Award
acceptance process. The Plan is available in the Documents section of the Morgan Stanley at Work®
website. This Award Notification (including the appendices), the Plan and the Additional Terms together
form your Award Agreement. You are being asked to confirm that you understand and agree to be bound
by these documents as part of the Award acceptance process, so we recommend you read them
carefully.
Type of Award Restricted Stock Units - This is a conditional right to receive $0.25 par value
common stock of the Company (Stock) in the future. You will not receive the Stock
(or have any shareholder rights) unless your Award vests.
Number of
shares of
Stock subject
to your Award
[INSERT]
Continuing
employment Your Award is subject to your continuing employment, as set out in the
Employment Events Appendix to this document and the Plan.
Date your
Award
normally vests
[INSERT DATE]
When your Award vests, you become entitled to the Stock subject to your Award.
You do not need to purchase that Stock - it is delivered automatically to you.
The number of shares of Stock that vest will normally be delivered to you as soon
as administratively possible following vesting, unless a different timing for
delivering the Stock applies under the Employment Events Appendix.
Your Award will generally be settled in Shares, except where the appendices to
this Award Notification apply and specify otherwise.
You are liable for any tax, fees and costs due on vesting, which may be withheld.
Remember: your Award will only vest if and to the extent that all of the terms and
conditions of your Award are satisfied. To the extent that your Award does not vest,
it will be forfeited.
Prohibited
Activities If you engage in certain activities (called Prohibited Activities), your Award will be
forfeited and you will be required to pay back any gain from your Award. Refer to
the Prohibited Activities Appendix to this document.
Details of Award
Finally, certain data privacy provisions apply to you in connection with your Award, as set out in the Data
Privacy Appendix to this document.
In the event of any conflict between this Award Notification (including the appendices), the Additional
Terms and the Plan, the Plan takes precedence.
Exhibit 10.4

-- 93 of 161 --

Action required!
If you wish to accept your Award, you must accept it using the Morgan Stanley at Work ® website by
[INSERT DATE/TIME]. If you fail to do so by this deadline, then the Company may declare your Award
grant null and void at any time. If this happens, your Award will be forfeited, and you will have no right to
the underlying Stock. Acceptance of this award will constitute acknowledgement of and consent to the
updated Annual Incentive and Long-Term Incentive design and mix of awards.
Interpretation
The appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning
given in the Plan, unless otherwise specified. For the purposes of the Prohibited Activities Appendix, references to your employer
include your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current
local employing entity or former local employing entity and the Company (where applicable). References to the Committee mean
The Talent and Compensation Committee of the Board of Directors of the Company, unless otherwise specified.

-- 94 of 161 --

Employment Events Appendix – Restricted Stock Unit
The table below sets out the impact to your Award (if any) upon certain employment events. The terms of
the table below apply to vested and unvested portions of an Award equally, unless otherwise stated.
Except as otherwise specified herein, all other terms and conditions of your Award continue to apply.
Disability If your employment with the Company or a Subsidiary terminates because of
Disability, your Award immediately vests, and shares of Stock will be released
within 90 days after your termination date. Otherwise, if you remain employed,
there is no impact to your Award.
Death Any Award that has not been accepted terminates immediately upon your death
and may not be transferred to your heirs.
If you die while employed with the Company or a Subsidiary, your Award
immediately vests, and your estate will be paid, within 90 days after your death, a
cash amount equal to the value of the shares of Stock subject to the Award. The
value shall be determined based on the closing price of the Stock on the date of
death (or in the case of a non-trading day, the next trading day).
Leave of
absences1 If you are on (1) US military leave, (2) a Company-paid leave of absence (meaning
paid under Company payroll), or (3) an unpaid leave of absence (approved
pursuant to a published Company policy available to all employees covered under
the policy) of 12 months or less, there is no impact to your Award.
For all other leaves of absence not specified in the paragraph above, including all
approved unpaid leaves that extend beyond 12 months:
• any portion of your Award that is unvested is immediately forfeited1; or
• if the Committee identifies a valid business interest in doing otherwise, it
may specify what provisions it deems appropriate at its sole discretion
(provided that the Committee shall have no obligation to consider any such
matters).
Transfer If you transfer (1) between the Company and any Subsidiary or, (2) at the
Committee’s discretion, to an Affiliate that is not a Subsidiary, there is no impact to
your Award.
Event Impact to your Award
1 If an approved unpaid leave of absence extends beyond 12 months, the portion of your Award that is unvested as of the end of
the 12th month is forfeited.

-- 95 of 161 --

Termination2
A. If your employment with the Company or a Subsidiary terminates after attaining
age 60:
• Awards held less than 12 months are immediately forfeited, and
• Awards held at least 12 months immediately vest and shares of Stock will
be released within 90 days after your termination date.
B. If your employment with the Company or a Subsidiary terminates involuntarily
for any reason other than for cause within one year after a Change in Control,
your Award will be treated as described in the Plan.
C. If your employment with the Company or a Subsidiary terminates prior to
attaining age 60 (or after attaining age 60 and your award is not immediately
vested under paragraph A) because of (1) an involuntarily termination due to a
reduction in workforce, internal reorganization, or job elimination and you sign a
release of all claims and, if requested, an agreement on confidentiality and
competition, or (2) you participate in a Company or Subsidiary-sponsored
voluntary separation program:
• if any portion of your Award normally vests within 10 months after your
termination date, there is no impact to that portion of your Award, and
• All other Awards, or portions thereof, are immediately forfeited.
D. If your employment (1) with the Company or a Subsidiary terminates for any
other reason, or (2) with an Affiliate (that is not a Subsidiary) terminates for any
reason3, your Award is immediately forfeited.
Notwithstanding anything herein, if your employment with an Affiliate terminates
and you immediately become employed by the Company or a Subsidiary, there
is no impact on your Award.
Event Impact to your Award
For the purposes of your Award, you are deemed to have terminated employment on the date you are no
longer actively providing services to the relevant entity or entities, regardless of the reasons for
termination and whether or not later found to be invalid or in breach of your employment agreement, if
any, or employment laws in the jurisdiction where you are employed. The Committee has exclusive
discretion to decide when you are considered to be no longer actively providing services for the purposes
of your Award. However, you will not be considered to be actively providing services during any
contractual notice period or any period of “garden leave” or similar period mandated under employment
laws in the jurisdiction where you are employed or in your employment agreement, if any, unless the
Committee decides otherwise.
2 If required by Section 409A of the Code, the payment may not be made (if applicable) until at least six months following the
termination date.
3 This also would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award.
If your employer no longer meets the definition of “Affiliate”, you are deemed to have terminated employment for the purposes of the
Plan.

-- 96 of 161 --

Prohibited Activities Appendix
1. Engaging in Prohibited Activity
1.1 Timing
Section 1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5
(Types of Prohibited Activity) below) at any time during the term of your Award or within one year
after the later of:
1.1.1 the termination of your employment with the Company, your employer or any Affiliate; and
1.1.2 the last date of vesting or exercise of all or any portion of your Award.
1.2 Implications
If this section 1.2 applies:
1.2.1 your Award will immediately terminate, be forfeited and (if relevant) cease to be
exercisable; and
1.2.2 within 10 days after receiving written notice from the Company that this section applies,
you must pay in cash to the Company:
(i) any and all gains associated with any previous vesting or exercise of all or any
portion of your Award; and
(ii) interest calculated from the time of the notice until the date of repayment to the
Company.
2. Implications for settled Awards
2.1 Calculation of gain
For the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any
portion of your Award will be calculated as:
2.1.1 where your Award is in the form of an Option, the closing price per share of Stock on the
date of exercise as reported on the New York Stock Exchange Composite Transactions
listing minus the exercise price per share of Stock, multiplied by the number of shares of
Stock over which the Award was exercised;
2.1.2 where your Award is in the form of Restricted Stock Units or Performance Share Units,
the closing price per share of Stock on the date of vesting as reported on the New York
Stock Exchange Composite Transactions listing, multiplied by the number of shares of
Stock that vested; and
2.1.3 where your Award is in the form of Performance Cash, the gross amount of the cash
payment that vested.

-- 97 of 161 --

3. Alternative payment
3.1 Return of Stock
If all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable
for any reason by any court with jurisdiction:
3.1.1 you will transfer to the Company all of the shares of Stock that you acquired on vesting or
exercise of your Award that you still hold (and if your Award is an Option, the Company
will pay to you the exercise price you paid for that Stock in exchange); and
3.1.2 where you have already sold, transferred or disposed of any shares of Stock you
acquired on vesting or exercise of your Award, you must pay to the Company:
(i) any and all gains associated with each sale, transfer or disposal; and
(ii) interest calculated from the date of each sale, transfer or disposal until the date
of repayment to the Company.
3.2 Calculation of gain
For the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in
each case be calculated as the closing price per share of Stock on the date of the sale, transfer
or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus,
where your Award is an Option, the exercise price per share of Stock), multiplied by the number
of shares of Stock sold, transferred or disposed of.
4. Interest
Any interest payable under this Prohibited Activities Appendix will be calculated using the
weighted prime rate at SunTrust Bank, Atlanta.
5. Types of Prohibited Activity
The term Prohibited Activity includes any and all of the following:
5.2 Disparagement
Making any statement, written or verbal, in any forum or media, or taking any action in
disparagement of the Company, your employer and/or any Affiliate, including but not limited to
negative references to the Company or its products, services, corporate policies, or current or
former officers or employees, customers, suppliers, or business partners or associates.
5.2 Publicity
Publishing any opinion, fact, or material, delivering any lecture or address, participating in the
making of any film, radio broadcast or television transmission, or communicating with any
representative of the media relating to confidential matters regarding the business or affairs of the
Company, your employer and/or any Affiliate which you were involved with during your
employment.

-- 98 of 161 --

5.3 Disclosure of a Trade Secret
Failure to hold in confidence any and all Trade Secrets of the Company that came into your
knowledge during your employment with the Company, your employer and/or any Affiliate, or
disclosing, publishing, or making use of, at any time, such Trade Secrets.
For these purposes, Trade Secret means any technical or non-technical data, formula, pattern,
compilation, program, device, method, technique, drawing, process, financial data, financial plan,
product plan, list of actual or potential customers or suppliers or other information similar to any of
the foregoing, which:
5.3.1 derives economic value, actual or potential, from not being generally known to and not
being readily ascertainable by proper means by other persons who can derive economic
value from its disclosure or use; and
5.3.2 is the subject of efforts that are reasonable under the circumstances to maintain its
secrecy.
5.4 Disclosure of Confidential Information
Failure to hold in confidence all Confidential Information of the Company, your employer and/or
any Affiliate that came into your knowledge during your employment with the Company, your
employer or any Affiliate, or disclosing, publishing, or making use of such Confidential
Information.
For these purposes, Confidential Information means any data or information, other than Trade
Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)), that is valuable to the
Company and not generally known to the public or to competitors of the Company.
5.5 Failing to return materials
Your failure, in the event of your termination of employment for any reason, promptly to deliver to
the Company all memoranda, notes, records, manuals or other documents, including all copies of
such materials and all documentation prepared or produced in connection therewith, containing
Trade Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential
Information (as defined in section 5.4 (Disclosure of Confidential Information)) regarding the
Company’s business, whether made or compiled by you or furnished to you by virtue of your
employment with the Company, your employer or any Affiliate, or failure promptly to deliver to the
Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office
equipment, and other property furnished to you by virtue of your employment with the Company,
your employer or any Affiliate.
5.6 Competing
Rendering services for any organization which, or engaging directly or indirectly in any business
which, in the sole judgment of the Committee or the Chief Executive Officer of the Company or
any senior officer designated by the Committee, is or becomes competitive with the Company.
Notwithstanding the preceding sentence, this Section 5.6 will not be applicable for any employee
living or working in California.

-- 99 of 161 --

5.7 Solicitation
Soliciting or attempting to solicit for employment, for or on behalf of any corporation, partnership,
or other business entity, any employee of the Company, your employer or an Affiliate with whom
you had professional interaction during the last twelve months of your employment with the
Company, your employer or the Affiliate.
5.8 Violation of Company policies
Violating any written policies of the Company or your employer applicable to you, including,
without limitation, The Coca-Cola Company Global Insider Trading Compliance Policy.
6. Release
You may be released from the effects of this Prohibited Activities Appendix if the Committee
determines in its sole discretion that such action is in the best interest of the Company and its
stockholders.
7. Other rights apply
Nothing in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or
otherwise limiting the Company’s right under applicable state or local law or any prior agreement
you have signed or made with the Company regarding trade secrets, confidential information, or
intellectual property.

-- 100 of 161 --

Data Privacy Appendix
1. General
1.1 Introduction
This Data Privacy Appendix sets out certain data privacy provisions that apply to you in
connection with your Award.
1.2 Meaning of Data
For the purposes of this Data Privacy Appendix, Data means personal information that directly or
indirectly identifies you, including: your name, home address and telephone number, your date of
birth, your government identification number, your salary information, nationality, job title and
employment location, any shares or directorships you hold or held in the Company or any Affiliate,
details of your Award and any equity or cash awards or any other entitlements to stock or cash
granted (regardless of whether or not exercised, vested or settled, and including any cancelled or
forfeited awards), any information necessary to process your Award or any other award (e.g. your
mailing address for a check payment or bank account wire transfer information), any other
information necessary to process mandatory tax withholding and reporting and/or, where
applicable, your employment or service termination date and the reason for the termination.
2. For Award recipients not located in the EEA or UK
This section applies if you reside anywhere in the world except the European Economic Area
(EEA) or the United Kingdom (UK). By accepting your Award, you confirm the following:
2.1 Consent
You voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data
by and between the Company, your employer or any Affiliate for the purpose of implementing,
administering, and managing your participation in the Plan.
2.2 Data collected
You understand that the Company and its Affiliates may hold Data for the exclusive purpose of
implementing, administering, and managing the Plan.
2.3 Purposes of collection
You understand that Data will be transferred to one or more stock or incentive plan service
providers selected by the Company, which may assist the Company with the implementation,
administration, and/or management of the Plan.
2.4 Recipients of Data
You understand that the recipients of Data may be located in the United States or elsewhere. The
Company also uses third party service providers who may assist with the implementation,
administration or management of the Plan. These service providers are bound by contract to
handle Data in a way that aligns with this Data Privacy Appendix and applicable law. If you have

-- 101 of 161 --

any questions about the local entities or services providers who may access or handle your Data,
please contact your local human resources representative.
By consenting at section 2.1 (Consent) above, you authorize the Company and any other
possible recipients that do or may assist the Company with implementing, administering or
managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other
form, for the sole purpose of implementing, administering and/or managing your participation in
the Plan.
2.5 Data retention
You understand that Data will be held only as long as is necessary to implement, administer and
manage your participation in the Plan. In some cases, your information will be retained for the
Company or your employer to comply with a legal or tax obligation.
2.6 Your rights
You understand that if you reside in certain jurisdictions, to the extent required by applicable laws,
you may, at any time and without cost:
2.6.1 request access to Data;
2.6.2 request additional information about the storage and processing of Data;
2.6.3 require any necessary amendments to Data; or
2.6.4 refuse or withdraw the consents you give by accepting the Award,
by contacting your local human resources representative in writing.
2.7 Implications of not consenting or withdrawing consent
You understand that you provide these consents on a purely voluntary basis. If you do not
consent, or if you later withdraw your consent, your employment or service contract with the
Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will
mean that the Company will not be able to grant new awards or administer or maintain any
existing awards (including this Award) under the Plan. You understand that refusing or
withdrawing your consent may affect your ability to participate in the Plan (including the right to
retain an award, such as this Award). You understand that you may contact a local human
resources representative for more information on the consequences of refusal to consent or
withdrawal of consent.
3. For Award recipients located in the EEA and/or UK
This section applies if you reside inside the United Kingdom (UK) and/or the European Economic
Area (EEA). By accepting your Award, you confirm the following:
3.1 Data collected
You understand that the your employer (acting as controller) and the Company may collect, to the
extent permissible under applicable law, Data for the exclusive purpose of implementing,
administering, and managing the Plan. The Data is collected from you, the employer, and the

-- 102 of 161 --

Company for the exclusive purpose of implementing, administering, and managing the Plan in
accordance with the terms of your Award.
3.2 Purposes of collection/processing
You acknowledge the legal basis for Data processing is performance of the contract comprising
your Award. The Data must be provided in order for you to participate in the Plan and for the
parties to your Award to perform their respective obligations as set out in your Award documents.
If you do not provide Data, you will not be able to participate in the Plan or continue to hold your
Award.
3.3 Transfers and retention of Data
You understand that your employer will transfer Data to the Company for Plan administration
purposes. The Company and your employer may also transfer your Data to other service
providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by
the Company now or in the future, to assist the Company and your employer with the
implementation, administration and/or management of your Award. You understand that recipients
of the Data may be located in a country that does not benefit from an adequacy decision issued
by the European Commission. When your information is transferred outside the EEA or the UK
(as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please
contact privacy@coca-cola.com. Your Data will be held only as long as is necessary to
implement, administer and manage your rights and obligations under the terms of your Award
documents, as well as in compliance with other laws requiring a longer retention period.
3.4 Accuracy
You understand the Company and your employer will take steps in accordance with applicable
legislation to keep Data accurate, complete and up to date.
3.5 Your rights
You understand you are entitled to:
3.5.1 have any inadequate, incomplete or incorrect Data corrected;
3.5.2 request access to your Data and additional information about the processing of that Data;
3.5.3 object to the processing of Data or have your Data erased, under certain circumstances;
and
3.5.4 subject to applicable law:
(i) restrict the processing of your Data so that it is stored but not actively processed
(e.g. while the Company assesses whether you are entitled to have Data
erased); and
(ii) receive a copy of the Data provided in connection with your Award or generated
by you, in a common machine-readable format,
and you may exercise these rights by contacting a local human resources representative.

-- 103 of 161 --

3.6 Other contacts
You understand you have the right to contact, and may lodge a complaint with, the relevant data
protection supervisory authority.
You may also contact the EU Data Protection Officer:
Coca-Cola Italia s.r.l.
Viale Edison 110
Building B
20099 Sesto San Giovanni (Milan)
Italy
DPO-Europe@coca-cola.com
4. Country specific provisions
The provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of
this Data Privacy Appendix. By accepting your Award, you confirm the following:
4.1 If you are subject to the laws of Canada
You authorize the Company, your employer, and your employer’s representatives to discuss with
and obtain all relevant information from all personnel (professional or not) involved in the
administration and operation of the Plan. You authorize your employer, the Company, any
Affiliates and any stock or incentive plan service provider that may be selected by the Company
to assist with the Plan to disclose and discuss the Plan with their respective advisors. You further
authorize your employer, the Company and any Affiliates to record this information and to keep it
in your employee file.
4.2 If you are subject to the laws of Russia
You acknowledge that you have read, understood and agree to the terms regarding the collection,
processing and transfer of data described in section 2 (For Award recipients not located in the
EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you
agree to provide an executed data privacy consent form or any similar agreements or consents
that the Company or your employer may deem necessary to obtain under the data privacy laws in
Russia, either now or in the future. You understand that you will not be able to participate in the
Plan if you fail to execute any such consent or agreement that may be requested.

-- 104 of 161 --

Awards made under
The Coca-Cola Company 2024 Equity Plan
Additional Terms
By accepting your Award you:
1. Plan Documents
Agree that you have been given all relevant information and materials regarding the terms and
conditions of your Award, which are set out in the rules of The Coca-Cola Company 2024 Equity
Plan, as amended from time to time (the Plan), your Award Notification (including any appendices
attached to it) and these Additional Terms (including the Global Appendix set out below)
(collectively, the Plan Documents).
2. Employment
2.1 Acknowledge that the grant of your Award does not form part of and does not affect or change
your employment contract or your employment relationship with your employer (which is entirely
separate from the Plan). The grant of your Award and your participation in the Plan does not
create a right to employment or continued service and will not be interpreted as forming an
employment or service contract with The Coca-Cola Company (the Company), your employer or
any Affiliate (as defined in the Plan). The Award does not impact the ability of the Company, your
employer or any Affiliate to terminate that employment or service relationship. All benefits granted
by your Award will constitute an occasional extraordinary payment and may not, in any way or for
any purpose, be considered part of your normal remuneration or constitute consideration for any
services you provide to the Company, your employer or any Affiliate, including when calculating
any other benefits.
2.2 Acknowledge that the Company’s decision to grant your Award is voluntary and discretionary, and
that you have no right to participate in the Plan. Acceptance of your Award and participation in the
Plan does not create any right to, or expectation of, future employment or service, future
participation in the Plan or the grant of future awards (on the same basis, or at all). The Company
may at any time decide to cease offering awards under the Plan, or amend, modify, suspend,
cancel or terminate the Plan and any benefits under it.
2.3 Acknowledge that you are not entitled to the exercise of any discretion under the Plan in your
favor, that decisions with respect to your Award and any future awards are at the sole discretion
of the Company and are final, binding and conclusive, and that you do not have any claim or right
of action in respect of any decision, omission, or discretion, which may in each case operate to
your disadvantage.
2.4 Agree, in consideration for and as a condition of your Award, to waive all rights which might arise
in connection with the Plan, including:
2.4.1 the right to institute any claim against the Company, your employer or any Affiliate; and
2.4.2 the right to pursue any claim that is allowed by a court,
other than the right to acquire, as relevant, $0.25 par value shares of common stock of the
Company (Stock) or cash (subject to and in accordance with the Plan).

-- 105 of 161 --

2.5 Acknowledge that you do not have any right to compensation or damages for any loss (actual or
potential) in relation to the Plan or your Award, including where it is forfeited on termination of
employment or cessation of services for any reason, whether or not lawful or in breach of
employment laws or the terms of your employment or service agreement, if any.
3. No transfer
Accept that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your
Award or any rights in respect of it, whether voluntarily or involuntarily (other than to your
personal representatives on death).
4. Modifications and additional requirements
4.1 Agree that the Company may modify any of the terms of your Award to be consistent with any
applicable law or applicable government agency regulation where, in the opinion of the Company,
that term might otherwise conflict or be inconsistent.
4.2 Agree that the Company may impose additional conditions, requirements and restrictions on your
Award, your participation in the Plan and any Stock or cash you acquire on vesting or exercise of
your Award, and that you will comply with them, including signing any additional agreements or
undertakings.
4.3 Agree to any amendment made to the Plan or any term of your Award (including an amendment
with retroactive effect) where the amendment is necessary or advisable to ensure the Plan or
your Award complies with any future law relating to plans of this nature or their administration
(including Section 409A of the U.S. Internal Revenue Code of 1986, as amended).
4.4 Agree to any amendment made to any of the terms of your Award (including rescinding your
Award entirely) to correct any error that occurred in connection with the grant or documentation of
your Award.
4.5 Acknowledge that your Award may be adjusted to reflect a change in capital structure, in
accordance with the terms of the Plan, and agree that, where your Award is over Stock and an
adjustment results in a fractional share, the fractional share may be disregarded at the
Company’s discretion.
5. Tax
5.1 Acknowledge that participating in the Plan will probably have tax consequences for you and that
all payments made with respect to your Award (including payments in Stock or cash) may be
subject to tax, social security and any similar charges in any country where you are employed,
reside, or are otherwise subject to tax (Tax).
5.2 Agree that you (or your personal representative) are ultimately responsible for and will bear any
liability for any Tax in respect of your Award and your participation in the Plan, and understand
that this liability may exceed any amounts withheld and paid on your behalf.
5.3 Acknowledge that the Company, your employer, an Affiliate, any trustee of any employee benefit
trust and any third party service provider (each, a Withholding Person) is entitled to do any, all
or a combination of the following methods (where relevant) to enable a Withholding Person to
raise an amount it considers necessary or desirable to recover the Liabilities:

-- 106 of 161 --

5.3.1 sell or procure the sale on your behalf of a sufficient number of the Stock you acquire on
vesting or exercise of your Award;
5.3.2 reduce the number of Stock you acquire on vesting or exercise of your Award accordingly
and settle the balance in cash; and
5.3.3 withhold amounts from:
(i) proceeds of sale under section 5.3.1;
(ii) the balance settled in cash under section 5.3.2; and
(iii) any other cash payments of any kind owed to you.
For these purposes, Liabilities means any obligation on the Withholding Person to pay or
account for Tax, any unpaid exercise price, any associated costs (including under section 7
(Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any
obligation of any nature whatsoever (including under a loan, the Company’s tax equalization
program or any travel or expenses policy) to the extent that the Company, the employer or any
Affiliate in its reasonable judgement determines you owe them that amount.
5.4 Agree that, for tax purposes, and where allowed by applicable law, you are deemed to have
received the full number of Stock where the number of Stock you acquire is reduced under
section 5.3.2.
5.5 Agree that, where permitted by the Company, you may elect to satisfy Tax and/or pay any
exercise price by delivering (including by attestation) Stock to the Company.
5.6 Agree that if a Withholding Person’s obligation to pay or account for Tax cannot or has not been
fully satisfied by the above methods, you must pay to the Withholding Person an amount
sufficient to enable them to discharge that obligation.
5.7 Agree to enter any tax elections for particular tax and/or social security treatment, execute any
documents, give any directions and take any action as may be requested by the Company, your
employer or any Affiliate in relation to any Liabilities.
5.8 Acknowledge that the Company, your employer and any Affiliate do not guarantee or warrant any
particular Tax treatment in relation to your Award, the cash or Stock you acquire in connection
with your Award (including any dividends on Stock), or your participation in the Plan and that they
are not under any obligation to structure the Award in a Tax favorable way or avoid adverse Tax
treatment in any jurisdiction.
5.9 Acknowledge that neither the Company, your employer nor any Affiliate will be liable for any Tax,
interest, penalties or other amounts owed by any taxpayer as a consequence of the Plan or an
Award and that any Tax information provided is for guidance purposes only.
5.10 Accept that the cash or Stock subject to your Award may only vest or be exercised (as applicable)
if satisfactory arrangements are in place to enable all Withholding Persons to obtain the funds
needed to satisfy any Liabilities.
5.11 Acknowledge that the vested (and, if applicable, exercised) Stock or cash subject to your Award
may not be delivered or paid to you unless you have complied with your obligation to pay the
Liabilities.

-- 107 of 161 --

6. Internationally mobile employees
6.1 Acknowledge that if you are a mobile employee, meaning that you are based in different
jurisdictions during the course of your employment or service that you are or may be subject to
Tax in more than one country, you are strongly encouraged to inform the Company and your
employer, and to speak with your personal tax adviser regarding the tax treatment of your
participation in the Plan.
6.2 Accept that, if you are a mobile employee, the Company or your employer may be required to
withhold for Tax in more than one jurisdiction.
6.3 Accept that if you are a “Global Mobility Associate” as defined in the Company’s Global Mobility
Policy (or the equivalent under any applicable international service policy from time to time), you
remain responsible for all Tax except where expressly stated otherwise in that policy and/or the
Company’s tax equalization program. A copy of the Company’s Global Mobility Policy is available
on the Company’s intranet.
7. Costs
Agree that you are responsible for the payment of any fees, dealing, commission or currency
conversion costs or any other costs associated with your Award, including costs associated with
the payment of any cash and the sale of any Stock.
8. Notices
8.1 Agree that any notice or other communication required in relation to your Award will be given in
writing, which may include electronic means.
8.2 Agree that any notice or other communication to be given to you in connection with your Award
may be delivered by electronic means (including by email, or through the Company or your
employer’s intranet or a share plan portal), personally delivered, or sent by ordinary post to the
principal address on file for you from time to time with the Company, your employer, an Affiliate or
the Company’s agents.
8.3 Agree that any notice or other communication to be given to the Company or its agents in
connection with your Award may be delivered or sent to its registered office or to such other place
and by such means as communicated to you by or on behalf of the Company from time to time.
8.4 Accept that notices or other communications:
8.4.1 sent electronically will be deemed to have been received immediately (if sent
during usual business hours) or at the opening of business on the next business
day (if sent outside usual business hours);
8.4.2 that are personally delivered will be deemed to have been received when left at the
relevant address (if left during usual business hours) or at the opening of business
on the next business day (if left outside usual business hours); and
8.4.3 sent by post will be deemed to have been received 24 hours after posting to a U.S.
address or 3 days after posting to an address outside the U.S.,
unless there is evidence to the contrary.

-- 108 of 161 --

8.5 Agree that all notices or communications to be given to you are given and sent at your risk and
that neither the Company, your employer nor any Affiliate has any liability in respect of any notice
or communication given or sent, nor need they be concerned to see that you actually receive it.
9. Insider trading and market abuse
9.1 Acknowledge that rules on insider trading, dealing notification requirements, and market abuse
laws may apply in relation to any actions or decisions taken relating to your Award, including in
relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment
of any Stock or cash, and the sale of any Stock. These rules, requirements and laws:
9.1.1 are separate from and in addition to the requirements that apply to you under The
Coca-Cola Company Global Insider Trading Compliance Policy; and
9.1.2 may prohibit or delay your actions or decisions.
9.2 Agree that it is your responsibility to comply with the rules, requirements and laws referred to in
section 9.1. You should consult with your personal legal adviser on these matters.
10. Currency risk
10.1 Acknowledge that if any Stock relating to your Award is traded in a currency that is not the
currency in your jurisdiction, the value of the Stock may also be affected by movements in the
exchange rate.
10.2 Agree that neither the Company, your employer nor any Affiliate is liable for any loss due to
movements in the exchange rate nor any charges imposed in relation to the conversion or
transfer of money.
11. No advice
11.1 Confirm you are accepting your Award and participating in the Plan voluntarily and understand
that the Company is not making any recommendations regarding your Award or any Stock or
cash relating to your Award.
11.2 Agree that neither the Company, your employer, any Affiliate nor any person or entity acting on
their behalf has provided you with any legal, investment, tax (including reporting) or financial
advice with respect to your participation in the Plan, your Award or any Stock or cash acquired
upon vesting or exercise of your Award. You should consult with your own suitably qualified
advisers before taking any action under the Plan.
11.3 Acknowledge that the information and materials provided do not take into account your
objectives, financial situation or needs and that if you do not understand the contents of the Plan
Documents, or you are in any doubt, you should consult an independent authorized financial
adviser.
11.4 Agree you will have no remedies for any statement, representation, assurance or warranty that is
not set out in your Plan Documents.
12. No guarantee
12.1 Acknowledge that neither the Company, your employer nor any Affiliate guarantees a specified
level of return in respect of your Award or any Stock.

-- 109 of 161 --

12.2 Acknowledge that there is a risk that any Stock relating to your Award may fall as well as rise in
value, that the future value of Stock cannot be predicted with certainty and that market forces will
impact the price of any Stock relating to your Award and, in the worst case, the market value of
the Stock may become zero. More information in relation to the Company, including its share
price, can be found at https://www.coca-colacompany.com/.
13. No public offer
13.1 Acknowledge that your Award is being offered to you in your capacity as an employee of the
Company’s group and that the offer is not intended for the general public and may not be used for
any public offer.
13.2 Acknowledge that the Company is not required to deliver any Stock or cash on settlement of your
Award before it completes, on terms to its satisfaction, any registration, listing, exemption or
qualification or other legal requirements or obtains any clearance or approval that the Company
considers is necessary or desirable, and you agree to provide any information, make any
agreements and give any representations that the Company requests as part of this process.
13.3 Agree that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse to
deliver any Stock or cash where the Company considers the delivery of Stock or cash may
conflict or be inconsistent with applicable law or applicable government agency regulation.
13.4 Acknowledge that neither the Company, your employer nor any Affiliate is under any obligation to
register, exempt or qualify, or seek clearance or approval for, your Award or any Stock or cash
that you may acquire in connection with your Award.
13.5 Acknowledge that your Award may not have been authorized or approved by any applicable
securities authorities and may have been offered pursuant to an exemption from registration in
your local jurisdiction.
13.6 Acknowledge that the regulatory bodies in your jurisdiction accept no responsibility for the
accuracy and completeness of the statements and information contained in the Plan Documents
and take no liability whatsoever for any loss arising from reliance upon the whole or any part of
the contents of those documents.
13.7 Acknowledge that a prospectus or similar offering or registration document may not have been
prepared, authorized or approved by any applicable authority in any jurisdiction outside the
United States.
14. Exchange controls and any reporting requirements
14.1 Accept that exchange control regulations and/or foreign asset reporting requirements may apply
to you in respect of your Award and/or any Stock or cash acquired in connection with your Award,
and that you are solely responsible for complying with those regulations and requirements.
14.2 Agree that neither the Company, your employer nor any Affiliate are responsible for obtaining
exchange control approval or making any reports on your behalf, nor for monitoring compliance
with those regulations and requirements and that if you fail to obtain any required exchange
control approval or make the necessary reports, neither the Company, your employer nor any
Affiliate will be liable in any way for any resulting fines or penalties. You should seek independent
professional advice if you are unsure about the obligations that apply to you as a result of your
participation in the Plan.

-- 110 of 161 --

14.3 Accept that you are solely responsible for complying with any filing, notification or reporting
requirements in respect of:
14.3.1 your participation in the Plan and/or
14.3.2 benefits received under the Plan,
as required by the local law in any jurisdiction. The Company accepts no responsibility for your
failure or delay in complying with such requirements. If you are in any doubt as to what actions
you should take, you should consult a duly authorized independent adviser.
15. General
15.1 Consent to the use of electronic communications in connection with the Plan.
15.2 Confirm that references to “employer” throughout these Additional Terms include your former
employer, where applicable.
15.3 Agree that all determinations and decisions on questions of interpretation in respect of your
Award and the Plan Documents will be made by the Company (or any committee on its behalf) in
its sole and absolute discretion. Those determinations and decisions will be final, binding and
conclusive. Any references to determinations or decisions made, or actions taken, by the
“Company” as referred to in these Additional Terms include any committee acting on its behalf.
15.4 Agree that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable
for any reason by any court in any jurisdiction then, for the purposes of that jurisdiction only:
15.4.1 such provision will be deleted; and
15.4.1 the remaining provisions will continue in full force and effect.
15.5 Agree that if the Company waives a breach of one or more provisions in the Plan Documents, this
does not constitute a waiver of any other provision of the Plan Documents, or a waiver of any
subsequent breach of the Plan Documents (by you or anyone else).
15.6 Accept that:
15.6.1 the federal laws of the United States of America and the state laws of the State of
Delaware, United States of America, govern your Plan Documents and your Award
without regard to the conflict of law provisions; and
15.6.2 the courts of the United States District Court for the District of Delaware or the Delaware
Superior Court, New Castle County have exclusive jurisdiction in respect of disputes
arising under or in connection with the Plan or your Award,
and you waive any current or future objection you may have to this choice of law and jurisdiction.
16. English language (this applies if you have received an English language version
only of any Plan Document)
16.1 Accept that you fully understand the contents of the English language version of the Plan
Documents.

-- 111 of 161 --

16.2 Acknowledge that you do not need a translation of the Plan Documents and that you are fluent
and regularly conduct business in the English language as part of your duties and responsibilities
to your employer.
17. Translations (this applies if you have received a Plan Document in a language
other than English)
17.1 Agree that if there is any conflict between the terms of the English language version of the Plan
Documents and a version in any other language, the English language version will prevail.
18. Options (this applies if your Award Notification specifies that your Award is an
Option)
18.1 Understand that, in order to exercise your Award, you will need to pay the exercise price.
18.2 Acknowledge that you will be informed of the acceptable forms and methods of paying the
exercise price when you come to exercise your Award.
19. Restricted resale (this applies if your Award is over Stock)
Acknowledge that any Stock you may acquire upon settlement of your Award may be subject to
restrictions on transfer and resale in your local jurisdiction and you agree that you will comply with
those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or
cause any of these to occur) in circumstances which constitute any type of public offering of
securities, unless an exemption applies.
20. Performance conditions (this applies if your Award Notification specifies that your
Award is subject to performance conditions)
20.1 Accept that the vesting of your Award is conditional on the satisfaction of one or more
performance conditions as set out in the Performance Criteria Appendix to your Award Notification
(the Performance Criteria) and, to the extent the Performance Criteria are not satisfied, your
Award may be forfeited.
20.2 Accept that the Performance Criteria may be altered in the circumstances specified in Section
10.2 of the Plan.
21. Malus and clawback (this applies if your Award Notification specifies that your
Award is subject to “Malus and clawback”)
21.1 Agree that any benefits you may receive with respect to your Award will be subject to reduction,
cancellation, repayment, forfeiture or recoupment if there is a determination that the vesting of, or
amount realized from, your Award was based on:
21.1.1 materially inaccurate financial statements; or
21.1.2 any other materially inaccurate performance metric criteria,
and you acknowledge that this applies regardless of whether you caused or contributed to the
material inaccuracy.
21.2 Agree that the Company may also seek to recover your Award where required by the provisions
of the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other “clawback”

-- 112 of 161 --

provision required by applicable law, regulation or listing standards, including the listing standards
of the New York Stock Exchange, and you authorize such recovery.
22. Stock ownership guidelines (this only applies if you are subject to the Company’s
stock ownership guidelines)
22.1 Accept that if you have not met the Company’s stock ownership guidelines before the applicable
compliance deadline but you are a “Section 16 officer” under the U.S. Securities Exchange Act of
1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of
your Award until you meet the relevant guidelines, except for any Stock that is sold or cash settled
to cover Tax and any exercise price.
22.2 Accept that if you have not met the guidelines by the applicable compliance deadline, you are
prohibited at all times after that compliance deadline from selling any Stock you obtain on vesting
or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax,
commissions and fees and any exercise price. Once you meet the guidelines, you can sell Stock
in excess of the guidelines.

-- 113 of 161 --

Global Appendix – Equity Awards4
1. If you are subject to the laws of the European Union
This offer is being made to selected employees as part of an employee incentive program in order
to provide an additional incentive and to encourage employee share ownership and to increase
your interest in the success of the Company. The company offering these rights is The Coca-Cola
Company. The Stock which is the subject of these rights is new or existing par value common stock
in the Company. More information in relation to the Company including the stock price can be found
at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU
Prospectus Regulation. The total maximum number of Stock which is the subject of this offer is
240,000,000.
2. If you are subject to the laws of Argentina
Neither the Award nor the underlying Stock are publicly offered or listed on any stock exchange in
Argentina.
This provision applies if your Award Notification specifies that your Award is an Option:
Depending upon the method of exercise chosen for the Option, you may be subject to
restrictions with respect to the purchase and/or remittance of U.S. dollars pursuant to Argentine
currency exchange regulations. The Company reserves the right to restrict the methods of
exercise if required or advisable to comply with Argentine laws.
3. If you are subject to the laws of Australia
The grant of Awards under the Plan is intended to comply with the provisions of the Corporations
Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000. Additional details are set
forth in the Australia Offer Document, which is available on the Morgan Stanley at Work® website.
The offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax
Assessment Act 1997(Cth). The conditions to receive such treatment are contained in the Award
Agreement.
4. If you are subject to the laws of Belgium
If your Award Notification specifies that your Award is an Option, you confirm you have read and
understood the information regarding the Belgian taxation of Options which has been separately
made available to you by email and/or on the Morgan Stanley at Work® website. You should review
this information thoroughly before accepting your Option grant.
__________________________
4 If your are subject to the laws of any of the following countries, there are no country-specific provisions for your country in this
appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador, Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico,
Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.

-- 114 of 161 --

5. If you are subject to the laws of Brazil
By accepting the Award, you agree that you are (i) making an investment decision, and (ii) the
value of the underlying Stock is not fixed and may increase or decrease in value over the vesting or
exercise period without compensation to you.
6. If you are subject to the laws of Canada
For purposes of your Award, your employment will be considered terminated and your right (if any)
to vest in any Award or exercise any Option after such termination (regardless of the reason for
such termination and whether or not later found to be invalid, unlawful or in breach of the
employment laws in the jurisdiction where you are employed or the terms of your employment
agreement, if any) will be measured as of the earlier of: (a) the date your employment with the
Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date
you receive written notice of termination from the Company or a Subsidiary or Affiliate, regardless of
any notice period or period of pay in lieu of such notice mandated under the employment laws in
the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c)
the date you are no longer employed by the Company or any of its Subsidiaries or Affiliates. You will
not be entitled to a pro-rata portion of the Award for any time before the date on which your right to
vest terminates, nor will you be entitled to any compensation for lost vesting. In the event the date
on which you are no longer actively providing services cannot be reasonably determined under the
terms of your Award, the Company, in its sole discretion, shall determine when you are no longer
employed for purposes of the Award (including whether you may still be considered employed or
actively providing services while on a leave of absence).
Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires
continued entitlement to vesting during a statutory notice period, your right to vest in the Award
under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice
period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end
of your statutory notice period, nor will you be entitled to any compensation for lost vesting.
In addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired
pursuant to the Plan will be subject to certain restrictions on resale imposed by Canadian provincial
securities laws (in general, you may not resell your Stock to Canadian purchasers). Accordingly,
you are encouraged to seek legal advice prior to any resale of the Stock.
Furthermore, notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards
granted to Canadian residents shall only be settled in Stock and shall not be settled in cash.
The following terms and conditions apply if you are resident in Quebec:
You agree that you wish the Plan Documents to be drawn up in English.
Vous confirmez que vous souhaitiez que les Documents du Plan soient rédigés en anglais
7. If you are subject to the laws of Chile
Neither the Company, the Plan nor the Stock have been registered in the Registro de Valores
(Securities Registry) or in the Registro de Valores Extranjeros (Foreign Securities Registry) of the

-- 115 of 161 --

Comisión para el Mercado Financiero de Chile (Chilean Commission for the Financial market or
CMF) and they are not subject to the control of the CMF. The Plan is governed by General
Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to
deliver public information regarding the Stock in Chile. Shares of Stock cannot be publicly offered in
Chile unless they are registered with the CMF.
Ni The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de
Valores o en el Registro de Valores Extranjeros que lleva la Comisión para el Mercado
Financiero de Chile (CMF) y ninguno de ellos está sujeto a la fiscalización de la CMF. Esta
oferta de Acciones se acoge a la Norma de Carácter General 336. Por tratarse de valores no
inscritos, el emisor de las Acciones no tiene obligación bajo la ley chilena de entregar en Chile
información pública acerca de las Acciones. Las Acciones no pueden ser ofrecidas
públicamente en Chile en tanto éstas no se inscriban en el Registro de Valores
correspondiente.
8. If you are subject to exchange control restrictions imposed by the China State
Administration of Foreign Exchange (SAFE), as determined by the Company in its
sole discretion
Notwithstanding any other provision in the Plan Documents, the following provisions apply in the
event of the termination of your employment (as interpreted in accordance with the Employment
Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your
Disability, or (2) after attaining age 55:
Awards that are Options and Awards held at least 12 months will immediately vest and will be
settled in cash. The cash amount will be determined based on the closing price of the Stock on
the date of your termination of employment (or, if a non-trading day, the next trading day) or the
exercise of your Option (if applicable) within the post-termination exercise period stated below.
Awards that are not Options and that are held less than 12 months from the date of grant are
forfeited.
Where Performance Criteria apply, the Performance Criteria will be measured over a shortened
performance period, ending at the end of the year prior to your termination of employment.
If your Award is an Option, the period over which you may exercise your Option expires upon
earlier of (1) six months from your termination of employment or (2) the Option expiration date
provided in the Plan Documents.
The Company has the discretion to arrange for the sale of any Stock issued upon settlement of
your Award, either immediately upon settlement or at any time thereafter. In any event, if you
terminate employment, you will be required to sell all Stock acquired upon settlement of the Award
within such time period as required by the Company in accordance with SAFE requirements. Any
Stock remaining in your brokerage account at the end of this period shall be sold by the broker (on
your behalf pursuant to this authorization and without further consent). In addition, any Award that
has not vested by the end of this period will then immediately be forfeited. The Company shall have
the exclusive discretion to determine when your employment has been terminated for the purposes
of the Award.

-- 116 of 161 --

You agree to sign any additional agreements, forms and/or consents that reasonably may be
requested by the Company (or the Company’s designated broker) to effectuate the sale of the
Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange
control matters noted below) and shall otherwise cooperate with the Company with respect to such
matters. You acknowledge that neither the Company nor the designated broker is under any
obligation to arrange for the sale of Stock at any particular price (it being understood that the sale
will occur in the market) and that broker’s fees and similar expenses may be incurred in any such
sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for applicable
taxes, any broker’s fees or commissions, and any similar expenses of the sale will be remitted to
you in accordance with applicable exchange control laws and regulations.
By accepting the Award, you acknowledge that you understand and agree that you are not
permitted to transfer any Stock acquired under the Plan out of your account established with the
Company’s designated broker until the Stock is sold. The limitation applies to all Stock issued to
you under the Plan, whether or not you remained employed with the Company or a Subsidiary.
You understand and agree that you will be required to immediately repatriate to China the
proceeds from the sale of any Stock acquired under the Plan and any such dividends paid on such
shares. You further understand that such repatriation proceeds may need to be effected through a
special bank account established by the Company (or a Subsidiary or Affiliate in China), and you
hereby consent and agree that any sale proceeds and cash dividends may be transferred to such
special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being
delivered to you and that no interest shall be paid with respect to funds held in such account.
The proceeds may be paid to you in U.S. dollars or local currency at the Company’s discretion. If
the proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account in
China must be established and maintained so that the proceeds may be deposited into such
account. If the proceeds are paid to you in local currency, you acknowledge that the Company
(and its Subsidiaries and Affiliates) are under no obligation to secure any particular exchange
conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in
converting the proceeds to local currency due to exchange control restrictions. You agree to bear
any currency fluctuation risk between the time the Stock is sold and the net proceeds are
converted into local currency and distributed to you. You further agree to comply with any other
requirements that may be imposed by the Company in the future in order to facilitate compliance
with exchange control requirements in China.
In addition to the vesting schedule for your Award, settlement of the Award is also conditioned on
the continued effectiveness of the Company’s registration of the Plan with SAFE (the SAFE
Registration Requirement). If or to the extent the Company is unable to maintain the registration,
no Stock for which a registration cannot be maintained shall be issued. In this case, the Company
retains the discretion to settle any Award for which the vesting schedule, but not the SAFE
Registration Requirement, has been met in cash paid through local payroll in an amount equal to
the market value of the Stock subject to the Award less any withholding for applicable taxes.
The Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost
interest or dividends or other losses that you may incur or suffer resulting from the enforcement of
the foregoing terms or otherwise from the Company’s operation and enforcement of the Plan, the

-- 117 of 161 --

Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and
requirements.
9. If you are subject to the laws of Colombia
You acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related
benefits do not constitute a component of “salary” for any legal purpose.
10. If you are subject to the laws of France
By accepting the Award, you confirm that you have read and understood the Plan Documents,
which were provided in English. You accept the terms of those Plan Documents and confirm that
you have a good knowledge of the English language.
En acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs à ce plan
d’incitation à long terme (qui vous ont été fournis en anglais) et que vous acceptez les termes
de ce plan.
11. If you are subject to the laws of Hong Kong
WARNING:
The contents of the Plan Documents have not been reviewed by any regulatory authority in Hong
Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any
of the contents of the Plan Documents, you should obtain independent professional advice.
This offer to receive an Award under the Plan (the Offer) is strictly private and only available to
eligible employees of Coca-Cola China Limited. The Offer has also not been approved by the
Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to
the public or any third-party.
No Awards granted under the Plan may be transferred or assigned, except as expressly permitted
by the Company in writing.
Sale of Stock. Any Stock received at vesting is accepted as a personal investment. In the event that
any portion of this Award vests within six months of the grant date, you agree that you will not offer
to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of the
grant date.
12. If you are subject to the laws of India
You must repatriate to India all funds resulting from the sale of Stock acquired in relation to your
Award within 90 days, and all proceeds from the receipt of any dividends within 180 days. You
should receive a foreign inward remittance certificate (FIRC) from your bank where you deposit the
foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event
that the Reserve Bank of India or your employer requests proof of repatriation.

-- 118 of 161 --

13. If you are subject to the laws of Indonesia
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to you
upon request to your local human resources representative. By accepting the grant of the Award,
you (i) confirm having read and understood the documents relating to this grant which were
provided in the English language, (ii) accept the terms of those documents accordingly, and (iii)
agree not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag,
Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when
issued).
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat
disediakan bagi anda berdasarkan permintaan kepada perwakilan sumber daya manusia lokal
anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah
membaca dan mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan
dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-dokumen tersebut, dan (iii)
setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-
Undang No. 24 Tahun 2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu
Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).
14. If you are subject to the laws of Italy
By accepting the grant of the Award, you acknowledge that you have received a copy of the Plan
Documents, you have reviewed the Plan Documents in their entirety and you fully understand and
accept all provisions of the Plan Documents. You further acknowledge that you have read and
expressly approve the following sections of the Additional Terms: section 2 (Employment); section 4
(Modifications and additional requirements); section 5 (Tax); and section 15 (General).
15. If you are subject to the laws of Mexico
By participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed
the Plan in its entirety and fully understand and accept all provisions of the Plan. You further
acknowledge that you have read and expressly approve the terms and conditions set forth in
section 2 (Employment) of the Additional Terms, in which the following is clearly described and
established: (i) your participation in the Plan does not constitute an acquired right; (ii) the Plan and
your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your
participation in the Plan is voluntary; and (iv) the Company and its Subsidiaries (as defined in the
Plan) are not responsible for any decrease in the value of the underlying Stock.
By participating in the Plan, you expressly recognize that The Coca Cola Company, with registered
offices at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA, is solely responsible for the
administration of the Plan and that your participation in the Plan and acquisition of Stock does not
constitute an employment relationship between you and the Company since you are participating in
the Plan on a wholly commercial basis. Based on the foregoing, you expressly recognize that the
Plan and the benefits that you may derive from participation in the Plan do not establish any rights
between you and the Company and do not form part of the employment conditions and/or benefits
provided by the Company and any modification of the Plan or its termination shall not constitute a
change or impairment of the terms and conditions of your employment.

-- 119 of 161 --

You further understand that your participation in the Plan is as a result of a unilateral and
discretionary decision of the Company; therefore, the Company reserves the absolute right to
amend and/or discontinue your participation at any time without any liability to you.
Finally, you hereby declare that you do not reserve any action or right to bring any claim against the
Company for any compensation or damages regarding any provision of the Plan or the benefits
derived under the Plan, and you therefore grant a full and broad release to the Company, its
Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal
representatives with respect to any claim that may arise.
Al participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el
Plan en su totalidad, y que entiende y acepta en su totalidad, todas y cada una de las
disposiciones del Plan. Asimismo reconoce que ha leído y aprueba expresamente los términos
y condiciones señalados en el párrafo titulado Naturaleza de la Oferta en el Convenio, en lo
que claramente se describe y establece lo siguiente: (i) su participación en el Plan no
constituye un derecho adquirido; (ii) el Plan y su participación en el Plan son ofrecidos por la
Compañía sobre una base completamente discrecional; (iii) su participación en el Plan es
voluntaria; y (iv) la Compañía y sus Afiliadas no son responsables de ninguna por la
disminución en el valor de las Acciones subyacentes.
Al participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con
oficinas registradas en One Coca-Cola Plaza, Atlanta, Georgia 30313, Estados Unidos de
América, es la única responsable por la administración del Plan, y que su participación en el
Plan, así como la adquisición de las Acciones, no constituye una relación laboral entre usted y
la Compañía, debido a que usted participa en el plan sobre una base completamente mercantil.
Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que
pudiera obtener por su participación en el Plan, no establecen derecho alguno entre usted y la
Compañía, y no forman parte de las condiciones y/o prestaciones laborales que la Compañía
ofrece, y que las modificaciones al Plan o su terminación, no constituirán un cambio ni
afectarán los términos y condiciones de su relación laboral.
Asimismo usted entiende que su participación en el Plan es el resultado de una decisión
unilateral y discrecional de la Compañía; por lo tanto, la Compañía se reserva el derecho
absoluto de modificar y/o suspender su participación en cualquier momento, sin que usted
incurra en responsabilidad alguna.
Finalmente, usted declara que no se reserva acción o derecho alguno para interponer
reclamación alguna en contra de la Compañía, por concepto de compensación o daños
relacionados con cualquier disposición del Plan o de los beneficios derivados del Plan, y por lo
tanto, usted libera total y ampliamente de toda responsabilidad a la Compañía, a sus Afiliadas,
sucursales, oficinas de representación, sus accionistas, funcionarios, agentes o representantes
legales, con respecto a cualquier reclamación que pudiera surgir.
The Stock underlying your Award has not been registered with the National Register of Securities
maintained by the Mexican Banking and Securities Commission and may not be offered or sold
publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials
are addressed to you only because of your existing relationship with the Company and its
Subsidiaries and may not be reproduced or copied in any form. The offer contained in these

-- 120 of 161 --

materials is addressed solely to the present employees of the Company and its Subsidiaries in
Mexico and any rights under the Plan may not be assigned or transferred. The Stock underlying
your Award will be offered pursuant to a private placement exception under the Mexican Securities
Law.
16. If you are subject to the laws of New Zealand
You are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with
the terms of the Plan Documents. The Stock, if issued, will give you a stake in the ownership of the
Company. You may receive a return if dividends are paid.
If the Company runs into financial difficulties and is wound up, you will be paid only after all
creditors and holders of preference shares (if any) have been paid. You may lose some or all of
your investment, if any.
New Zealand law normally requires people who offer financial products to give information to
investors before they invest. This information is designed to help investors to make an informed
decision. The usual rules do not apply to this offer because it is made under an employee share
scheme. As a result, you may not be given all the information usually required. You will also have
fewer other legal protections for this investment. You are advised to ask questions, read all
documents carefully, and seek independent financial advice before committing.
The Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under
the Plan, you may be able to sell the Stock on the New York Stock Exchange if there are interested
buyers. You may get less than you invested. The price will depend on the demand for the Stock.
For information on risk factors impacting the Company’s business that may affect the value of the
Stock, you should refer to the risk factors discussion on the Company’s Annual Report on Form 10-
K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange
Commission and are available online at www.sec.gov, as well as on the Company’s “Investor
Relations” website at https://investors.coca-colacompany.com/.
17. If you are subject to the laws of Peru
The grant of the Award is considered a private offering in Peru; therefore, it is not subject to
registration in Peru. For more information concerning the offer, please refer to the Plan Documents
and any other materials or documentation made available by the Company. For more information
regarding the Company, please refer to the Company’s Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are
available at www.sec.gov, as well as the Company’s “Investor Relations” website at https://
investors.coca-colacompany.com/.
By accepting the Award, you acknowledge that the Award is being granted ex gratia with the
purpose of rewarding you.
18. If you are subject to the laws of Philippines
The following wording is hereby made a part of the Plan Documents:

-- 121 of 161 --

The securities being offered or sold under the Plan have not been registered with the Philippine
Securities and Exchange Commission under the Philippine Securities Regulation Code. Any
future offer or sale of the securities in the Philippines is subject to registration requirements
under the Securities Regulation Code unless such offer or sale qualifies as an exempt
transaction.
This applies if your Award Notification specifies that your Award is an Option:
Notwithstanding any terms or conditions of the Plan Documents, you acknowledge and agree
that you will be restricted to the cashless sell-all method of exercise. To complete a cashless
sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise
of the Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and
brokerage fees or commissions; and (iii) remit the balance in cash to you. You will not be
permitted to hold the Stock after exercise. Depending on the development of local laws, the
Company reserves the right to modify the methods of exercising the Option and, in its sole
discretion, to permit cash exercise, cashless sell-to cover exercise or any other method of
exercise and payment of Liabilities permitted under the Plan.
19. If you are subject to the laws of Russia
Information contained in the Plan Documents does not constitute an advertisement of any
securities in Russia and must not be passed on to third parties or otherwise be made publicly
available in Russia. The Awards and the Stock to be granted under the Plan have not been and will
not be registered in Russia and are not intended for 'placement' or 'circulation' in Russia.
20. If you are subject to the laws of Singapore
You acknowledge that the Plan Documents have not been registered as a prospectus with the
Monetary Authority of Singapore. Accordingly, the Plan Documents and any other document or
material in connection with the offer or sale, or invitation for subscription or purchase of the Stock
may not be circulated or distributed, nor may the Stock be offered or sold, or be made the subject
of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore
other than pursuant to, and in accordance with the conditions of, an exemption under any provision
(other than Section 280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures
Act, Chapter 289 of Singapore.
The Awards under the Plan are prescribed capital markets products (as defined in the Securities
and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as
defined in MAS Notices SFA 04-N12 and FAA-N16).
21. If you are subject to the laws of South Africa
By accepting the Award, you agree to immediately notify your employer of the amount of any
income realized upon exercise or vesting of the Award. If you fail to advise your employer of the
income realized upon exercise or vesting of the Award, then you may be liable for a fine. You
personally will be responsible for paying the difference between the actual tax liability and the
amount withheld by the Company or your employer.

-- 122 of 161 --

The documents listed below are available for your review on the Company’s website at https://
investors.coca-colacompany.com/ and the Company’s intranet:
1. The Company’s most recent annual financial statements; and
2. The Company’s most recent Plan prospectus.
A copy of the above-listed documents will be sent to you free of charge on written request to Global
Equity, The Coca-Cola Company, at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA. You
should read these materials carefully before making a decision whether to participate in the Plan.
22. If you are subject to the laws of Spain
By accepting the Award, you acknowledge that you consent to participation in the Plan and have
received a copy of the Plan Documents. Except as otherwise provided in the Plan Documents,
termination of your employment for any reason (including for the reasons listed below) will
automatically result in the forfeiture of any unvested Awards; in particular, you understand and
agree that such Awards will be forfeited without entitlement to the underlying Stock or to any
amount as indemnification in the event of a termination of your employment prior to vesting by
reason of, including, but not limited to, resignation, disciplinary dismissal with or without cause,
individual or collective layoff with or without cause, material modification of employment under
Article 41 of the Worker’s Statute, relocation under Article 40 of the Worker’s Statute, Article 50 of
the Worker’s Statute, Article 10.3 of Royal Decree 1382/1985 and unilateral withdrawal by your
employer.
Furthermore, you understand that the Company has unilaterally, gratuitously, and in its sole
discretion decided to grant Awards under the Plan to individuals who may be employees of the
Company's group throughout the world. The decision is a limited decision that is entered into upon
the express assumption and condition that any grant will not bind the Company or any Subsidiary
(as defined in the Plan) or Affiliate, other than to the extent set forth in the Plan Documents.
Consequently, you understand that the Awards are offered on the assumption and condition that the
Awards and any Stock acquired under the Plan are not part of any employment contract (either with
the Company or any Subsidiary or Affiliate), and shall not be considered a mandatory benefit, salary
for any purposes (including severance compensation), or any other right whatsoever. In addition,
you understand that this offer would not be made but for the assumptions and conditions referred to
above; thus, you acknowledge and freely accept that, should any or all of the assumptions be
mistaken or should any of the conditions not be met for any reason, then any grant of or right to the
Award shall be null and void.
23. If you are subject to the laws of Sweden
The following provision supplements section 5 (Tax) of the Additional Terms:
Without limiting the authority of any Withholding Person to satisfy their withholding obligations
for Tax as set forth in section 5 (Tax) of the Additional Terms, by accepting the grant of the
Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable
to you to satisfy Tax, regardless of whether the Withholding Person has an obligation to
withhold such Tax.

-- 123 of 161 --

24. If you are subject to the laws of Switzerland
The offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a
prospectus under the Swiss Financial Services Act (FinSA) because such offering by the Company
is made exclusively to current or former members of the board of directors, members of the
management board or employees of the Company, the employer and its Affiliates. The Plan
Documents do not constitute a prospectus pursuant to FinSA, and no such prospectus has been or
will be prepared for or in connection with the offering of the Plan.
25. If you are subject to the laws of Turkey
Under Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The
shares are currently traded on the New York Stock Exchange, which is located outside of Turkey,
under the ticker symbol “KO” and the Stock may be sold through this exchange.
You acknowledge that any activity related to investments in foreign securities (e.g. the sale of
Stock) should be conducted through a bank or financial intermediary institution licensed by the
Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You
are solely responsible for complying with this requirement and should consult with a personal legal
advisor for further information regarding any obligations in this respect.
26. If you are subject to the laws of the United Arab Emirates
The Awards are granted under the Plan only to select employees of the Company's group and are
in the nature of providing employee equity incentives in the United Arab Emirates. The Plan
Documents are intended for distribution only to such employees and must not be delivered to, or
relied on by, any other person. Prospective purchasers of the securities offered should conduct
their own due diligence on the securities. If you do not understand the contents of the Plan
Documents, you should consult an authorized financial adviser. The Emirates Securities and
Commodities Authority has no responsibility for reviewing or verifying any documents in connection
with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic
Development has approved the Plan Documents nor taken steps to verify the information set out
herein, and has no responsibility for such documents.
27. If you are subject to the laws of the United Kingdom
This offer is being made to selected employees as part of an employee incentive program in order
to provide an additional incentive and to encourage employee share ownership and to increase
your interest in the success of the Company. The company offering these rights is The Coca-Cola
Company. The Stock which is the subject of these rights is new or existing par value common stock
in the Company. More information in relation to the Company including the stock price can be found
at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial
Services and Markets Act 2000 (as amended, supplemented or substituted by any UK legislation
enacted in connection with the UK’s exit from the European Union). The total maximum number of
Stock which is the subject of this offer is 240,000,000.

-- 124 of 161 --

28. If you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or
Vietnam
The Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your
Award. Instead, the Company reserves the right to make a payment to you in cash upon exercise or
vesting of your Award. Any references to the issuance of shares or Stock in any documents related
to the Award shall not be applicable in these circumstances.

-- 125 of 161 --

Award Notification – Stock Option
Congratulations [INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the
Company) granted you an award (your Award) under The Coca-Cola Company 2024 Equity Plan, as
amended from time to time (the Plan). Your Award is a great opportunity to share in the long-term
success of the Company and contribute to its future growth.
This document provides details of the key terms of your Award. Your Award is subject to the formal rules
of the Plan, plus the additional terms and conditions (including country specific terms) as set out in a
document called the “Additional Terms”. The Additional Terms is available to review as part of the Award
acceptance process. The Plan is available in the Documents section of the Morgan Stanley at Work®
website. This Award Notification (including the appendices), the Plan and the Additional Terms together
form your Award Agreement. You are being asked to confirm that you understand and agree to be bound
by these documents as part of the Award acceptance process, so we recommend you read them
carefully.
Type of Award Option - This is a conditional right to purchase $0.25 par value common stock of
the Company (Stock) in the future, at the exercise price specified below. For tax
purposes, this is a nonqualified stock option.
BELGIUM
ONLY - Option
offer date
[INSERT DATE]
BELGIUM ONLY - If you accept your Award within 60 days of this date, the Award
is taxable on the 60th day following the offer date. If you do not accept within the
60-day period, your Award is taxed at exercise.
Number of
shares of
Stock subject
to your Award
[INSERT]
Exercise price [INSERT]
This is the price you will pay per share of Stock.
Continuing
employment Your Award is subject to your continuing employment, as set out in the
Employment Events Appendix to this document and the Plan.
Date your
Award
normally vests
25% per year over 4 years, as follows:
[INSERT DATE] - 25% of your Award vests
[INSERT DATE] - a further 25% of your Award vests
[INSERT DATE] - a further 25% of your Award vests
[INSERT DATE] - the final 25% of your Award vests
When your Award vests, you become entitled to exercise your Award.
Remember: your Award will only vest if and to the extent that all of the terms and
conditions of your Award are satisfied. To the extent that your Award does not vest,
it will be forfeited.
Details of Award
Exhibit 10.5

-- 126 of 161 --

Exercise of
your Award ‘Exercising’ your Award simply means exercising your right to buy the vested Stock
subject to your Award.
In order to exercise your Award, you must submit any required documentation, pay
the exercise price (see above), arrange to pay any tax, fees and costs (which may
be withheld), and take any other steps that might be required from you. You will be
informed of the acceptable form(s) and method(s) of paying the exercise price
when you exercise your Award.
Expiration
date [INSERT]
This is the date your Award will normally expire (unless it expires earlier under the
Plan or the Award terms and conditions). When your Award expires, you lose your
right to buy the Stock.
Prohibited
Activities If you engage in certain activities (called Prohibited Activities), your Award will be
forfeited and you will be required to pay back any gain from your Award. Refer to
the Prohibited Activities Appendix to this document.
Details of Award
Finally, certain data privacy provisions apply to you in connection with your Award, as set out in the Data
Privacy Appendix to this document.
In the event of any conflict between this Award Notification (including the appendices), the Additional
Terms and the Plan, the Plan takes precedence.
Action required!
If you wish to accept your Award, you must accept it using the Shareworks by Morgan Stanley® website
by [Insert Date]. If you fail to do so by this deadline, then the Company may declare your Award grant
null and void at any time. If this happens, your Award will be forfeited, and you will have no right to the
underlying Stock. Acceptance of this award will constitute acknowledgement of and consent to the
updated Annual Incentive and Long-Term Incentive design and mix of awards.
Interpretation
The appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning
given in the Plan, unless otherwise specified. For the purposes of the Prohibited Activities Appendix, references to your employer
include your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current
local employing entity or former local employing entity and the Company (where applicable). References to the Committee mean
The Talent and Compensation Committee of the Board of Directors of the Company, unless otherwise specified.

-- 127 of 161 --

Employment Events Appendix – Performance Share
The table below sets out the impact to your Award (if any) upon certain employment events. The terms of
the table below apply to vested and unvested portions of an Award equally, unless otherwise stated.
Except as otherwise specified herein, all other terms and conditions of your Award continue to apply.
Disability If your employment with the Company or a Subsidiary terminates because of
Disability, your Award immediately vests. Otherwise, if you remain employed, there
is no impact to your Award.
Death Any Award that has not been accepted terminates immediately upon your death
and may not be transferred to your heirs.
If you die while employed with the Company or a Subsidiary, your Award
immediately vests, however, it expires on the earlier of (1) one year from your date
of death, or (2) the expiration date in the Award Notification.
If you die after your termination of employment (but before your Award has
expired), your Award expires on the earlier of (1) one year from your date of death,
or (2) the expiration date that applied to your Award at your date of death.
Leave of
absences 1 If you are on (1) US military leave, (2) a Company-paid leave of absence (meaning
paid under Company payroll), or (3) an unpaid leave of absence (approved
pursuant to a published Company policy available to all employees covered under
the policy) of 12 months or less, there is no impact to your Award.
For all other leaves of absence not specified in the paragraph above, including
all approved unpaid leaves that extend beyond 12 months, your Award will be
treated in accordance with the general termination provision at (C) below1,
except that if the Committee identifies a valid business interest in doing
otherwise, it may specify what provisions it deems appropriate at its sole
discretion (provided that the Committee shall have no obligation to consider
any such matters).
Transfer If you transfer (1) between the Company and any Subsidiary or, (2) at the
Committee’s discretion, to an Affiliate that is not a Subsidiary, there is no impact to
your Award.
Event Impact to your Award
1 If an approved unpaid leave of absence extends beyond 12 months, the terms of the general termination provision (C) will apply at
the end of the 12th month.

-- 128 of 161 --

Termination2 A. If your employment with the Company or a Subsidiary terminates after attaining
age 60:
• Awards held less than 12 months are immediately forfeited, and
• Awards held at least 12 months immediately vest.
B. If your employment with the Company or a Subsidiary terminates involuntarily
for any reason other than for cause within one year after a Change in Control,
your Award will be treated as described in the Plan.
C. If your employment with the Company or a Subsidiary terminates prior to
attaining age 60 because of (1) an involuntarily termination due to a reduction
in workforce, internal reorganization, or job elimination and you sign a release
of all claims and, if requested, an agreement on confidentiality and competition,
or (2) you participate in a Company or Subsidiary-sponsored voluntary
separation program:
• any unvested portion of the Award is immediately forfeited, and
• any vested portion of the Award will be forfeited upon the earlier of (1) 12
months from your termination date, or (2) the expiration date in the Award
Notification.
D. If your employment (1) with the Company or a Subsidiary terminates for any
other reason, or (2) with an Affiliate (that is not a Subsidiary) terminates for any
reason2:
• any unvested portion of the Award is immediately forfeited, and
• any vested portion of the Award will be forfeited upon the earlier of (1) six
months from your termination date, or (2) the expiration date in the Award
Notification.
Notwithstanding anything herein, if your employment with an Affiliate terminates
and you immediately become employed by the Company or a Subsidiary, there
is no impact on your Award.
Event Impact to your Award
For the purposes of your Award, you are deemed to have terminated employment on the date you are no
longer actively providing services to the relevant entity or entities, regardless of the reasons for
termination and whether or not later found to be invalid or in breach of your employment agreement, if
any, or employment laws in the jurisdiction where you are employed. The Committee has exclusive
discretion to decide when you are considered to be no longer actively providing services for the purposes
of your Award. However, you will not be considered to be actively providing services during any
contractual notice period or any period of “garden leave” or similar period mandated under employment
laws in the jurisdiction where you are employed or in your employment agreement, if any, unless the
Committee decides otherwise.
2 This also would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award.
If your employer no longer meets the definition of “Affiliate”, you are deemed to have terminated employment for the purposes of the
Plan.

-- 129 of 161 --

Prohibited Activities Appendix
1. Engaging in Prohibited Activity
1.1 Timing
Section 1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5
(Types of Prohibited Activity) below) at any time during the term of your Award or within one year
after the later of:
1.1.1 the termination of your employment with the Company, your employer or any Affiliate; and
1.1.2 the last date of vesting or exercise of all or any portion of your Award.
1.2 Implications
If this section 1.2 applies:
1.2.1 your Award will immediately terminate, be forfeited and (if relevant) cease to be
exercisable; and
1.2.2 within 10 days after receiving written notice from the Company that this section applies,
you must pay in cash to the Company:
(i) any and all gains associated with any previous vesting or exercise of all or any
portion of your Award; and
(ii) interest calculated from the time of the notice until the date of repayment to the
Company.
2. Implications for settled Awards
2.1 Calculation of gain
For the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any
portion of your Award will be calculated as:
2.1.1 where your Award is in the form of an Option, the closing price per share of Stock on the
date of exercise as reported on the New York Stock Exchange Composite Transactions
listing minus the exercise price per share of Stock, multiplied by the number of shares of
Stock over which the Award was exercised;
2.1.2 where your Award is in the form of Restricted Stock Units or Performance Share Units,
the closing price per share of Stock on the date of vesting as reported on the New York
Stock Exchange Composite Transactions listing, multiplied by the number of shares of
Stock that vested; and
2.1.3 where your Award is in the form of Performance Cash, the gross amount of the cash
payment that vested.

-- 130 of 161 --

3. Alternative payment
3.1 Return of Stock
If all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable
for any reason by any court with jurisdiction:
3.1.1 you will transfer to the Company all of the shares of Stock that you acquired on vesting or
exercise of your Award that you still hold (and if your Award is an Option, the Company
will pay to you the exercise price you paid for that Stock in exchange); and
3.1.2 where you have already sold, transferred or disposed of any shares of Stock you
acquired on vesting or exercise of your Award, you must pay to the Company:
(i) any and all gains associated with each sale, transfer or disposal; and
(ii) interest calculated from the date of each sale, transfer or disposal until the date
of repayment to the Company.
3.2 Calculation of gain
For the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in
each case be calculated as the closing price per share of Stock on the date of the sale, transfer
or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus,
where your Award is an Option, the exercise price per share of Stock), multiplied by the number
of shares of Stock sold, transferred or disposed of.
4. Interest
Any interest payable under this Prohibited Activities Appendix will be calculated using the
weighted prime rate at SunTrust Bank, Atlanta.
5. Types of Prohibited Activity
The term Prohibited Activity includes any and all of the following:
5.2 Disparagement
Making any statement, written or verbal, in any forum or media, or taking any action in
disparagement of the Company, your employer and/or any Affiliate, including but not limited to
negative references to the Company or its products, services, corporate policies, or current or
former officers or employees, customers, suppliers, or business partners or associates.
5.2 Publicity
Publishing any opinion, fact, or material, delivering any lecture or address, participating in the
making of any film, radio broadcast or television transmission, or communicating with any
representative of the media relating to confidential matters regarding the business or affairs of the
Company, your employer and/or any Affiliate which you were involved with during your
employment.

-- 131 of 161 --

5.3 Disclosure of a Trade Secret
Failure to hold in confidence any and all Trade Secrets of the Company that came into your
knowledge during your employment with the Company, your employer and/or any Affiliate, or
disclosing, publishing, or making use of, at any time, such Trade Secrets.
For these purposes, Trade Secret means any technical or non-technical data, formula, pattern,
compilation, program, device, method, technique, drawing, process, financial data, financial plan,
product plan, list of actual or potential customers or suppliers or other information similar to any of
the foregoing, which:
5.3.1 derives economic value, actual or potential, from not being generally known to and not
being readily ascertainable by proper means by other persons who can derive economic
value from its disclosure or use; and
5.3.2 is the subject of efforts that are reasonable under the circumstances to maintain its
secrecy.
5.4 Disclosure of Confidential Information
Failure to hold in confidence all Confidential Information of the Company, your employer and/or
any Affiliate that came into your knowledge during your employment with the Company, your
employer or any Affiliate, or disclosing, publishing, or making use of such Confidential
Information.
For these purposes, Confidential Information means any data or information, other than Trade
Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)), that is valuable to the
Company and not generally known to the public or to competitors of the Company.
5.5 Failing to return materials
Your failure, in the event of your termination of employment for any reason, promptly to deliver to
the Company all memoranda, notes, records, manuals or other documents, including all copies of
such materials and all documentation prepared or produced in connection therewith, containing
Trade Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential
Information (as defined in section 5.4 (Disclosure of Confidential Information)) regarding the
Company’s business, whether made or compiled by you or furnished to you by virtue of your
employment with the Company, your employer or any Affiliate, or failure promptly to deliver to the
Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office
equipment, and other property furnished to you by virtue of your employment with the Company,
your employer or any Affiliate.
5.6 Competing
Rendering services for any organization which, or engaging directly or indirectly in any business
which, in the sole judgment of the Committee or the Chief Executive Officer of the Company or
any senior officer designated by the Committee, is or becomes competitive with the Company.
Notwithstanding the preceding sentence, this Section 5.6 will not be applicable for any employee
living or working in California.

-- 132 of 161 --

5.7 Solicitation
Soliciting or attempting to solicit for employment, for or on behalf of any corporation, partnership,
or other business entity, any employee of the Company, your employer or an Affiliate with whom
you had professional interaction during the last twelve months of your employment with the
Company, your employer or the Affiliate.
5.8 Violation of Company policies
Violating any written policies of the Company or your employer applicable to you, including,
without limitation, The Coca-Cola Company Global Insider Trading Compliance Policy.
6. Release
You may be released from the effects of this Prohibited Activities Appendix if the Committee
determines in its sole discretion that such action is in the best interest of the Company and its
stockholders.
7. Other rights apply
Nothing in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or
otherwise limiting the Company’s right under applicable state or local law or any prior agreement
you have signed or made with the Company regarding trade secrets, confidential information, or
intellectual property.

-- 133 of 161 --

Data Privacy Appendix
1. General
1.1 Introduction
This Data Privacy Appendix sets out certain data privacy provisions that apply to you in
connection with your Award.
1.2 Meaning of Data
For the purposes of this Data Privacy Appendix, Data means personal information that directly or
indirectly identifies you, including: your name, home address and telephone number, your date of
birth, your government identification number, your salary information, nationality, job title and
employment location, any shares or directorships you hold or held in the Company or any Affiliate,
details of your Award and any equity or cash awards or any other entitlements to stock or cash
granted (regardless of whether or not exercised, vested or settled, and including any cancelled or
forfeited awards), any information necessary to process your Award or any other award (e.g. your
mailing address for a check payment or bank account wire transfer information), any other
information necessary to process mandatory tax withholding and reporting and/or, where
applicable, your employment or service termination date and the reason for the termination.
2. For Award recipients not located in the EEA or UK
This section applies if you reside anywhere in the world except the European Economic Area
(EEA) or the United Kingdom (UK). By accepting your Award, you confirm the following:
2.1 Consent
You voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data
by and between the Company, your employer or any Affiliate for the purpose of implementing,
administering, and managing your participation in the Plan.
2.2 Data collected
You understand that the Company and its Affiliates may hold Data for the exclusive purpose of
implementing, administering, and managing the Plan.
2.3 Purposes of collection
You understand that Data will be transferred to one or more stock or incentive plan service
providers selected by the Company, which may assist the Company with the implementation,
administration, and/or management of the Plan.
2.4 Recipients of Data
You understand that the recipients of Data may be located in the United States or elsewhere. The
Company also uses third party service providers who may assist with the implementation,
administration or management of the Plan. These service providers are bound by contract to
handle Data in a way that aligns with this Data Privacy Appendix and applicable law. If you have

-- 134 of 161 --

any questions about the local entities or services providers who may access or handle your Data,
please contact your local human resources representative.
By consenting at section 2.1 (Consent) above, you authorize the Company and any other
possible recipients that do or may assist the Company with implementing, administering or
managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other
form, for the sole purpose of implementing, administering and/or managing your participation in
the Plan.
2.5 Data retention
You understand that Data will be held only as long as is necessary to implement, administer and
manage your participation in the Plan. In some cases, your information will be retained for the
Company or your employer to comply with a legal or tax obligation.
2.6 Your rights
You understand that if you reside in certain jurisdictions, to the extent required by applicable laws,
you may, at any time and without cost:
2.6.1 request access to Data;
2.6.2 request additional information about the storage and processing of Data;
2.6.3 require any necessary amendments to Data; or
2.6.4 refuse or withdraw the consents you give by accepting the Award,
by contacting your local human resources representative in writing.
2.7 Implications of not consenting or withdrawing consent
You understand that you provide these consents on a purely voluntary basis. If you do not
consent, or if you later withdraw your consent, your employment or service contract with the
Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will
mean that the Company will not be able to grant new awards or administer or maintain any
existing awards (including this Award) under the Plan. You understand that refusing or
withdrawing your consent may affect your ability to participate in the Plan (including the right to
retain an award, such as this Award). You understand that you may contact a local human
resources representative for more information on the consequences of refusal to consent or
withdrawal of consent.
3. For Award recipients located in the EEA and/or UK
This section applies if you reside inside the United Kingdom (UK) and/or the European Economic
Area (EEA). By accepting your Award, you confirm the following:
3.1 Data collected
You understand that the your employer (acting as controller) and the Company may collect, to the
extent permissible under applicable law, Data for the exclusive purpose of implementing,
administering, and managing the Plan. The Data is collected from you, the employer, and the

-- 135 of 161 --

Company for the exclusive purpose of implementing, administering, and managing the Plan in
accordance with the terms of your Award.
3.2 Purposes of collection/processing
You acknowledge the legal basis for Data processing is performance of the contract comprising
your Award. The Data must be provided in order for you to participate in the Plan and for the
parties to your Award to perform their respective obligations as set out in your Award documents.
If you do not provide Data, you will not be able to participate in the Plan or continue to hold your
Award.
3.3 Transfers and retention of Data
You understand that your employer will transfer Data to the Company for Plan administration
purposes. The Company and your employer may also transfer your Data to other service
providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by
the Company now or in the future, to assist the Company and your employer with the
implementation, administration and/or management of your Award. You understand that recipients
of the Data may be located in a country that does not benefit from an adequacy decision issued
by the European Commission. When your information is transferred outside the EEA or the UK
(as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please
contact privacy@coca-cola.com. Your Data will be held only as long as is necessary to
implement, administer and manage your rights and obligations under the terms of your Award
documents, as well as in compliance with other laws requiring a longer retention period.
3.4 Accuracy
You understand the Company and your employer will take steps in accordance with applicable
legislation to keep Data accurate, complete and up to date.
3.5 Your rights
You understand you are entitled to:
3.5.1 have any inadequate, incomplete or incorrect Data corrected;
3.5.2 request access to your Data and additional information about the processing of that Data;
3.5.3 object to the processing of Data or have your Data erased, under certain circumstances;
and
3.5.4 subject to applicable law:
(i) restrict the processing of your Data so that it is stored but not actively processed
(e.g. while the Company assesses whether you are entitled to have Data
erased); and
(ii) receive a copy of the Data provided in connection with your Award or generated
by you, in a common machine-readable format,
and you may exercise these rights by contacting a local human resources representative.

-- 136 of 161 --

3.6 Other contacts
You understand you have the right to contact, and may lodge a complaint with, the relevant data
protection supervisory authority.
You may also contact the EU Data Protection Officer:
Coca-Cola Italia s.r.l.
Viale Edison 110
Building B
20099 Sesto San Giovanni (Milan)
Italy
DPO-Europe@coca-cola.com
4. Country specific provisions
The provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of
this Data Privacy Appendix. By accepting your Award, you confirm the following:
4.1 If you are subject to the laws of Canada
You authorize the Company, your employer, and your employer’s representatives to discuss with
and obtain all relevant information from all personnel (professional or not) involved in the
administration and operation of the Plan. You authorize your employer, the Company, any
Affiliates and any stock or incentive plan service provider that may be selected by the Company
to assist with the Plan to disclose and discuss the Plan with their respective advisors. You further
authorize your employer, the Company and any Affiliates to record this information and to keep it
in your employee file.
4.2 If you are subject to the laws of Russia
You acknowledge that you have read, understood and agree to the terms regarding the collection,
processing and transfer of data described in section 2 (For Award recipients not located in the
EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you
agree to provide an executed data privacy consent form or any similar agreements or consents
that the Company or your employer may deem necessary to obtain under the data privacy laws in
Russia, either now or in the future. You understand that you will not be able to participate in the
Plan if you fail to execute any such consent or agreement that may be requested.

-- 137 of 161 --

Awards made under
The Coca-Cola Company 2024 Equity Plan
Additional Terms
By accepting your Award you:
1. Plan Documents
Agree that you have been given all relevant information and materials regarding the terms and
conditions of your Award, which are set out in the rules of The Coca-Cola Company 2024 Equity
Plan, as amended from time to time (the Plan), your Award Notification (including any appendices
attached to it) and these Additional Terms (including the Global Appendix set out below)
(collectively, the Plan Documents).
2. Employment
2.1 Acknowledge that the grant of your Award does not form part of and does not affect or change
your employment contract or your employment relationship with your employer (which is entirely
separate from the Plan). The grant of your Award and your participation in the Plan does not
create a right to employment or continued service and will not be interpreted as forming an
employment or service contract with The Coca-Cola Company (the Company), your employer or
any Affiliate (as defined in the Plan). The Award does not impact the ability of the Company, your
employer or any Affiliate to terminate that employment or service relationship. All benefits granted
by your Award will constitute an occasional extraordinary payment and may not, in any way or for
any purpose, be considered part of your normal remuneration or constitute consideration for any
services you provide to the Company, your employer or any Affiliate, including when calculating
any other benefits.
2.2 Acknowledge that the Company’s decision to grant your Award is voluntary and discretionary, and
that you have no right to participate in the Plan. Acceptance of your Award and participation in the
Plan does not create any right to, or expectation of, future employment or service, future
participation in the Plan or the grant of future awards (on the same basis, or at all). The Company
may at any time decide to cease offering awards under the Plan, or amend, modify, suspend,
cancel or terminate the Plan and any benefits under it.
2.3 Acknowledge that you are not entitled to the exercise of any discretion under the Plan in your
favor, that decisions with respect to your Award and any future awards are at the sole discretion
of the Company and are final, binding and conclusive, and that you do not have any claim or right
of action in respect of any decision, omission, or discretion, which may in each case operate to
your disadvantage.
2.4 Agree, in consideration for and as a condition of your Award, to waive all rights which might arise
in connection with the Plan, including:
2.4.1 the right to institute any claim against the Company, your employer or any Affiliate; and
2.4.2 the right to pursue any claim that is allowed by a court,
other than the right to acquire, as relevant, $0.25 par value shares of common stock of the
Company (Stock) or cash (subject to and in accordance with the Plan).

-- 138 of 161 --

2.5 Acknowledge that you do not have any right to compensation or damages for any loss (actual or
potential) in relation to the Plan or your Award, including where it is forfeited on termination of
employment or cessation of services for any reason, whether or not lawful or in breach of
employment laws or the terms of your employment or service agreement, if any.
3. No transfer
Accept that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your
Award or any rights in respect of it, whether voluntarily or involuntarily (other than to your
personal representatives on death).
4. Modifications and additional requirements
4.1 Agree that the Company may modify any of the terms of your Award to be consistent with any
applicable law or applicable government agency regulation where, in the opinion of the Company,
that term might otherwise conflict or be inconsistent.
4.2 Agree that the Company may impose additional conditions, requirements and restrictions on your
Award, your participation in the Plan and any Stock or cash you acquire on vesting or exercise of
your Award, and that you will comply with them, including signing any additional agreements or
undertakings.
4.3 Agree to any amendment made to the Plan or any term of your Award (including an amendment
with retroactive effect) where the amendment is necessary or advisable to ensure the Plan or
your Award complies with any future law relating to plans of this nature or their administration
(including Section 409A of the U.S. Internal Revenue Code of 1986, as amended).
4.4 Agree to any amendment made to any of the terms of your Award (including rescinding your
Award entirely) to correct any error that occurred in connection with the grant or documentation of
your Award.
4.5 Acknowledge that your Award may be adjusted to reflect a change in capital structure, in
accordance with the terms of the Plan, and agree that, where your Award is over Stock and an
adjustment results in a fractional share, the fractional share may be disregarded at the
Company’s discretion.
5. Tax
5.1 Acknowledge that participating in the Plan will probably have tax consequences for you and that
all payments made with respect to your Award (including payments in Stock or cash) may be
subject to tax, social security and any similar charges in any country where you are employed,
reside, or are otherwise subject to tax (Tax).
5.2 Agree that you (or your personal representative) are ultimately responsible for and will bear any
liability for any Tax in respect of your Award and your participation in the Plan, and understand
that this liability may exceed any amounts withheld and paid on your behalf.
5.3 Acknowledge that the Company, your employer, an Affiliate, any trustee of any employee benefit
trust and any third party service provider (each, a Withholding Person) is entitled to do any, all
or a combination of the following methods (where relevant) to enable a Withholding Person to
raise an amount it considers necessary or desirable to recover the Liabilities:

-- 139 of 161 --

5.3.1 sell or procure the sale on your behalf of a sufficient number of the Stock you acquire on
vesting or exercise of your Award;
5.3.2 reduce the number of Stock you acquire on vesting or exercise of your Award accordingly
and settle the balance in cash; and
5.3.3 withhold amounts from:
(i) proceeds of sale under section 5.3.1;
(ii) the balance settled in cash under section 5.3.2; and
(iii) any other cash payments of any kind owed to you.
For these purposes, Liabilities means any obligation on the Withholding Person to pay or
account for Tax, any unpaid exercise price, any associated costs (including under section 7
(Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any
obligation of any nature whatsoever (including under a loan, the Company’s tax equalization
program or any travel or expenses policy) to the extent that the Company, the employer or any
Affiliate in its reasonable judgement determines you owe them that amount.
5.4 Agree that, for tax purposes, and where allowed by applicable law, you are deemed to have
received the full number of Stock where the number of Stock you acquire is reduced under
section 5.3.2.
5.5 Agree that, where permitted by the Company, you may elect to satisfy Tax and/or pay any
exercise price by delivering (including by attestation) Stock to the Company.
5.6 Agree that if a Withholding Person’s obligation to pay or account for Tax cannot or has not been
fully satisfied by the above methods, you must pay to the Withholding Person an amount
sufficient to enable them to discharge that obligation.
5.7 Agree to enter any tax elections for particular tax and/or social security treatment, execute any
documents, give any directions and take any action as may be requested by the Company, your
employer or any Affiliate in relation to any Liabilities.
5.8 Acknowledge that the Company, your employer and any Affiliate do not guarantee or warrant any
particular Tax treatment in relation to your Award, the cash or Stock you acquire in connection
with your Award (including any dividends on Stock), or your participation in the Plan and that they
are not under any obligation to structure the Award in a Tax favorable way or avoid adverse Tax
treatment in any jurisdiction.
5.9 Acknowledge that neither the Company, your employer nor any Affiliate will be liable for any Tax,
interest, penalties or other amounts owed by any taxpayer as a consequence of the Plan or an
Award and that any Tax information provided is for guidance purposes only.
5.10 Accept that the cash or Stock subject to your Award may only vest or be exercised (as applicable)
if satisfactory arrangements are in place to enable all Withholding Persons to obtain the funds
needed to satisfy any Liabilities.
5.11 Acknowledge that the vested (and, if applicable, exercised) Stock or cash subject to your Award
may not be delivered or paid to you unless you have complied with your obligation to pay the
Liabilities.

-- 140 of 161 --

6. Internationally mobile employees
6.1 Acknowledge that if you are a mobile employee, meaning that you are based in different
jurisdictions during the course of your employment or service that you are or may be subject to
Tax in more than one country, you are strongly encouraged to inform the Company and your
employer, and to speak with your personal tax adviser regarding the tax treatment of your
participation in the Plan.
6.2 Accept that, if you are a mobile employee, the Company or your employer may be required to
withhold for Tax in more than one jurisdiction.
6.3 Accept that if you are a “Global Mobility Associate” as defined in the Company’s Global Mobility
Policy (or the equivalent under any applicable international service policy from time to time), you
remain responsible for all Tax except where expressly stated otherwise in that policy and/or the
Company’s tax equalization program. A copy of the Company’s Global Mobility Policy is available
on the Company’s intranet.
7. Costs
Agree that you are responsible for the payment of any fees, dealing, commission or currency
conversion costs or any other costs associated with your Award, including costs associated with
the payment of any cash and the sale of any Stock.
8. Notices
8.1 Agree that any notice or other communication required in relation to your Award will be given in
writing, which may include electronic means.
8.2 Agree that any notice or other communication to be given to you in connection with your Award
may be delivered by electronic means (including by email, or through the Company or your
employer’s intranet or a share plan portal), personally delivered, or sent by ordinary post to the
principal address on file for you from time to time with the Company, your employer, an Affiliate or
the Company’s agents.
8.3 Agree that any notice or other communication to be given to the Company or its agents in
connection with your Award may be delivered or sent to its registered office or to such other place
and by such means as communicated to you by or on behalf of the Company from time to time.
8.4 Accept that notices or other communications:
8.4.1 sent electronically will be deemed to have been received immediately (if sent
during usual business hours) or at the opening of business on the next business
day (if sent outside usual business hours);
8.4.2 that are personally delivered will be deemed to have been received when left at the
relevant address (if left during usual business hours) or at the opening of business
on the next business day (if left outside usual business hours); and
8.4.3 sent by post will be deemed to have been received 24 hours after posting to a U.S.
address or 3 days after posting to an address outside the U.S.,
unless there is evidence to the contrary.

-- 141 of 161 --

8.5 Agree that all notices or communications to be given to you are given and sent at your risk and
that neither the Company, your employer nor any Affiliate has any liability in respect of any notice
or communication given or sent, nor need they be concerned to see that you actually receive it.
9. Insider trading and market abuse
9.1 Acknowledge that rules on insider trading, dealing notification requirements, and market abuse
laws may apply in relation to any actions or decisions taken relating to your Award, including in
relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment
of any Stock or cash, and the sale of any Stock. These rules, requirements and laws:
9.1.1 are separate from and in addition to the requirements that apply to you under The
Coca-Cola Company Global Insider Trading Compliance Policy; and
9.1.2 may prohibit or delay your actions or decisions.
9.2 Agree that it is your responsibility to comply with the rules, requirements and laws referred to in
section 9.1. You should consult with your personal legal adviser on these matters.
10. Currency risk
10.1 Acknowledge that if any Stock relating to your Award is traded in a currency that is not the
currency in your jurisdiction, the value of the Stock may also be affected by movements in the
exchange rate.
10.2 Agree that neither the Company, your employer nor any Affiliate is liable for any loss due to
movements in the exchange rate nor any charges imposed in relation to the conversion or
transfer of money.
11. No advice
11.1 Confirm you are accepting your Award and participating in the Plan voluntarily and understand
that the Company is not making any recommendations regarding your Award or any Stock or
cash relating to your Award.
11.2 Agree that neither the Company, your employer, any Affiliate nor any person or entity acting on
their behalf has provided you with any legal, investment, tax (including reporting) or financial
advice with respect to your participation in the Plan, your Award or any Stock or cash acquired
upon vesting or exercise of your Award. You should consult with your own suitably qualified
advisers before taking any action under the Plan.
11.3 Acknowledge that the information and materials provided do not take into account your
objectives, financial situation or needs and that if you do not understand the contents of the Plan
Documents, or you are in any doubt, you should consult an independent authorized financial
adviser.
11.4 Agree you will have no remedies for any statement, representation, assurance or warranty that is
not set out in your Plan Documents.
12. No guarantee
12.1 Acknowledge that neither the Company, your employer nor any Affiliate guarantees a specified
level of return in respect of your Award or any Stock.

-- 142 of 161 --

12.2 Acknowledge that there is a risk that any Stock relating to your Award may fall as well as rise in
value, that the future value of Stock cannot be predicted with certainty and that market forces will
impact the price of any Stock relating to your Award and, in the worst case, the market value of
the Stock may become zero. More information in relation to the Company, including its share
price, can be found at https://www.coca-colacompany.com/.
13. No public offer
13.1 Acknowledge that your Award is being offered to you in your capacity as an employee of the
Company’s group and that the offer is not intended for the general public and may not be used for
any public offer.
13.2 Acknowledge that the Company is not required to deliver any Stock or cash on settlement of your
Award before it completes, on terms to its satisfaction, any registration, listing, exemption or
qualification or other legal requirements or obtains any clearance or approval that the Company
considers is necessary or desirable, and you agree to provide any information, make any
agreements and give any representations that the Company requests as part of this process.
13.3 Agree that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse to
deliver any Stock or cash where the Company considers the delivery of Stock or cash may
conflict or be inconsistent with applicable law or applicable government agency regulation.
13.4 Acknowledge that neither the Company, your employer nor any Affiliate is under any obligation to
register, exempt or qualify, or seek clearance or approval for, your Award or any Stock or cash
that you may acquire in connection with your Award.
13.5 Acknowledge that your Award may not have been authorized or approved by any applicable
securities authorities and may have been offered pursuant to an exemption from registration in
your local jurisdiction.
13.6 Acknowledge that the regulatory bodies in your jurisdiction accept no responsibility for the
accuracy and completeness of the statements and information contained in the Plan Documents
and take no liability whatsoever for any loss arising from reliance upon the whole or any part of
the contents of those documents.
13.7 Acknowledge that a prospectus or similar offering or registration document may not have been
prepared, authorized or approved by any applicable authority in any jurisdiction outside the
United States.
14. Exchange controls and any reporting requirements
14.1 Accept that exchange control regulations and/or foreign asset reporting requirements may apply
to you in respect of your Award and/or any Stock or cash acquired in connection with your Award,
and that you are solely responsible for complying with those regulations and requirements.
14.2 Agree that neither the Company, your employer nor any Affiliate are responsible for obtaining
exchange control approval or making any reports on your behalf, nor for monitoring compliance
with those regulations and requirements and that if you fail to obtain any required exchange
control approval or make the necessary reports, neither the Company, your employer nor any
Affiliate will be liable in any way for any resulting fines or penalties. You should seek independent
professional advice if you are unsure about the obligations that apply to you as a result of your
participation in the Plan.

-- 143 of 161 --

14.3 Accept that you are solely responsible for complying with any filing, notification or reporting
requirements in respect of:
14.3.1 your participation in the Plan and/or
14.3.2 benefits received under the Plan,
as required by the local law in any jurisdiction. The Company accepts no responsibility for your
failure or delay in complying with such requirements. If you are in any doubt as to what actions
you should take, you should consult a duly authorized independent adviser.
15. General
15.1 Consent to the use of electronic communications in connection with the Plan.
15.2 Confirm that references to “employer” throughout these Additional Terms include your former
employer, where applicable.
15.3 Agree that all determinations and decisions on questions of interpretation in respect of your
Award and the Plan Documents will be made by the Company (or any committee on its behalf) in
its sole and absolute discretion. Those determinations and decisions will be final, binding and
conclusive. Any references to determinations or decisions made, or actions taken, by the
“Company” as referred to in these Additional Terms include any committee acting on its behalf.
15.4 Agree that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable
for any reason by any court in any jurisdiction then, for the purposes of that jurisdiction only:
15.4.1 such provision will be deleted; and
15.4.1 the remaining provisions will continue in full force and effect.
15.5 Agree that if the Company waives a breach of one or more provisions in the Plan Documents, this
does not constitute a waiver of any other provision of the Plan Documents, or a waiver of any
subsequent breach of the Plan Documents (by you or anyone else).
15.6 Accept that:
15.6.1 the federal laws of the United States of America and the state laws of the State of
Delaware, United States of America, govern your Plan Documents and your Award
without regard to the conflict of law provisions; and
15.6.2 the courts of the United States District Court for the District of Delaware or the Delaware
Superior Court, New Castle County have exclusive jurisdiction in respect of disputes
arising under or in connection with the Plan or your Award,
and you waive any current or future objection you may have to this choice of law and jurisdiction.
16. English language (this applies if you have received an English language version
only of any Plan Document)
16.1 Accept that you fully understand the contents of the English language version of the Plan
Documents.

-- 144 of 161 --

16.2 Acknowledge that you do not need a translation of the Plan Documents and that you are fluent
and regularly conduct business in the English language as part of your duties and responsibilities
to your employer.
17. Translations (this applies if you have received a Plan Document in a language
other than English)
17.1 Agree that if there is any conflict between the terms of the English language version of the Plan
Documents and a version in any other language, the English language version will prevail.
18. Options (this applies if your Award Notification specifies that your Award is an
Option)
18.1 Understand that, in order to exercise your Award, you will need to pay the exercise price.
18.2 Acknowledge that you will be informed of the acceptable forms and methods of paying the
exercise price when you come to exercise your Award.
19. Restricted resale (this applies if your Award is over Stock)
Acknowledge that any Stock you may acquire upon settlement of your Award may be subject to
restrictions on transfer and resale in your local jurisdiction and you agree that you will comply with
those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or
cause any of these to occur) in circumstances which constitute any type of public offering of
securities, unless an exemption applies.
20. Performance conditions (this applies if your Award Notification specifies that your
Award is subject to performance conditions)
20.1 Accept that the vesting of your Award is conditional on the satisfaction of one or more
performance conditions as set out in the Performance Criteria Appendix to your Award Notification
(the Performance Criteria) and, to the extent the Performance Criteria are not satisfied, your
Award may be forfeited.
20.2 Accept that the Performance Criteria may be altered in the circumstances specified in Section
10.2 of the Plan.
21. Malus and clawback (this applies if your Award Notification specifies that your
Award is subject to “Malus and clawback”)
21.1 Agree that any benefits you may receive with respect to your Award will be subject to reduction,
cancellation, repayment, forfeiture or recoupment if there is a determination that the vesting of, or
amount realized from, your Award was based on:
21.1.1 materially inaccurate financial statements; or
21.1.2 any other materially inaccurate performance metric criteria,
and you acknowledge that this applies regardless of whether you caused or contributed to the
material inaccuracy.
21.2 Agree that the Company may also seek to recover your Award where required by the provisions
of the Dodd-Frank Wall Street Reform and Consumer Protection Act or any other “clawback”

-- 145 of 161 --

provision required by applicable law, regulation or listing standards, including the listing standards
of the New York Stock Exchange, and you authorize such recovery.
22. Stock ownership guidelines (this only applies if you are subject to the Company’s
stock ownership guidelines)
22.1 Accept that if you have not met the Company’s stock ownership guidelines before the applicable
compliance deadline but you are a “Section 16 officer” under the U.S. Securities Exchange Act of
1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of
your Award until you meet the relevant guidelines, except for any Stock that is sold or cash settled
to cover Tax and any exercise price.
22.2 Accept that if you have not met the guidelines by the applicable compliance deadline, you are
prohibited at all times after that compliance deadline from selling any Stock you obtain on vesting
or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax,
commissions and fees and any exercise price. Once you meet the guidelines, you can sell Stock
in excess of the guidelines.

-- 146 of 161 --

Global Appendix – Equity Awards3
1. If you are subject to the laws of the European Union
This offer is being made to selected employees as part of an employee incentive program in order
to provide an additional incentive and to encourage employee share ownership and to increase
your interest in the success of the Company. The company offering these rights is The Coca-Cola
Company. The Stock which is the subject of these rights is new or existing par value common stock
in the Company. More information in relation to the Company including the stock price can be found
at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU
Prospectus Regulation. The total maximum number of Stock which is the subject of this offer is
240,000,000.
2. If you are subject to the laws of Argentina
Neither the Award nor the underlying Stock are publicly offered or listed on any stock exchange in
Argentina.
This provision applies if your Award Notification specifies that your Award is an Option:
Depending upon the method of exercise chosen for the Option, you may be subject to
restrictions with respect to the purchase and/or remittance of U.S. dollars pursuant to Argentine
currency exchange regulations. The Company reserves the right to restrict the methods of
exercise if required or advisable to comply with Argentine laws.
3. If you are subject to the laws of Australia
The grant of Awards under the Plan is intended to comply with the provisions of the Corporations
Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000. Additional details are set
forth in the Australia Offer Document, which is available on the Morgan Stanley at Work® website.
The offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax
Assessment Act 1997(Cth). The conditions to receive such treatment are contained in the Award
Agreement.
4. If you are subject to the laws of Belgium
If your Award Notification specifies that your Award is an Option, you confirm you have read and
understood the information regarding the Belgian taxation of Options which has been separately
made available to you by email and/or on the Morgan Stanley at Work® website. You should review
this information thoroughly before accepting your Option grant.
__________________________
3. If your are subject to the laws of any of the following countries, there are no country-specific provisions for your country in this
appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador, Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico,
Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.

-- 147 of 161 --

5. If you are subject to the laws of Brazil
By accepting the Award, you agree that you are (i) making an investment decision, and (ii) the
value of the underlying Stock is not fixed and may increase or decrease in value over the vesting or
exercise period without compensation to you.
6. If you are subject to the laws of Canada
For purposes of your Award, your employment will be considered terminated and your right (if any)
to vest in any Award or exercise any Option after such termination (regardless of the reason for
such termination and whether or not later found to be invalid, unlawful or in breach of the
employment laws in the jurisdiction where you are employed or the terms of your employment
agreement, if any) will be measured as of the earlier of: (a) the date your employment with the
Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date
you receive written notice of termination from the Company or a Subsidiary or Affiliate, regardless of
any notice period or period of pay in lieu of such notice mandated under the employment laws in
the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c)
the date you are no longer employed by the Company or any of its Subsidiaries or Affiliates. You will
not be entitled to a pro-rata portion of the Award for any time before the date on which your right to
vest terminates, nor will you be entitled to any compensation for lost vesting. In the event the date
on which you are no longer actively providing services cannot be reasonably determined under the
terms of your Award, the Company, in its sole discretion, shall determine when you are no longer
employed for purposes of the Award (including whether you may still be considered employed or
actively providing services while on a leave of absence).
Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires
continued entitlement to vesting during a statutory notice period, your right to vest in the Award
under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice
period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end
of your statutory notice period, nor will you be entitled to any compensation for lost vesting.
In addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired
pursuant to the Plan will be subject to certain restrictions on resale imposed by Canadian provincial
securities laws (in general, you may not resell your Stock to Canadian purchasers). Accordingly,
you are encouraged to seek legal advice prior to any resale of the Stock.
Furthermore, notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards
granted to Canadian residents shall only be settled in Stock and shall not be settled in cash.
The following terms and conditions apply if you are resident in Quebec:
You agree that you wish the Plan Documents to be drawn up in English.
Vous confirmez que vous souhaitiez que les Documents du Plan soient rédigés en anglais
7. If you are subject to the laws of Chile
Neither the Company, the Plan nor the Stock have been registered in the Registro de Valores
(Securities Registry) or in the Registro de Valores Extranjeros (Foreign Securities Registry) of the

-- 148 of 161 --

Comisión para el Mercado Financiero de Chile (Chilean Commission for the Financial market or
CMF) and they are not subject to the control of the CMF. The Plan is governed by General
Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to
deliver public information regarding the Stock in Chile. Shares of Stock cannot be publicly offered in
Chile unless they are registered with the CMF.
Ni The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de
Valores o en el Registro de Valores Extranjeros que lleva la Comisión para el Mercado
Financiero de Chile (CMF) y ninguno de ellos está sujeto a la fiscalización de la CMF. Esta
oferta de Acciones se acoge a la Norma de Carácter General 336. Por tratarse de valores no
inscritos, el emisor de las Acciones no tiene obligación bajo la ley chilena de entregar en Chile
información pública acerca de las Acciones. Las Acciones no pueden ser ofrecidas
públicamente en Chile en tanto éstas no se inscriban en el Registro de Valores
correspondiente.
8. If you are subject to exchange control restrictions imposed by the China State
Administration of Foreign Exchange (SAFE), as determined by the Company in its
sole discretion
Notwithstanding any other provision in the Plan Documents, the following provisions apply in the
event of the termination of your employment (as interpreted in accordance with the Employment
Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your
Disability, or (2) after attaining age 55:
Awards that are Options and Awards held at least 12 months will immediately vest and will be
settled in cash. The cash amount will be determined based on the closing price of the Stock on
the date of your termination of employment (or, if a non-trading day, the next trading day) or the
exercise of your Option (if applicable) within the post-termination exercise period stated below.
Awards that are not Options and that are held less than 12 months from the date of grant are
forfeited.
Where Performance Criteria apply, the Performance Criteria will be measured over a shortened
performance period, ending at the end of the year prior to your termination of employment.
If your Award is an Option, the period over which you may exercise your Option expires upon
earlier of (1) six months from your termination of employment or (2) the Option expiration date
provided in the Plan Documents.
The Company has the discretion to arrange for the sale of any Stock issued upon settlement of
your Award, either immediately upon settlement or at any time thereafter. In any event, if you
terminate employment, you will be required to sell all Stock acquired upon settlement of the Award
within such time period as required by the Company in accordance with SAFE requirements. Any
Stock remaining in your brokerage account at the end of this period shall be sold by the broker (on
your behalf pursuant to this authorization and without further consent). In addition, any Award that
has not vested by the end of this period will then immediately be forfeited. The Company shall have
the exclusive discretion to determine when your employment has been terminated for the purposes
of the Award.

-- 149 of 161 --

You agree to sign any additional agreements, forms and/or consents that reasonably may be
requested by the Company (or the Company’s designated broker) to effectuate the sale of the
Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange
control matters noted below) and shall otherwise cooperate with the Company with respect to such
matters. You acknowledge that neither the Company nor the designated broker is under any
obligation to arrange for the sale of Stock at any particular price (it being understood that the sale
will occur in the market) and that broker’s fees and similar expenses may be incurred in any such
sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for applicable
taxes, any broker’s fees or commissions, and any similar expenses of the sale will be remitted to
you in accordance with applicable exchange control laws and regulations.
By accepting the Award, you acknowledge that you understand and agree that you are not
permitted to transfer any Stock acquired under the Plan out of your account established with the
Company’s designated broker until the Stock is sold. The limitation applies to all Stock issued to
you under the Plan, whether or not you remained employed with the Company or a Subsidiary.
You understand and agree that you will be required to immediately repatriate to China the
proceeds from the sale of any Stock acquired under the Plan and any such dividends paid on such
shares. You further understand that such repatriation proceeds may need to be effected through a
special bank account established by the Company (or a Subsidiary or Affiliate in China), and you
hereby consent and agree that any sale proceeds and cash dividends may be transferred to such
special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being
delivered to you and that no interest shall be paid with respect to funds held in such account.
The proceeds may be paid to you in U.S. dollars or local currency at the Company’s discretion. If
the proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account in
China must be established and maintained so that the proceeds may be deposited into such
account. If the proceeds are paid to you in local currency, you acknowledge that the Company
(and its Subsidiaries and Affiliates) are under no obligation to secure any particular exchange
conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in
converting the proceeds to local currency due to exchange control restrictions. You agree to bear
any currency fluctuation risk between the time the Stock is sold and the net proceeds are
converted into local currency and distributed to you. You further agree to comply with any other
requirements that may be imposed by the Company in the future in order to facilitate compliance
with exchange control requirements in China.
In addition to the vesting schedule for your Award, settlement of the Award is also conditioned on
the continued effectiveness of the Company’s registration of the Plan with SAFE (the SAFE
Registration Requirement). If or to the extent the Company is unable to maintain the registration,
no Stock for which a registration cannot be maintained shall be issued. In this case, the Company
retains the discretion to settle any Award for which the vesting schedule, but not the SAFE
Registration Requirement, has been met in cash paid through local payroll in an amount equal to
the market value of the Stock subject to the Award less any withholding for applicable taxes.
The Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost
interest or dividends or other losses that you may incur or suffer resulting from the enforcement of
the foregoing terms or otherwise from the Company’s operation and enforcement of the Plan, the

-- 150 of 161 --

Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and
requirements.
9. If you are subject to the laws of Colombia
You acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related
benefits do not constitute a component of “salary” for any legal purpose.
10. If you are subject to the laws of France
By accepting the Award, you confirm that you have read and understood the Plan Documents,
which were provided in English. You accept the terms of those Plan Documents and confirm that
you have a good knowledge of the English language.
En acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs à ce plan
d’incitation à long terme (qui vous ont été fournis en anglais) et que vous acceptez les termes
de ce plan.
11. If you are subject to the laws of Hong Kong
WARNING:
The contents of the Plan Documents have not been reviewed by any regulatory authority in Hong
Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any
of the contents of the Plan Documents, you should obtain independent professional advice.
This offer to receive an Award under the Plan (the Offer) is strictly private and only available to
eligible employees of Coca-Cola China Limited. The Offer has also not been approved by the
Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to
the public or any third-party.
No Awards granted under the Plan may be transferred or assigned, except as expressly permitted
by the Company in writing.
Sale of Stock. Any Stock received at vesting is accepted as a personal investment. In the event that
any portion of this Award vests within six months of the grant date, you agree that you will not offer
to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of the
grant date.
12. If you are subject to the laws of India
You must repatriate to India all funds resulting from the sale of Stock acquired in relation to your
Award within 90 days, and all proceeds from the receipt of any dividends within 180 days. You
should receive a foreign inward remittance certificate (FIRC) from your bank where you deposit the
foreign currency. You should maintain the FIRC as evidence of the repatriation of funds in the event
that the Reserve Bank of India or your employer requests proof of repatriation.

-- 151 of 161 --

13. If you are subject to the laws of Indonesia
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to you
upon request to your local human resources representative. By accepting the grant of the Award,
you (i) confirm having read and understood the documents relating to this grant which were
provided in the English language, (ii) accept the terms of those documents accordingly, and (iii)
agree not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag,
Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when
issued).
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat
disediakan bagi anda berdasarkan permintaan kepada perwakilan sumber daya manusia lokal
anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah
membaca dan mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan
dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-dokumen tersebut, dan (iii)
setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-
Undang No. 24 Tahun 2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu
Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).
14. If you are subject to the laws of Italy
By accepting the grant of the Award, you acknowledge that you have received a copy of the Plan
Documents, you have reviewed the Plan Documents in their entirety and you fully understand and
accept all provisions of the Plan Documents. You further acknowledge that you have read and
expressly approve the following sections of the Additional Terms: section 2 (Employment); section 4
(Modifications and additional requirements); section 5 (Tax); and section 15 (General).
15. If you are subject to the laws of Mexico
By participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed
the Plan in its entirety and fully understand and accept all provisions of the Plan. You further
acknowledge that you have read and expressly approve the terms and conditions set forth in
section 2 (Employment) of the Additional Terms, in which the following is clearly described and
established: (i) your participation in the Plan does not constitute an acquired right; (ii) the Plan and
your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your
participation in the Plan is voluntary; and (iv) the Company and its Subsidiaries (as defined in the
Plan) are not responsible for any decrease in the value of the underlying Stock.
By participating in the Plan, you expressly recognize that The Coca Cola Company, with registered
offices at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA, is solely responsible for the
administration of the Plan and that your participation in the Plan and acquisition of Stock does not
constitute an employment relationship between you and the Company since you are participating in
the Plan on a wholly commercial basis. Based on the foregoing, you expressly recognize that the
Plan and the benefits that you may derive from participation in the Plan do not establish any rights
between you and the Company and do not form part of the employment conditions and/or benefits
provided by the Company and any modification of the Plan or its termination shall not constitute a
change or impairment of the terms and conditions of your employment.

-- 152 of 161 --

You further understand that your participation in the Plan is as a result of a unilateral and
discretionary decision of the Company; therefore, the Company reserves the absolute right to
amend and/or discontinue your participation at any time without any liability to you.
Finally, you hereby declare that you do not reserve any action or right to bring any claim against the
Company for any compensation or damages regarding any provision of the Plan or the benefits
derived under the Plan, and you therefore grant a full and broad release to the Company, its
Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal
representatives with respect to any claim that may arise.
Al participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el
Plan en su totalidad, y que entiende y acepta en su totalidad, todas y cada una de las
disposiciones del Plan. Asimismo reconoce que ha leído y aprueba expresamente los términos
y condiciones señalados en el párrafo titulado Naturaleza de la Oferta en el Convenio, en lo
que claramente se describe y establece lo siguiente: (i) su participación en el Plan no
constituye un derecho adquirido; (ii) el Plan y su participación en el Plan son ofrecidos por la
Compañía sobre una base completamente discrecional; (iii) su participación en el Plan es
voluntaria; y (iv) la Compañía y sus Afiliadas no son responsables de ninguna por la
disminución en el valor de las Acciones subyacentes.
Al participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con
oficinas registradas en One Coca-Cola Plaza, Atlanta, Georgia 30313, Estados Unidos de
América, es la única responsable por la administración del Plan, y que su participación en el
Plan, así como la adquisición de las Acciones, no constituye una relación laboral entre usted y
la Compañía, debido a que usted participa en el plan sobre una base completamente mercantil.
Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que
pudiera obtener por su participación en el Plan, no establecen derecho alguno entre usted y la
Compañía, y no forman parte de las condiciones y/o prestaciones laborales que la Compañía
ofrece, y que las modificaciones al Plan o su terminación, no constituirán un cambio ni
afectarán los términos y condiciones de su relación laboral.
Asimismo usted entiende que su participación en el Plan es el resultado de una decisión
unilateral y discrecional de la Compañía; por lo tanto, la Compañía se reserva el derecho
absoluto de modificar y/o suspender su participación en cualquier momento, sin que usted
incurra en responsabilidad alguna.
Finalmente, usted declara que no se reserva acción o derecho alguno para interponer
reclamación alguna en contra de la Compañía, por concepto de compensación o daños
relacionados con cualquier disposición del Plan o de los beneficios derivados del Plan, y por lo
tanto, usted libera total y ampliamente de toda responsabilidad a la Compañía, a sus Afiliadas,
sucursales, oficinas de representación, sus accionistas, funcionarios, agentes o representantes
legales, con respecto a cualquier reclamación que pudiera surgir.
The Stock underlying your Award has not been registered with the National Register of Securities
maintained by the Mexican Banking and Securities Commission and may not be offered or sold
publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials
are addressed to you only because of your existing relationship with the Company and its
Subsidiaries and may not be reproduced or copied in any form. The offer contained in these

-- 153 of 161 --

materials is addressed solely to the present employees of the Company and its Subsidiaries in
Mexico and any rights under the Plan may not be assigned or transferred. The Stock underlying
your Award will be offered pursuant to a private placement exception under the Mexican Securities
Law.
16. If you are subject to the laws of New Zealand
You are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with
the terms of the Plan Documents. The Stock, if issued, will give you a stake in the ownership of the
Company. You may receive a return if dividends are paid.
If the Company runs into financial difficulties and is wound up, you will be paid only after all
creditors and holders of preference shares (if any) have been paid. You may lose some or all of
your investment, if any.
New Zealand law normally requires people who offer financial products to give information to
investors before they invest. This information is designed to help investors to make an informed
decision. The usual rules do not apply to this offer because it is made under an employee share
scheme. As a result, you may not be given all the information usually required. You will also have
fewer other legal protections for this investment. You are advised to ask questions, read all
documents carefully, and seek independent financial advice before committing.
The Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under
the Plan, you may be able to sell the Stock on the New York Stock Exchange if there are interested
buyers. You may get less than you invested. The price will depend on the demand for the Stock.
For information on risk factors impacting the Company’s business that may affect the value of the
Stock, you should refer to the risk factors discussion on the Company’s Annual Report on Form 10-
K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange
Commission and are available online at www.sec.gov, as well as on the Company’s “Investor
Relations” website at https://investors.coca-colacompany.com/.
17. If you are subject to the laws of Peru
The grant of the Award is considered a private offering in Peru; therefore, it is not subject to registration in
Peru. For more information concerning the offer, please refer to the Plan Documents and any other
materials or documentation made available by the Company. For more information regarding the
Company, please refer to the Company’s Annual Report on Form 10-K and Quarterly Reports on
Form 10-Q, which are filed with the U.S. Securities and Exchange Commission and are available at
www.sec.gov, as well as the Company’s “Investor Relations” website at https://investors.coca-
colacompany.com/.
By accepting the Award, you acknowledge that the Award is being granted ex gratia with the
purpose of rewarding you.
18. If you are subject to the laws of Philippines
The following wording is hereby made a part of the Plan Documents:

-- 154 of 161 --

The securities being offered or sold under the Plan have not been registered with the Philippine
Securities and Exchange Commission under the Philippine Securities Regulation Code. Any
future offer or sale of the securities in the Philippines is subject to registration requirements
under the Securities Regulation Code unless such offer or sale qualifies as an exempt
transaction.
This applies if your Award Notification specifies that your Award is an Option:
Notwithstanding any terms or conditions of the Plan Documents, you acknowledge and agree
that you will be restricted to the cashless sell-all method of exercise. To complete a cashless
sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise
of the Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and
brokerage fees or commissions; and (iii) remit the balance in cash to you. You will not be
permitted to hold the Stock after exercise. Depending on the development of local laws, the
Company reserves the right to modify the methods of exercising the Option and, in its sole
discretion, to permit cash exercise, cashless sell-to cover exercise or any other method of
exercise and payment of Liabilities permitted under the Plan.
19. If you are subject to the laws of Russia
Information contained in the Plan Documents does not constitute an advertisement of any
securities in Russia and must not be passed on to third parties or otherwise be made publicly
available in Russia. The Awards and the Stock to be granted under the Plan have not been and will
not be registered in Russia and are not intended for 'placement' or 'circulation' in Russia.
20. If you are subject to the laws of Singapore
You acknowledge that the Plan Documents have not been registered as a prospectus with the
Monetary Authority of Singapore. Accordingly, the Plan Documents and any other document or
material in connection with the offer or sale, or invitation for subscription or purchase of the Stock
may not be circulated or distributed, nor may the Stock be offered or sold, or be made the subject
of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore
other than pursuant to, and in accordance with the conditions of, an exemption under any provision
(other than Section 280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures
Act, Chapter 289 of Singapore.
The Awards under the Plan are prescribed capital markets products (as defined in the Securities
and Futures (Capital Markets Products) Regulations 2018) and Excluded Investment Products (as
defined in MAS Notices SFA 04-N12 and FAA-N16).
21. If you are subject to the laws of South Africa
By accepting the Award, you agree to immediately notify your employer of the amount of any
income realized upon exercise or vesting of the Award. If you fail to advise your employer of the
income realized upon exercise or vesting of the Award, then you may be liable for a fine. You
personally will be responsible for paying the difference between the actual tax liability and the
amount withheld by the Company or your employer.

-- 155 of 161 --

The documents listed below are available for your review on the Company’s website at https://
investors.coca-colacompany.com/ and the Company’s intranet:
1. The Company’s most recent annual financial statements; and
2. The Company’s most recent Plan prospectus.
A copy of the above-listed documents will be sent to you free of charge on written request to Global
Equity, The Coca-Cola Company, at One Coca-Cola Plaza, Atlanta, Georgia 30313, USA. You
should read these materials carefully before making a decision whether to participate in the Plan.
22. If you are subject to the laws of Spain
By accepting the Award, you acknowledge that you consent to participation in the Plan and have
received a copy of the Plan Documents. Except as otherwise provided in the Plan Documents,
termination of your employment for any reason (including for the reasons listed below) will
automatically result in the forfeiture of any unvested Awards; in particular, you understand and
agree that such Awards will be forfeited without entitlement to the underlying Stock or to any
amount as indemnification in the event of a termination of your employment prior to vesting by
reason of, including, but not limited to, resignation, disciplinary dismissal with or without cause,
individual or collective layoff with or without cause, material modification of employment under
Article 41 of the Worker’s Statute, relocation under Article 40 of the Worker’s Statute, Article 50 of
the Worker’s Statute, Article 10.3 of Royal Decree 1382/1985 and unilateral withdrawal by your
employer.
Furthermore, you understand that the Company has unilaterally, gratuitously, and in its sole
discretion decided to grant Awards under the Plan to individuals who may be employees of the
Company's group throughout the world. The decision is a limited decision that is entered into upon
the express assumption and condition that any grant will not bind the Company or any Subsidiary
(as defined in the Plan) or Affiliate, other than to the extent set forth in the Plan Documents.
Consequently, you understand that the Awards are offered on the assumption and condition that the
Awards and any Stock acquired under the Plan are not part of any employment contract (either with
the Company or any Subsidiary or Affiliate), and shall not be considered a mandatory benefit, salary
for any purposes (including severance compensation), or any other right whatsoever. In addition,
you understand that this offer would not be made but for the assumptions and conditions referred to
above; thus, you acknowledge and freely accept that, should any or all of the assumptions be
mistaken or should any of the conditions not be met for any reason, then any grant of or right to the
Award shall be null and void.
23. If you are subject to the laws of Sweden
The following provision supplements section 5 (Tax) of the Additional Terms:
Without limiting the authority of any Withholding Person to satisfy their withholding obligations
for Tax as set forth in section 5 (Tax) of the Additional Terms, by accepting the grant of the
Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable
to you to satisfy Tax, regardless of whether the Withholding Person has an obligation to
withhold such Tax.

-- 156 of 161 --

24. If you are subject to the laws of Switzerland
The offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a
prospectus under the Swiss Financial Services Act (FinSA) because such offering by the Company
is made exclusively to current or former members of the board of directors, members of the
management board or employees of the Company, the employer and its Affiliates. The Plan
Documents do not constitute a prospectus pursuant to FinSA, and no such prospectus has been or
will be prepared for or in connection with the offering of the Plan.
25. If you are subject to the laws of Turkey
Under Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The
shares are currently traded on the New York Stock Exchange, which is located outside of Turkey,
under the ticker symbol “KO” and the Stock may be sold through this exchange.
You acknowledge that any activity related to investments in foreign securities (e.g. the sale of
Stock) should be conducted through a bank or financial intermediary institution licensed by the
Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You
are solely responsible for complying with this requirement and should consult with a personal legal
advisor for further information regarding any obligations in this respect.
26. If you are subject to the laws of the United Arab Emirates
The Awards are granted under the Plan only to select employees of the Company's group and are
in the nature of providing employee equity incentives in the United Arab Emirates. The Plan
Documents are intended for distribution only to such employees and must not be delivered to, or
relied on by, any other person. Prospective purchasers of the securities offered should conduct
their own due diligence on the securities. If you do not understand the contents of the Plan
Documents, you should consult an authorized financial adviser. The Emirates Securities and
Commodities Authority has no responsibility for reviewing or verifying any documents in connection
with the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic
Development has approved the Plan Documents nor taken steps to verify the information set out
herein, and has no responsibility for such documents.
27. If you are subject to the laws of the United Kingdom
This offer is being made to selected employees as part of an employee incentive program in order
to provide an additional incentive and to encourage employee share ownership and to increase
your interest in the success of the Company. The company offering these rights is The Coca-Cola
Company. The Stock which is the subject of these rights is new or existing par value common stock
in the Company. More information in relation to the Company including the stock price can be found
at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial
Services and Markets Act 2000 (as amended, supplemented or substituted by any UK legislation
enacted in connection with the UK’s exit from the European Union). The total maximum number of
Stock which is the subject of this offer is 240,000,000.

-- 157 of 161 --

28. If you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or
Vietnam
The Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your
Award. Instead, the Company reserves the right to make a payment to you in cash upon exercise or
vesting of your Award. Any references to the issuance of shares or Stock in any documents related
to the Award shall not be applicable in these circumstances.

-- 158 of 161 --

Exhibit 31.1
CERTIFICATIONS
I, James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, certify that:
1. I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: July 29, 2024
/s/ James Quincey
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of
The Coca-Cola Company

-- 159 of 161 --

Exhibit 31.2
CERTIFICATIONS
I, John Murphy, President and Chief Financial Officer of The Coca-Cola Company, certify that:
1. I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present
in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,
summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: July 29, 2024
/s/ John Murphy
John Murphy
President and Chief Financial Officer of The Coca-Cola Company

-- 160 of 161 --

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of The Coca-Cola Company (“Company”) on Form 10-Q for the period ended June 28,
2024 (“Report”), I, James Quincey, Chairman of the Board of Directors and Chief Executive Officer of the Company and I,
John Murphy, President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
/s/ JAMES QUINCEY
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company
July 29, 2024
/s/ JOHN MURPHY
John Murphy
President and Chief Financial Officer of The Coca-Cola Company
July 29, 2024

-- 161 of 161 --